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Abstract	  Human	   labour	   is	   shown	   to	  be	   an	   inflammatory	  process,	  which	   involves	   a	  marked	  leukocyte	  infiltrate	  into	  myometrium	  during	  labour.	  My	  study	  focused	  on	  the	  role	  of	  chemokines,	  key	  mediators	  of	  leukocyte	  trafficking,	  in	  labour.	  
Previous	  gene	  array	  data	  obtained	  from	  human	  labouring	  myometrium	  showed	  that	  the	  mRNA	  expression	  of	  the	  following	  chemokines	  was	  increased	  in	  term	  labouring	  myometrium,	  CCL2,	  CCL20,	  CXCL1,	  CXCL5,	  CXCL8.	  I	  decided	  to	  focus	  on	  myometrial	  expression	   of	   these	   chemokines	   and	   also	   to	   include	   CCL5,	   another	   important	  chemokine.	   My	   data	   confirmed	   that	   the	   expression	   of	   human	   myometrial	  chemokines	  was	  increased	  in	  labour	  and	  that	  their	  expression	  was	  up	  regulated	  by	  cytokines	   and	   mechanical	   stretch	   via	   NFKB	   and	   MAPK,	   but	   decreased	   by	  prostaglandins	   and	   oxytocin	   via	   PLC.	   I	   also	   studied	   the	   expression	   of	  myometrial	  chemokine	   receptors,	   which	   may	   mediate	   some	   of	   the	   effects	   of	   chemokines	   on	  myometrial	   function	   and/or	   act	   as	   decoys,	   minimising	   the	   effects	   of	   locally	  produced	   chemokines.	   I	   found	   that	   the	   expression	   of	   the	   chemokine	   receptors	  decreased	  with	  the	  onset	  of	  labour,	  mainly	  through	  the	  action	  of	  prostaglandins	  and	  oxytocin.	  	  
I	   then	   used	   the	   established	   model	   of	   LPS-­‐induced	   preterm	   labour	   (PTL)	   in	   the	  mouse	  and	  found	  that	  chemokines	  and	  cytokines	  both	  increased	  in	  the	  myometrium	  and	   placenta.	   CCL2	   is	   consistently	   increased	   with	   human	   labour	   and	   has	   been	  shown	  to	  be	   important	   in	  rodent	  parturition	  too.	   I	   therefore	  studied	  the	   impact	  of	  LPS	   in	   the	   CCR2	   (the	   main	   receptor	   for	   CCL2)	   knockout	   mouse.	   There	   was	   less	  inflammation	  in	  both	  the	  myometrium	  and	  placenta	  and	  a	  better	  pup	  survival	  rate	  in	  the	  CCR2-­‐/-­‐	  mouse.	  However,	   the	  PTL	  was	  not	  delayed,	  suggesting	  that	  CCR2	  is	  not	  essential	  for	  the	  induction	  of	  PTL	  labour	  by	  LPS	  in	  the	  mouse.	  	  
I	  then	  turned	  my	  attention	  to	  CCL20,	  which	  acts	  only	  via	  CCR6.	  It	  is	  known	  to	  drive	  dendritic	  cell	  recruitment	  and	  I	  found	  that	  its	  expression	  was	  increased	  with	  labour,	  while	   that	   of	   its	   receptor	   was	   reduced.	   Functionally,	   I	   found	   that	   CCL20	   up-­‐regulated	   the	  myometrial	   expression	   of	   chemokines.	  Next	   I	   used	   the	   LPS-­‐induced	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preterm	   labour	  model	   in	   the	  mouse	   and	   found	   that	   CCR6	   knockout	   delayed	   LPS-­‐induced	   preterm	   delivery	   and	   improved	   pup	   survival.	   These	   findings	   were	  associated	  with	  much	  lower	   inflammation	  in	  myometrium	  and	  plasma.	  These	  data	  suggest	  that	  CCR6	  could	  be	  a	  therapeutic	  target	  in	  the	  management	  of	  PTL.	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1.1	  Preterm	  delivery	  
For	   much	   of	   the	   20th	   century,	   preterm	   birth,	   defined	   as	   birth	   at	   less	   than	   37	  completed	  weeks	   of	   gestation,	   was	   viewed	   as	   an	   unpredictable	   and	   unpreventable	  fact	  of	   life.	  Preterm	  delivery	  accounts	   for	  up	  to	  70%	  of	  neonatal	  deaths	  and	  75%	  of	  neonatal	   morbidity	   and	   complicates	   between	   5	   and	   11%	   of	   pregnancies	   1.	   The	  neonatal	   morbidity	   associated	   with	   preterm	   delivery	   includes	   cerebral	   palsy,	  blindness,	  deafness,	  respiratory	  illness	  and	  other	  complications	  of	  neonatal	  intensive	  care	   2,3.	   Medical	   efforts	   have	   focused	   on	   ameliorating	   the	   consequences	   of	  prematurity	   rather	   than	   preventing	   its	   occurrence.	   This	   approach	   has	   resulted	   in	  improved	   neonatal	   outcomes,	   but	   rates	   of	   preterm	   delivery	   have	   remained	  unchanged	  or	  even	  increased	  while	  the	  costs	  of	  preterm	  delivery,	  both	  in	  terms	  of	  the	  suffering	  of	  infants	  and	  their	  families	  and	  of	  the	  economic	  burden	  to	  society,	  persist	  4.	  According	   to	   estimates	   by	   the	   World	   Health	   Organization,	   among	   the	   130	   million	  infants	  born	  each	  year	  worldwide,	  8	  million	  die	  before	   reaching	   their	   first	  birthday	  predominantly	   due	   to	   preterm	   birth	   5.	   Prevention	   (of	   preterm	   delivery),	   in	   this	  instance,	  is	  by	  far	  better	  than	  our	  current	  “cures”	  of	  the	  consequences.	  Preterm	   labour	   (PTL)	   is	   the	   most	   important	   cause	   of	   preterm	   delivery.	   Its	  management	  is	  still	  suboptimal,	  with	  prophylactic	  progesterone	  reducing	  the	  risk	  of	  PTL	   by	   40%	   and	   acute	   interventions	   usually	   giving	   sufficient	   time	   for	   steroid	  administration,	   but	   neither	   intervention	   has	   yet	   been	   proven	   to	   improve	   neonatal	  outcome	   6.	   This	   lack	   of	   success	   in	   the	   management	   of	   PTL	   reflects	   our	   limited	  understanding	   of	   the	   mechanisms	   involved	   and	   until	   these	   are	   elucidated	   it	   is	  unlikely	  that	  we	  will	  be	  able	  to	  significantly	  reduce	  the	  burden	  of	  premature	  birth.	  Three	  types	  of	  factors	  may	  contribute	  to	  spontaneous	  preterm	  birth:	  social	  stress	  and	  race,	   infection	   and	   inflammation,	   and	   genetics	   7.	   Current	   concepts	   of	   PTL	   implicate	  infection	  and	  inflammation	  as	  the	  main	  causative	  factors.	  	  
Reduction	  of	  interval	  between	  uterine	  contractions	  was	  considered	  as	  one	  of	  the	  most	  useful	   criteria	   to	   establish	   the	   onset	   of	   labour8.	   The	   question	   of	   what	   triggers	   the	  change	   in	   state	   of	   the	   myometrium	   from	   quiescence	   to	   contractile	   is	   key	   to	   the	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understanding	   of	   the	   onset	   of	   preterm	   and	   term	   labour.	   	   Thus,	   I	   focussed	   on	  myometrium	  in	  this	  thesis.	  	  
1.2	  Inflammatory	  cell	  infiltration	  
Labour	  is	  characterized	  by	  an	  influx	  of	  inflammatory	  cells	  into	  the	  myometrium	  and	  cervix	   9-­‐13.	   Cervical	   ripening,	   which	   usually	   precedes	   the	   onset	   of	   labour,	   has	   been	  compared	   to	   an	   inflammatory	   reaction	   and	   is	   characterized	   by	   an	   accumulation	   of	  leukocytes	  in	  the	  cervical	  stroma	  14;	  unlike	  myometrium,	  this	  effect	  only	  occurs	  prior	  to	   the	   onset	   of	   labour	   at	   term	   and	   no	  more	   of	   infiltrated	   cells	   were	   found	   during	  labour.	   The	   inflammatory	   infiltration	   of	   the	   cervix	   consists	   predominantly	   of	  neutrophils	   and	   macrophages	   9.	   Similar	   inflammatory	   cells	   infiltrate	   the	   placenta,	  maternal	  decidua	  and	  the	  fetal	  membranes	  during	  parturition,	  and	  may	  play	  a	  role	  in	  spontaneous	  rupture	  of	  the	  membranes	  either	  during	  or	  prior	  to	  the	  onset	  of	  labour	  15,16.	  In	  myometrium,	  inflammatory	  leukocytes	  selectively	  invade	  by	  following	  homing	  (chemokines)	   signals	  and	   then	   release	   cytokines,	  which	   stimulate	   the	  expression	  of	  myometrial	   PGs,	   more	   chemokines	   and	   other	   labour	   related	   factors.	   The	  inflammatory	  infiltration	  is	  more	  intense	  in	  lower	  segment	  myometrium	  17.	  However,	  the	  function	  of	  these	  leukocytes	  remains	  unclear.	  It	  is	  known	  that	  they	  were	  from	  the	  local	   circulation	   and	   were	   recruited	   by	   chemotactic	   process	   during	   labour	   and	  induced	   the	   rupture	   of	   fetal	  membranes	   11,18,19.	    Interestingly,	   circulating	   leukocyte	  concentrations	   have	   been	   suggested	   to	   predict	   pregnancy	   outcome	   in	   the	   first	  trimester	  and	  to	  be	  a	  marker	  of	  cervical	  dilation	  in	  later	  pregnancy	  20,21.	  
1.2.1	  T	  cells	  The	   human	   T	   cell	   is	   one	   of	   the	   most	   important	   subpopulations	   of	   leukocytes	   in	  pregnant	  uterus	  22-­‐24.	  There	  are	  only	  6-­‐30%	  of	  the	  decidual	  T	  cells	  that	  will	  eventually	  take	   up	   residence	  presenting	  during	   the	   transformation	   of	   the	   endometrium	   in	   the	  first	  trimester	  of	  human	  pregnancy25-­‐27.	  This	  low	  number	  of	  T	  cells	  in	  early	  pregnancy	  suggests	   that	  T	   cells	  may	  not	  be	   critical	   in	   the	  early	  events	  of	  human	  pregnancy	   28.	  However,	   T	   cells	   are	   reported	   to	   be	   increased	   in	   the	   uterus	   at	   term	   17,	   45-­‐50%	   of	  them	  were	  CD3+	  cells	  and	  express	  cell	  markers	  such	  as	  CD25,	  CD69	  and	  HLA-­‐DR	  that	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indicated	  activation	  and	  suggests	  they	  may	  play	  a	  role	  of	  maintenance	  of	  pregnancy	  27,29.	  Other	  studies	  showed	  that	  there	  is	  an	  increase	  in	  regulatory	  uterine	  T	  cells	  (Treg)	  induced	  by	  pregnancy	  and	   the	  cell	   surface	  markers	   indicate	   that	   they	  are	  activated.	  These	  cells	  were	  suggested	  to	  be	  involved	  in	  the	  protection	  of	  fetus	  from	  the	  maternal	  immune	  attack	  in	  the	  maternal-­‐fetal	  interface	  30-­‐32.	  T	  cells	  in	  the	  choriodecidua	  are	  γδ	  T	  cells,	  a	  subtype	  of	  T	  cells	  that	  act	  as	  a	  professional	  antigen－presenting	  cells	  (APC) by	  processing	  antigens	  and	  presenting	  such	  antigens	   to	  αβ	  T	  cells.	  These	  cells	  were	  presented	  at	   term	  and	  significantly	   increased	  during	   labour	  33,34.	  Furthermore,	  γδ	  T	  cells	   could	   also	   act	   as	   αβ	   T	   cells	   and	   secret	   cytokines	   and	   lyse	   target	   cells.	   These	  features	  indicate	  that	  γδ	  T	  cells	  may	  play	  important	  role	  in	  the	  initiation	  of	  adaptive	  immune	  responses	  and	  uterine	  remodelling	  35,36.	  	  
Chemokines	  CCL5,	  CXCL9,	  CXCL10	  and	  CXCL11	  are	  responsible	  for	  the	  recruitment	  of	  T	  cells	  37-­‐39.	  Recently,	   I	  have	  shown	  that	  myometrial	  CCL5	   is	  up-­‐regulated	   in	  human	  term	  labour	  40.	  	  
1.2.2	  Monocytes/Macrophages	  Monocytes	   have	   multiple	   functions	   in	   immune	   system,	   such	   as	   replenishing	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  residential	   macrophages	   and	   dendritic	   cells.	   In	   respond	   to	   inflammatory	   signals,	  monocytes	   migrate	   to	   sites	   of	   inflammation	   and	   divide/differentiate	   into	  macrophages	  and	  dendritic	  cells	  41.	  They	  stimulate	  the	  activation	  and	  differentiation	  of	  other	  leukocytes	  subpopulations	  42.	  	   
In	  human	  parturition,	  macrophages	  and	  other	  leukocytes	  appear	  in	  the	  early	  phase	  of	  pregnancy	   and	   increase	   at	   the	   onset	   of	   labour	   17.	   Macrophages	   are	   found	   in	   the	  endometrial	   stroma	   as	   well.	   Since	   they	   produced	   a	   variety	   of	   factors,	   including	  prostaglandins	   and	   cytokines,	   macrophages	   were	   suggested	   to	   contribute	   to	  contractile	   activity	   43,44.	   These	   cells	   may	   be	   the	   source	   of	   MMP-­‐9,	   an	   enzyme	   that	  plays	  an	  important	  role	  in	  the	  rupture	  of	  fetal	  membrane	  45-­‐47.	  Decidual	  macrophages	  are	   the	   give	   rise	   to	   the	   CD45+	   cells	   and	   10%	  of	   the	   decidual	   leukocytes	   48-­‐50.	   Their	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secretory	   products	   such	   as	   IL-­‐6,	   IL-­‐1	   and	   CXCL8	   regulate	   the	   development	   and	  activation	  of	  human	  monocytes/macrophages	  51,52.	  	  
The	   recruitment	   of	   monocytes/macrophages	   depend	   on	   the	   concentration	   of	   local	  chemokines,	  such	  as	  CCL2,	  which	  have	  been	  shown	  to	  up-­‐regulated	  during	  labour	  40.	  Monocytes	   in	   fetal	  membrane	  were	   shown	   to	   respond	   to	   chemokines	   such	  as	  CCL2	  and	  CCL3	  and	   their	   activity	   increased	  during	   labour	   18.	   	   Fetus-­‐derived	   trophoblasts	  attract	   monocytes	   by	   expressing	   CXCL16,	   which	   interacts	   with	   CXCR6	   on	   decidual	  cells,	  which	  leads	  to	  the	  fetal-­‐maternal	  immune	  activity	  53.	  	  
Macrophages	  were	  found	  to	  be	  the	  major	  cell	  type	  of	  leukocytes	  in	  mouse	  uterus	  54.	  In	  mouse	   parturition,	   macrophage	   numbers	   in	   the	   uterus	   were	   inversely	   related	   to	  those	   in	   the	   cervix.	   In	  myometrium,	   total	  macrophage	   numbers	  were	   increased	   on	  Day	  15	  of	  mouse	  pregnancy	  when	  compare	   to	   those	   in	  non-­‐pregnant	  controls,	   then	  declined	   before	   birth,	   and	   increased	   postpartum.	   Uterine	   macrophages	   were	  clustered	   in	   stromal	   connective	   tissue	   and,	   they	   appeared	   to	   surround	   the	   muscle	  bundles	   near	   term	   and	   postpartum.	   Cervical	  macrophage	   numbers	   are	   reported	   to	  peak	  on	  Day	  18,	  then	  to	  decline	  to	  non-­‐pregnant	  levels	  by	  the	  day	  after	  birth;	  they	  are	  localized	  to	  the	  subepithelium,	  often	  perivascular	  or	  near	  ganglia	  43.	  	  These	  findings	  suggest	  that	  macrophages	  and	  their	  products	  may	  be	  more	  important	  in	   the	   process	   of	   cervical	   remodeling	   than	   in	   uterine	   contractility	   during	   mouse	  pregnancy	  and	  parturition.	  
1.2.3	  Dendritic	  cells	  During	  pregnancy,	  several	  mechanisms	  are	  involved	  in	  the	  maintenance	  of	  maternal	  tolerance	   of	   the	   fetus.	   Medawar	   considered	   three	   mechanisms,	   1)	   anatomic	  separation	   of	   fetus	   and	   mother,	   2)	   antigenic	   immaturity	   of	   the	   fetus,	   and	   3)	  immunologic	  tolerance	  of	  the	  mother.	  The	  maternal	  balance	  between	  active	  immunity	  and	  tolerance	  at	  the	  fetomaternal	  interface	  is	  of	  crucial	  importance.  
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Natural	   killer	   (NK)	   cells	   and	   antigen-­‐presenting	   cells	   (APCs)	   are	   the	   predominant	  populations	  of	   immune	  cells	   that	  gain	  access	   to	   the	  maternal-­‐fetal	   interface	   in	  both	  mice	  and	  humans	  55.	  APCs	  are	  specifically	  equipped	  to	  initiate	  and	  maintain	  immune	  responses.	   Special	   attention	   has	   been	   paid	   to	   dendritic	   cells	   (DCs)	   due	   to	   their	  immunological	   importance	  and	   their	  migratory	  properties.	  DCs	  are	   found	   in	  almost	  all	  peripheral	  tissues,	  including	  the	  pregnant	  uterus	  of	  mice	  and	  humans,	  as	  well	  as	  in	  primary	  and	  secondary	  lymphoid	  organs.	  DCs	  are	  not	  only	  essential	  for	  the	  induction	  of	   primary	   immune	   responses	   but	   may	   also	   be	   important	   for	   the	   induction	   of	  immunological	  tolerance	  as	  well	  as	  for	  the	  regulation	  of	  some	  type	  of	  T-­‐cell-­‐mediated	  immune	   responses	   56.	   The	  maturity	   of	   DCs	   seems	   to	   influence	   their	   immunological	  function,	   so	   that	   immature	   DCs	   contribute	   to	   the	   induction	   of	   tolerance,	   whereas	  mature	   DCs	   influence	   the	   generation	   of	   pro-­‐inflammatory	   responses	   57.	  Immunostimulatory	  mature	  DCs	  have	  been	   found	   in	  decidual	   tissue	  early	   in	  human	  pregnancy,	   where	   they	   may	   contribute	   to	   the	   development	   of	   tolerance	   to	   the	  conceptus	   58	   and	   they	   are	   suggested	   to	   play	   a	   similar	   role	   in	   mouse	   pregnancy.	  However,	   uterine	   DCs	   may	   also	   promote	   immune	   tolerance	   of	   the	   pregnancy	   by	  producing	  IL-­‐10,	  an	  inhibitor	  of	  the	  immune	  response	  59.	  	  
1.2.4	  NK	  cells	  NK	   cells	   are	   an	   important	   cell	   population,	   which	   may	   determine	   early	   placental	  growth	   and	  development.	   They	  make	  up	  70%	  of	   decidual	   leukocytes	   (70%)	  during	  first	  trimester,	  but	  decrease	  to	  3%	  at	  term	  25,60,61.	  	  The	  possible	  roles	  of	  these	  NK	  cells	  include	  control	  of	  uterine	  vascular	  remodelling	  and	  extravillous	  trophoblast	  invasion	  while	  providing	  local	  antiviral	  activity	  62.	  It	  is	  suggested	  that	  there	  are	  two	  potential	  origins	   of	   decidual	   NK	   cells,	   either	   developing	   locally	   in	   the	   decidua	   from	   a	  hematopoietic	   precursor	   or	   from	  mature	   peripheral	   blood	  NK	   cells	   63.	   Decidual	  NK	  cells	   express	   TGF-­‐β	   and	   IL-­‐10	   in	   normal	   pregnancy	   suggesting	   a	   role	   in	   immune	  tolerance.	   They	   also	   express	   IFN-­‐γ	   and	   kill	   extravillous	   trophoblasts	   in	  miscarriage	  tissue	  64.	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1.2.5	  Mast	  cells	  In	  human	  reproductive	  system,	  mast	  cells	  are	  found	  in	  high	  density	  in	  myometrium,	  endometrium	  and	  cervix,	  especially	  near	  the	  blood	  and	  lymph	  vessels	  and	  nerves	  65-­‐67.	  However,	   there	  was	  no	  change	  of	  myometrial	  mast	  cell	  density	  before	  and	  after	   the	  onset	  of	  labour	  at	  term	  17.	  In	  mouse	  pregnant	  uterus,	  on	  the	  contrary,	  the	  density	  of	  mast	  cells	  were	  shown	  to	  constantly	   increase	  with	  the	  gestational	  age	  starting	  from	  the	  second	  half	  of	  pregnancy	  and	  peaked	  at	  term	  68.	  It	  is	  suggested	  that	  the	  presence	  of	  mast	  cells	   in	   the	  uterus	   is	   to	  maintain	   the	  quiescence	  of	   the	  myometrium	  during	  pregnancy	  69.	  	  
Some	  of	  the	  mast	  cells	  have	  cell-­‐bound	  IgE	  and	  membrane-­‐bound	  electron	  granules,	  which	  contain	  histamine	  68,70.	  In	  the	  bovine,	  the	  degranulation	  of	  mast	  cells	  produce	  tryptase	  and	  other	  protease	  71.	  In	  general,	  mast	  cells	  express	  three	  types	  of	  mediators	  including	   5-­‐HT,	   which	   has	   been	   shown	   to	   be	   involved	   in	   cervical	   ripening	   72;	  prostaglandins	  and	  COX-­‐1,	  2,	  which	  may	   induce	  uterine	  contractions;	  and	  cytokines	  such	  as	  TNFα	  and	  chemokines	  which	  attract	  other	  leukocytes	  into	  myometrium	  73,74.	  The	  activation	  of	  mast	  cells	  is	  regulated	  by	  endocrine	  system.	  For	  example,	  estrogens	  potentiate	  mast	  cells	  degranulation	  and	  histamine	  release	  75.	  The	  density	  of	  mast	  cells	  also	  changes	  in	  pathological	  conditions	  of	  human	  parturition.	  In	  pre-­‐eclampsia,	  mast	  cells	  are	  increased,	  whereas	  in	  intrauterine	  growth	  retardation,	  the	  mast	  cell	  density	  is	  lower	  76,77. 	  
Nine	  chemokine	  receptors	  are	  found	  to	  present	  on	  the	  surface	  of	  mast	  cells,	  including	  CXCR1,	   CXCR2,	   CCR1,	   CCR3	   and	   CCR4.	   Chemokines,	   which	   interact	   with	   these	  receptors,	  are	  responsible	  for	  the	  recruitment	  of	  mast	  cell	  78.	  	  
Although	  there	  is	  a	  lack	  of	  change	  in	  mast	  cell	  numbers	  in	  human	  labour,	  these	  data	  suggest	   that	   the	  mediators	   produced	   by	  mast	   cells	   can	   influence	   labour	   promoting	  uterine	  contractility	  and	  increasing	  the	  inflammatory	  infiltration	  68,79,80.	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1.2.6	  Granulocytes	  Granulocytes	  are	  a	  type	  of	  white	  blood	  cells	  that	  present	  granules	  in	  their	  cytoplasm.	  There	   are	   three	   types	   of	   them,	   neutrophils,	   eosinophils	   and	   basophils.	   They	   are	   a	  major	   source	   of	   inflammatory	   mediators	   including	   plasminogen	   activators,	  collagenase,	   elastase,	   and	   pro-­‐inflammatory	   cytokines	   such	   as	   IL-­‐1β	   and	   TNFα	   in	  human	  labour	  81,82.	  Granulocytes	  are	  present	  in	  the	  uterus	  throughout	  pregnancy	  and	  their	   density,	   especially	   neutrophils,	   increase	   at	   term	   17,83.	   Granulocytes	   were	  suggested	   to	   be	   involved	   in	   different	   events	   of	   parturition,	   and	   being	   the	   major	  subpopulation	  of	  leukocytes	  that	  infiltrated	  into	  choriodecidua	  during	  labour	  at	  term	  84.	   In	   human,	   collagenase-­‐containing	   neutrophils	   infiltrated	   into	   cervix	   before	   the	  onset	  of	  labour,	  which	  might	  be	  associated	  with	  the	  increase	  of	  collagenolytic	  activity,	  that	   induces	   cervical	   ripening.	  Furthermore,	   the	  density	  of	  neutrophils	  was	  parallel	  with	   the	   process	   of	   cervical	   dilation	   14,82,85.	   Uterine	   neutrophils	   also	   can	   produce	  MMP-­‐9,	  which	  may	  contribute	  to	  the	  placental	  abruption	  and	  premature	  membrane	  rupture	  86,87.	  Neutrophils	  and	  basophils	  were	  found	  to	  be	  increased	  in	  myometrium	  at	  term	   and	   during	   labour	   in	   both	   upper	   and	   lower	   segment	   of	   myometrium,	   which	  suggest	   they	  have	   important	  roles	   in	  human	  parturition	  17.	   In	  mice,	  neutrophils	  and	  macrophages	   infiltrate	   into	   cervix	   before	   the	   onset	   of	   labour	   and	   are	   probably	  involved	  in	  the	  process	  of	  cervical	  remodelling	  88.	  	  	  CXCL2,	   CXCL3	   and	   CXCL8	   are	   the	   three	   chemokines	   that	   regulate	   the	   density	   of	  granulocytes	  in	  human	  reproductive	  tissues	  89,90.	  CXCL8,	  which	  is	  associated	  with	  the	  influx	  of	  neutrophils,	  is	  up	  regulated	  during	  labour	  in	  human	  myometrium	  40,	  while	  in	  the	   fetal	  membranes,	   the	   expression	   of	   the	   CXCL8	   receptors,	   CXCR1	   and	   CXCR2,	   is	  increased	  during	  labour	  84.	  	  	  	  	  
1.2.7	  B	  cells	  The	  density	   of	  B	   cells	   only	   change	  during	   antigenic	   challenges	   such	   as	   intrauterine	  infection,	  when	  germinal	  centers	  form	  91.	  Unlike	  other	  leukocyte	  subtypes,	  there	  is	  no	  change	  of	  B	  cell	  numbers	  in	  the	  myometrium	  with	  the	  onset	  of	  labour	  17.	  However,	  an	  increase	  of	  B	  cells	  could	  be	  found	  in	  human	  peripheral	  blood	  in	  preterm	  labour	  92.	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The	  recruitment	  of	  B	  cells	  depends	  on	  the	  level	  of	  CXCL13,	  a	  chemokine	  that	  attracts	  both	  T	  cell	  and	  B	  cells.	  There	  is	  no	  change	  of	  CXCL13	  during	  labour.	  But	  the	  level	  of	  CXCL13	  increased	  dramatically	  in	  amniotic	  fluid	  during	  intra-­‐amniotic	  infection	  93.	  In	  that	  clinical	  scenario,	  B	  cells	  were	  suggested	  to	  “cooperated”	  with	  other	  leukocytes	  to	  promote	  the	  onset	  of	  labour	  42.	  	  
1.3	  Cytokines	  in	  human	  parturition	  
Activated	  inflammatory	  cells,	  such	  as	  neutrophils	  and	  macrophages	  are	  a	  rich	  source	  of	   inflammatory	  mediators,	  which	   include	   inflammatory	   cytokines	   and	   chemokines.	  Cytokines	  are	  secreted	  proteins	  with	  growth,	  differentiation	  and	  activation	  functions	  that	  regulate	  and	  determine	  the	  nature	  of	  immune	  responses	  and	  control	  immune	  cell	  trafficking	  and	  the	  cellular	  arrangement	  of	   immune	  organs.	  Cytokines	  are	  known	  to	  play	  a	  pivotal	  role	  in	  human	  reproduction,	  being	  involved	  in	  ovulation,	  implantation,	  placentation	   and	   parturition	   94.	   Several	   studies	   have	   highlighted	   the	   association	  between	  elevated	  cytokine	  expression	  and	  preterm	  delivery,	  with	  increased	  levels	  in	  maternal	  serum,	  amniotic	  fluid	  and	  placenta	  95-­‐98.	  
1.3.1	  Pro-­‐inflammatory	  cytokines	  Pro-­‐inflammatory	  cytokines	  IL-­‐1β,	  IL-­‐6	  and	  TNFα	  are	  considered	  to	  be	  biomarkers	  of	  preterm	  delivery	  99.	  IL-­‐1β	  is	  a	  cytokine	  produced	  by	  activated	  macrophages,	  it	  plays	  an	  important	  role	  in	  inflammatory	  process	  100,	  stimulating	  T	  cell	  and	  macrophages	  to	  secrete	  IL-­‐6.	  Interestingly,	  IL-­‐6	  promotes	  smooth	  muscle	  contractility	  directly	  101,102.	  	  Comparing	   term	   labour	  with	  preterm	   labour,	   IL-­‐1β	  and	   IL-­‐6	  mRNA	  expression	  was	  greater	  in	  term	  myometrium.	  	  There	  was	  no	  difference	  in	  TNFα	  mRNA	  expression	  103.	  The	  expression	  of	  myometrial	  IL-­‐1β	  and	  IL-­‐6	  mRNA	  is	  increased	  in	  labouring	  women	  as	   compared	   to	   non-­‐labour	   controls	   103. IL-­‐1β,	   IL-­‐6	   and	   TNFα	   staining	   is	   weakly	  localized	   to	   myometrial	   cells	   and	   is	   much	   greater	   in	   leukocytes.	   The	   density	   is	  greatest	  in	  samples	  obtained	  during	  term	  labour	  104.	  
The	  fetal	  membrane	  production	  of	  IL-­‐1β	  and	  IL-­‐6	  is	  greater	  in	  preterm	  labour	  and	  the	  expression	  of	  all	  three	  cytokines	  is	  up-­‐regulated	  with	  chorioamnionitis	  90.	  In	  women	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with	  premature	  rupture	  of	   the	  membranes	   (PROM)	  or	   intraamniotic	   infection	  (IAI),	  the	   amniotic	   fluid	   and	   fetal	   membrane	   levels	   of	   IL-­‐1,	   IL-­‐1β,	   IL-­‐6	   and	   TNFα	   are	  elevated	   105,106.	   In	   a	   mouse	   model	   of	   preterm	   labour,	   LPS	   increased	   the	   fetal	  membrane	  expression	  of	   IL-­‐1β,	   IL-­‐6	  and	  TNFα	   107.	   Inflammatory	  cytokines	   increase	  the	  production	  of	  prostaglandins	  and	  other	  factors	  that	  lead	  to	  cervical	  ripening	  and	  uterine	  contraction.	  In	  addition,	  fetal	  membrane	  cytokines	  play	  an	  important	  role	  in	  the	  pathway	  of	  cells	  apoptosis,	  which	  leads	  to	  PROM.	  	  
TNFα	  is	  secreted	  by	  macrophages,	  as	  well	  as	  other	  leukocytes.	  The	  main	  role	  of	  TNFα	  is	   to	  regulate	   immune	  cell	   function	  and	   to	  promote	   inflammation	  acting	   through	   its	  two	   receptors,	   TNF-­‐R1	   and	   2	   108,109.	   These	   two	   receptors	   may	   activate	   different	  pathways,	  which	  cause	  different	  actions	  when	  engaged	  with	  TNFα110.	  When	  binding	  to	  TNFR1,	  TNFα	  activates	  caspase	  by	  activating	  the	  two	  death	  domaines.	  On	  the	  other	  hand,	   TNFα	   activates	   TRAF2	   via	   TNFR2,	   which	   is	   an	   anti-­‐apoptotic,	   but	   pro-­‐inflammatory	  factor.	  TRAF2	  activates	  NF-­‐κB,	  which	  increases	  local	  inflammation	  and	  prostaglandins	   concentrations	   leading	   to	   preterm	   labour	   111	   (Figure	   1.1).	   Other	  studies	   suggested	   that	   NF-­‐κB	   activation	   induces	   MMP	   expression	   and	   promotes	  apoptosis	  112.	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Table 4 Expression of Fas-FasL mediated apoptotic pathway
genes during PROM and PTL.
FAS Fas L Caspase 8 FADD TRADD GAPDH
PROM H I H H H H
PTL " I I H " H
" – Expression seen in at least 50% of the tissues.
GAPDH – House keeping gene.
Table 5a Cytokine induction of MMP activity.
Gene Expression IL-1 IL-6 TNF Control
MMP2 H H H H
MMP9 H H H y
*MMP2 Specific activity H H H H
*MMP9 Specific activity y y H y
Documented by zymogram analysis using gelatin substrate.
Table 5b MMP and Caspase activity in cytokine-stimulated
amniochorion compared to unstimulated controls.
Activity Assay IL-1 IL-6 TNF
MMP2 l l l
MMP9 l l ≠
Caspase 2 ≠ l ≠
Caspase 3 ≠ l ≠
Caspase 8 ≠ l ≠
Caspase 9 ≠ l ≠
TUNEL positive cells* 55% 25% 80%
*Unstimulated control membranes showed ;15% TUNEL pos-
itive cells.
l No change.
Figure 3 The potential role of TNF receptors (TNFRI and
TNFRII) in fetal membrane apoptosis and inflammation. See text
for details w3, 6, 19, 42x.
pathways that lead to PTL and PROM, we have identified
three major elements that should be considered as fac-
tors in determining the outcome and they are: inflam-
matory cytokines, increased matrix metalloproteinase
(MMP) activity and apoptosis. MMP activity and apop-
tosis are most strongly associated with PROM, whereas
inflammatory cytokines are increased in both of these
conditions. As discussed earlier in this review, all of these
cytokines induce prostaglandin production from the pla-
cental tissues, resulting in contractions. This leads us to
theorize that one or more of these cytokines may act as
a switch between the pathways that lead to PTL vs.
PROM. Cytokines may increase MMP activity or accel-
erate apoptosis, each of which is associated with PROM
(Table 4).
In an attempt to identify the factors that determine
which pathway is followed (i.e. PTL vs. PROM) we exam-
ined the ability of inflammatory cytokines to induce MMP
activation, induction of mRNA for pro-apoptotic factors
and the presence of apoptosis after cytokine stimulation.
The studies were conducted in vitro using amniochorion
collected from women undergoing elective repeat c-sec-
tion at term with no documented pregnancy related
complications. These membranes were exposed to con-
centrations of IL-1, IL-6 and TNF-a seen in the amniotic
fluid of women with intraamniotic infection and the tissue
MMP and apoptotic response was evaluated w54, 55x.
The results are summarized in Table 5a and 5b. IL-1b and
TNF may direct the events that promote PROM over PTL.
TNF can activate MMPs, while both IL-1b and TNF can
activate apoptosis, both of which are commonly asso-
ciated with PROM. Conversely, IL-6 is neither an acti-
vator of MMPs nor an inducer of apoptosis. We propose
that during intraamniotic infection, the outcome will be
determined based on the concentration of the individual
cytokines in the amniotic fluid. IL-6 seems to have a
higher concentration (in the microgram range) compared
to the other two (picogram range). Additionally, as a pros-
taglandin stimulant IL-6 may lead to preterm labor and
not directly promote PROM w11x.
TNF as a switching mechanism in PTL, PROM
pathways
Multiple factors may be involved in TNF mediated MMP
and apoptosis activation as opposed to TNF mediated
prostaglandin production. The concentration of bioactive
TNF, the availability of TNF receptors (namely TNFR1 and
TNFR2) and TNF’s affinity for binding to these receptors
all may play a role. The different TNFR signaling path-
ways engender different actions by TNF-a. TNFR1 is
mainly involved in MMP9 activation w42x. Signaling of
TNF through TNFR1 and TNF receptor associated death
domain (TRADD) activates transactivator nuclear factor
kappa-B (Nf-kB) (see Figure 1). This activation promotes
apoptosis, induces MMP expression and increase inflam-
mation leading to PROM. TNF binding to TNFR2 can also
activate Nf-kB, however, it does not interact with TRADD,
instead the TNF-TNFR2 complex directly recruits TNF
receptor associated factor-2 (TRAF2) which is anti-apop-
totic but pro-inflammatory w3, 6, 42x. If TNF binds to
TNFR2, this can lead to increased prostaglandin produc-
	  
Figure 1.1 The potential role of TNFα in PROM and preterm labour.  
Adapted from Ramkumar Menon and Stephen J. Fortunato. Fetal membrane inflammatory cytokines: a 
switching mechanism between the preterm premature rupture of the membranes and preterm labor pathways. 
J. Perinat. Med. 32 (2004) 391–399 
 Pro-­‐inflammatory	  cytokines	  are	  present	  in	  the	  placenta	  throughout	  normal	  gestation	  and	  their	  levels	  increases	  in	  the	  presence	  of	  infection	  and	  inflammation.	  	  Besides	  their	  ability	   to	   induce	   apoptosis,	   which	   occurs	   in	   both	   early	   and	   late	   gestation,	   the	  cytokines	   keep	   the	   balance	   between	   placental	   growth	   and	   apoptosis	   and	   are	   also	  involved	  in	  the	  regulation	  of	  hormone	  secretion	  113,114.	   	  The	  secretion	  of	  hCG,	  one	  of	  the	  major	  polypeptides	  produced	  by	  placenta,	  is	  stimulated	  by	  both	  IL-­‐1β	  and	  TNFα	  indirectly	  115,116,	  via	  an	  increase	  in	  IL-­‐6	  and	  the	  activation	  of	  IL-­‐6	  receptor	  system	  117.	  	  IL-­‐1β	  also	   increases	   the	  placental	  production	  of	  CRH	  and	  ATCH	  118.	   In	   this	  case,	   the	  effect	  of	  IL-­‐1β	  is	  mediated	  via	  an	  increase	  in	  prostaglandin	  synthesis	  119.	  	  	  
Several	   cytokines,	   including	   IL-­‐1β,	   IL-­‐6	   and	  TNFα	   are	   present	   in	   the	   amniotic	   fluid	  during	  the	  third	  trimester	  and	  increase	  with	  the	  onset	  of	  labour.	  The	  concentrations	  correlate	  with	  the	  number	  of	  granulocytes	  present	  in	  the	  placenta	  15,120,121.	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Cytokines	  also	  contribute	  to	  cervical	  ripening	  and	  the	  concentrations	  of	  cytokines	  in	  cervicovaginal	  secretion	  are	  elevated	  during	  spontaneous	  labour	  at	  term	  and,	  peak	  at	  the	  time	  of	  full	  cervical	  dilation	  122.	  
1.3.2	  Anti-­‐inflammatory	  cytokines	  In	  addition	   to	  pro-­‐inflammatory	  cytokines,	  gestational	   tissues	  also	  produce	  some	  of	  the	   anti-­‐inflammatory	   cytokines,	   such	   as	   IL-­‐10	   and	   IL-­‐4	   123,124.	   Choriodecidua	   IL-­‐10	  levels	  are	   increased	   in	   response	   to	  LPS,	   IL-­‐1β	  or	  TNFα	   treatment	   125,126.	  As	  an	  anti-­‐inflammatory	  cytokine,	  the	  administration	  of	  IL-­‐10	  delayed	  the	  LPS	  induced	  preterm	  labour	  in	  rats	  127.	  A	  fall	  in	  the	  expression	  of	  anti-­‐inflammatory	  cytokines	  may	  facilitate	  the	   inflammatory	   process	   that	   is	   suggested	   to	   lead	   to	   preterm	   labour	   and	   it	   is	  reported	   that	   placental	   IL-­‐10	   levels	   are	   decreased	   prior	   to	   the	   onset	   of	   labour	   and	  remain	   low	   throughout	   labour	   128,129.	   In	   some	   in	   vitro	   studies,	   IL-­‐10	   inhibited	   the	  production	   of	   pro-­‐inflammatory	   cytokines	   and	   prostaglandins	   by	   the	   amnion	   and	  choriodecidua	  130.	  Another	  anti-­‐inflammatory	  cytokine,	  IL-­‐4,	  reduced	  the	  production	  of	  prostaglandins	   in	  decidual	   cells	   and	   increased	   the	   level	  of	   IL-­‐1RA	   131.	  Both	   IL-­‐10	  and	   IL-­‐4	   showed	   no	   change	   in	   amniotic	   fluid	   before	   or	   after	   labour	   126.	   	   However,	  these	  two	  cytokines	  were	  reported	  to	  exert	  inflammatory	  effects	  in	  gestational	  tissues	  132,133.	  For	  example,	  IL-­‐10	  up-­‐regulated	  PGE2	  and	  IL-­‐6	  expression	  in	  amnion	  explants.	  This	   led	   to	   the	   hypothesis	   that	   the	   withdrawal	   or	   reversal	   of	   anti-­‐inflammatory	  cytokines	  might	  be	  required	  for	  the	  onset	  of	  labour	  129.	  
In	   general,	   labour	   is	   associated	   with	   an	   increase	   of	   pro-­‐inflammatory	   cytokines,	  which	  stimulate	  the	  secretion	  of	  PGs,	  which	  in	  turn	  induces	  a	  series	  of	  changes	  such	  as	   cervical	   ripening	  or	  membrane	   rupture	   leading	   to	   the	  onset	   of	   labour.	  However,	  this	   effect	   can	   be	   inhibited	   by	   anti-­‐inflammatory	   cytokines,	   such	   as	   IL-­‐10	   and	   IL-­‐4	  (Figure	  1.2)	  134.	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part in cytokine signalling in the process of labour than is
currently thought and this process may well be controlled by
SOCS proteins.
CYTOKINE REGULATION OF INTRAUTERINE
PROSTAGLANDIN PRODUCTION
Regulation of arachidonic acid metabolism in the gestational
membranes is believed to be key to the maintenance of
pregnancy and the initiation and progression of labour in
women. Extensive studies over many decades have charted
changes in prostanoid levels and prostanoid production rates in
intrauterine tissues prior to and during labour (Mitchell et al.,
1995; Olson, Mijovic and Sadowsky, 1995). Biosynthetic
capacity for prostaglandins, especially of amnion-derived
PGE2, increases in women with term or preterm labour (Gibb,
1998). More recent focus has been on the changes in expres-
sion of the two isoforms of PGHS and their respective roles in
the biosynthesis of prostanoids in parturition (Teixeira et al.,
1994; Slater et al., 1995; Mijovic et al., 1998). Similarly, the
upregulation of PGHS-2 expression by cytokines in gestational
tissues has been the subject of intensive investigation (Kniss,
1999). It has become dogma that cytokines regulate prosta-
glandin production and that this is an important aspect of
parturition (Hansen et al., 1999); cytokines such as TNF-!
and IL-1" have been shown by numerous studies to act in a
coordinated fashion at multiple points of the prostanoid
biosynthetic pathway (Figure 3). Production of prostaglandins
by cells from the amnion (Romero et al., 1989; Bry and
Hallman, 1992), chorion (Lundin-Schiller and Mitchell, 1991),
decidua (Mitchell, Edwin and Romero, 1990), and myo-
metrium (Hertelendy et al., 1993; Pollard and Mitchell, 1996)
is enhanced by IL-1" and TNF-!, at least in part through
increased expression of prostaglandin H synthase (PGHS)-2
(Hansen et al., 1999; Kniss, 1999; Rauk and Chiao, 2000). The
stimulatory effects of LPS on choriodecidual PG production is
predominantly dependent upon local TNF-! release and
action (Sato, Keelan and Mitchell, 2003). IL-6 (albeit at high
doses) has also been shown to stimulate prostaglandin produc-
tion by the amnion and decidua (Mitchell et al., 1991), while
the chemokine macrophage inhibitory protein (MIP)-1!
stimulates amnion and chorion cell prostaglandin production
(Dudley, Edwin and Mitchell, 1996). The important
Figure 3. Cytokine-prostaglandin interactions. Proinflammatory cytokines such as TNF-! act in a coordinated fashion to up-regulate prostanoid biosynthesis and
down-regulate metabolism. Effects on expression and activity of isomerases and PG receptors in gestational tissues are, as yet, unknown. Figure modified and
redrawn from Hansen et al. (Key enzymes of prostaglandin biosynthesis and metabolism. Coordinate regulation of expression by cytokines in gestational tissues:
a review. Prostaglandins Other Lipid Mediators, 57, 243–57, 1999, with permission from Elsevier Science).
Keelan et al.: Cytokines, Prostaglandins and Parturition S39
	  
Figu e 1.2 I teractions between cytokines and prostaglandins.  
Adopted from Hansen WR, Keelan JA, Skinner SJ, Mitchell MD. Key enzymes of prostaglandin biosynthesis 
and metabolism. Coordinate regulation of expression by cytokines in gestational tissues: a review. 
Prostaglandins Other Lipid Mediat. 1999 Jun;57(4):243-57. 
1.4	  Chemokines	  and	  chemokine	  receptors	  in	  hu an	  labour	  	  	  
1.4.1	  Chem kine	  	  	  	  	  	  	  	  	  	  	  	  	  	  Chemokines	  play	  an	  important	  role	  in	  leukocyte	  recruitment	  and	  activation	  135.	  They	  are	  a	   large	  family	  of	  small	  chemotactic	  cytokines	  (8-­‐10	  KD).	  Chemokines	  have	  rapid	  local	   biological	   actions	   and	   act	   through	   specific	   G	   protein-­‐coupled	   receptors.	   More	  than	   50	   chemokines	   have	   been	   identified;	   they	   are	   divided	   into	   four	   structural	  subclasses	  based	  on	   their	  amino-­‐terminal	   cysteine	  motif,	  designated	  CC,	  C,	  CXC	  and	  CX3C	  chemokines.	  The	  chemokines	  are	  known	  as	  CC	  or	  β-­‐chemokines	  if	  the	  first	  two	  cysteines	   are	   adjacent	   to	   each	   other.	   Chemokine	   agonists	   that	   have	   an	   intervening	  amino	  acid	  between	  the	  first	  two	  cysteines	  are	  sub	  classified	  as	  CXC	  or	  α-­‐chemokines.	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Another	  subfamily,	   the	  CX3C	  or	   the	  γ	   -­‐chemokine,	  possesses	  only	  one	  protein	   in	   its	  category	  and	  is	  defined	  by	  three	  intervening	  residues	  between	  the	  first	  two	  cysteines.	  In	  C	  or	  δ-­‐chemokine,	  the	  polypeptide	  has	  only	  two	  of	  the	  four	  cysteines	  136.	  There	  is	  a	  considerable	  redundancy	  between	  the	  chemokines,	  largely	  because	  of	  the	  limited	  number	  of	  chemokine	  receptors	  as	  compared	  with	  chemokine	  ligands,	  leading	  to	  promiscuous	  ligand–receptor	  binding.	  A	  simple	  nomenclature	  system	  was	  recently	  devised	  for	  chemokines	  and	  their	  receptors,	  which	  had	  previously	  been	  named	  based	  on	   their	   first	   identified	   functions137.	   Chemokines	   can	   be	   divided	   into	   two	   types,	  inflammatory	  and	  homeostatic	  chemokines.	  Inflammatory	  chemokines	  are	  expressed	  in	   inflamed	   tissues	   and	   are	   critical	   for	   attracting	   leukocytes,	   whereas	   homeostatic	  chemokines	  maintain	  physiological	  traffic	  and	  immune	  surveillance	  by	  leukocytes	  138.	  
1.4.2	  Chemokine	  receptor	  Leukocytes	  migrate	  to	  sites	  of	  inflammation	  in	  response	  to	  chemokines	  139,	  which	  act	  through	   seven-­‐transmembrane	   domain	   G	   protein-­‐coupled	   receptors	   termed	  chemokine	  receptors.	  Seven	  CXC	  (CXCR1–7),	  10	  CCR	  (CCR1–10),	  1	  CX3CR	  (CX3CR1),	  and	  1	  CR	  (XCR1)	  chemokine	  receptor	  have	  been	  identified	  140.	  CC	  chemokines	  mainly	  interact	   with	   lymphocytes,	   macrophages,	   and	   monocytes	   141.	   Neutrophils	   express	  only	  a	  very	   limited	  number	  of	  chemokine	  receptors	  142-­‐144,	  predominantly	  receptors	  of	  the	  CXC	  or	  CX3C	  family,	  in	  particular	  CXCR1	  and	  CXCR2	  145	  and	  consequently,	  with	  the	   exception	   of	   CXCR1/CXCR2	   ligands,	   the	   majority	   of	   chemokines	   have	   no	  functional	   effect	   on	   human	   neutrophils	   146.	   It	   is	   not	   yet	   known	   which	   chemokine	  receptor	   interactions	   trigger	   which	   corresponding	   intracellular	   pathway.	   It	   is	  suggested	   that	   when	   bound	   by	   the	   same	   chemokine	   different	   receptors	   may	   elicit	  distinct	   functional	   responses.	   For	   example,	   CXCR1	   and	   CXCR2	   mediate	   changes	   in	  Ca+2,	   release	  of	  granule	  enzymes	  and	  chemotaxis	  when	  bound	  by	  CXCL-­‐8.	  However,	  CXCR1	  also	  specifically	  activates	  phospholipase	  D	  147,148.	  	  	  
1.4.3	  Function	  of	  chemokine/chemokine	  receptor	  The	   major	   function	   of	   chemokines	   is	   to	   act	   as	   chemoattractants	   to	   guide	   the	  migration	  of	  cells.	  Cells	  that	  are	  attracted	  by	  chemokines	  follow	  a	  signal	  of	  increasing	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chemokine	  concentration	  towards	  the	  source	  of	  the	  chemokine.	  Recent	  experimental	  evidence	   suggests	   that	   the	   process	   of	   chemotaxis	   is	   dependent	   not	   only	   on	   a	  chemokine	  concentration	  gradient	  but	  also	  on	   the	  presence	  and	  activity	  of	  multiple	  proteolytic	   enzymes.	  MMPs	  were	   shown	   to	   affect	   chemotaxis	   of	   inflammatory	   cells	  through	   multiple	   mechanisms.	   In	   an	   asthma	   mouse	   model,	   S100A8,	   which	   is	   a	  homologous	   myeloid-­‐related	   protein	   that	   induced	   the	   chemotaxis	   and	   adhesion	   of	  neutrophils,	  was	   found	   to	  be	   cleaved	  by	  MMP2	  and	   to	   lose	   some	  of	   its	   chemotactic	  activity	   149.	   The	   activity	   of	   chemokines	   is	   initiated	   when	   binding	   to	   a	   specific	   G-­‐protein	   receptor.	   The	  well-­‐known	   function	   of	   chemokines	   and	   their	   receptors	   is	   to	  develop	  and	  respond	  to	  the	  immune	  system.	  However,	  they	  are	  found	  to	  have	  broader	  roles.	   In	   animal	   models,	   the	   fetus	   of	   mothers	   deficient	   in	   CXCL12	   or	   its	   receptor	  CXCR4,	  developed	  cerebellar,	  cardiac	  septum	  and	  B	  cell	  lymphopoesis	  abnormalities	  and	  died	  in	  utero	  or	  at	  birth	  150,151.	  	  
In	   general,	   chemokine/chemokine	   receptors	   regulate	   inflammatory	   cell	   infiltration.	  They	  act	  as	  messengers	  of	  adaptive	  immunity	  152.	  For	  example,	  mice	  lacking	  CCR7	  or	  its	  ligand	  CCL21	  and	  mice	  lacking	  CXCR5	  have	  defects	  in	  the	  entry	  and	  positioning	  of	  T-­‐lymphocytes	   and	   B-­‐lymphocytes	   in	   secondary	   lymphoid	   organs	   153,154.	   Several	  chemokines	   are	   involved	   in	   both	   B	   and	   T	   cell	   maturation	   at	   different	   stages	   of	  development	   155-­‐157.	   The	   chemokine	   systems	   involved	   in	   B	   cell	   maturation	   include	  CXCL12/CXCR4,	  CXCL13,	  and	  CCL20	  151,158.	  CCL2,	  CCL3	  and	   the	  receptors	  CCR2	  and	  CCR5	  have	  been	  observed	  to	  regulate	  T-­‐cell	  maturation	  155.	  CCL5	  activates	  monocytes,	  T	   lymphocytes,	   basophils,	   and	   eosinophils.	   It	   participates	   in	   the	   adhesion	   and	  transmigration	  of	  T	  cells	  to	  the	  endothelium	  and	  is	  produced	  by	  T	  cells,	  macrophages,	  endothelial	  cells,	  and	  gestational	  tissues	  159.	  The	   migration	   of	   dendritic	   cells	   (DCs)	   to	   tissues	   and	   lymph	   nodes	   is	   central	   to	  immunity	  and	  surveillance	  by	  the	  immune	  system.	  There	  are	  several	  receptors	  on	  the	  dendritic	   cell	   surface	   including	   CCR1,	   CCR2,	   CCR5,	   CCR6,	   CCR7,	   and	   CXCR2.	   The	  chemokines	   that	   bind	   these	   receptors	   regulate	   the	   migration	   of	   monocytes	   and	  immature	  dendritic	  cells	  160-­‐162.	  Chemokine	  receptor	  expression	  is	  regulated	  on	  these	  DCs.	  Inflammatory	  chemokines	  promote	  recruitment	  and	  localization	  of	  DCs	  to	  sites	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of	   inflammation	   and	   infection.	  When	   expose	   to	   maturation	   signals,	   DCs	   undergo	   a	  chemokine	   receptor	   switch,	   with	   down	   regulation	   of	   inflammatory	   chemokine	  receptors	   followed	   by	   the	   induction	   of	   CCR7,	   which	   drives	   immature	   DCs	   to	   leave	  tissues	   and	   to	   localize	   in	   lymphoid	   organs	  where	   antigen	   presentation	   takes	   place	  162,163.	  Chemokine	   biology	   is	   intrinsically	   linked	   to	   the	   activities	   of	   other	   cytokines.	   An	  example	   of	   how	   chemokines	   modulate	   the	   immune	   response	   is	   evident	   from	   the	  function	   of	   CCL2	   on	   T	   helper	   cell	   polarization	   164.	   In	   response	   to	   challenges	   to	   the	  host,	  type	  1	  and	  type	  2	  T	  helper	  (TH1	  and	  TH2)	  cells	  secrete	  cytokines	  that	  enhance	  cell-­‐mediated	  and	  humoral	  immunity,	  respectively.	  However,	  CCL2	  deficient	  mice	  are	  unable	  to	  mount	  TH2	  responses	  and	  thus	  synthesize	  extremely	  low	  levels	  of	  IL-­‐4,	  IL-­‐5,	   and	   IL-­‐10.	   Since	   wild	   type	   mice	   are	   normally	   susceptible	   to	   Leishmania	   major	  owing	   to	   the	   TH2	   response,	   CCL2	   deficient	   mice,	   which	   can	   only	   mount	   a	   TH1	  response,	  are	  far	  more	  resistant	  to	  Leishmania	  major	  infection.	  
1.4.4	  Chemokines/chemokine	  receptors	  in	  human	  reproductive	  system	  	  	  	  	  	  	  	  	  	  Prior	   to	   and	   during	   labour	   it	   is	   likely	   that	   specific	   subsets	   of	   pro-­‐inflammatory	  chemokines	  direct	  uterine	  and	  cervical	  leukocyte	  homing	  and	  control	  their	  behaviour	  on	  arrival.	  In	  the	  mouse,	  the	  expression	  of	  CCL2	  is	  significantly	  increased	  by	  IL-­‐1β.	  It	  also	   markedly	   increased	   after	   intrauterine	   LPS	   while	   TLR4	   expression	   did	   not	  significantly	   change,	   which	   indicates	   that	   CCL2	   potentially	   plays	   an	   important	   role	  during	  the	  pro-­‐inflammatory	  immune	  response,	  leading	  to	  preterm	  labour	  165.	  In	  rats,	  level	  of	  CCL2	  increased	  with	  advancing	  gestational	  age.	  Furthermore,	  administration	  of	   P4	   receptor	   antagonist	   RU486	   induced	   an	   increase	   in	   CCL2	   mRNA,	   whereas	  maintenance	   of	   elevated	   P4	   levels	   as	   late	   gestation	   cause	   a	   significant	   decrease	   in	  gene	   expression	   166.	   The	   Nelson	   group	   recent	   found	   in	   a	   gene	   array	   on	   labouring	  human	  myometrium	  samples	  that	  CXC	  chemokines	  CXCL1,	  CXCL2,	  CXCL3,	  CXCL5	  and	  CXCL8;	   CC	   chemokines	   CCL2	   and	   CCL20	   are	   up	   regulated	   in	   term	   labouring	  myometrium	  167.	  In	  addition,	  I	  included	  CCL5	  in	  this	  study	  since	  other	  studies	  showed	  that	  the	  concentration	  of	  CCL5,	  and	  also	  CXCL8,	  were	  increased	  in	  amniotic	  fluid	  with	  the	  gestational	  age	  and	  further	  with	  the	  spontaneous	  onset	  of	  labour	  170,171.	  I	  chose	  to	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study	   the	   receptors	   of	   these	   chemokines,	   CXCR1	   and	   CXCR2	   for	   CXCL5	   and	   CXCL8,	  CCR2	  for	  CCL2	  and	  CCR6	  for	  CCL20.	  
There	   is	   evidence	   that	   fetal	   membrane	   chemokine	   levels,	   including	   CCL13,	   CCL19,	  CCL21,	   are	   increased	   at	   the	   end	   of	   pregnancy,	   while	   others,	   CXCL10,	   CCL2,	   CCL8,	  CCL3	  and	  CCL13,	  increase	  with	  the	  onset	  of	   labour.	  Fetal	  membranes	  obtained	  from	  women	  undergoing	  spontaneous	  labour	  induced	  a	  stronger	  chemotaxis	  to	  leukocytes	  than	   none	   labour	   samples.	   Furthermore,	   chemotaxis	   from	   labouring	   samples	   was	  selective	   to	   monocytes	   and	   T	   lymphocytes	   18.	   CCL2	   levels	   are	   also	   increased	   in	  amniotic	   fluid	   of	   women	   experiencing	   term	   and	   preterm	   delivery	   168,169.	   Similarly,	  choriodecidual	  CXCL8	  levels	  are	  increased	  in	  term	  labour	  172.	  CXCL8	  is	  also	  thought	  to	  have	   a	   role	   in	   PPROM	   as	   women	   who	   present	   with	   PPROM	   have	   higher	   levels	   of	  CXCL8	   173.	   Interestingly,	   women	   destined	   to	   undergo	   PPROM	   have	   higher	   levels	   of	  CXCL8	   in	   early	   pregnancy	   than	   in	   late	   pregnancy,	   which	   suggests	   that	   different	  mechanisms	  are	  responsible	  for	  PROM	  at	  different	  gestations	  174.	  	  	  
The	  human	  cervix	  produces	  large	  amounts	  of	  CXCL8	  and	  this	  is	  regulated	  by	  steroid	  hormones	   52.	   CXCL8	   was	   first	   described	   as	   a	   potent	   chemotactic	   and	   neutrophil-­‐activating	   factor	   in	  1980s	   175.	  Cervical	  CXCL8	   increases	  progressively	  during	   labour	  without	   infection	   as	   the	   cervix	   dilates	   176.	   It	   is	   believed	   that	   neutrophils	   which	  infiltrate	  into	  the	  cervical	  stroma	  and	  the	  lower	  segment	  myometrium	  contribute	  to	  in	  the	  production	  of	  MMPs	  that	  play	  a	  central	  role	  in	  cervical	  dilation	  177.	  	  	  
Chemokine	  receptors	  are	  expressed	  in	  uterus	  178,	  where	  they	  play	  an	  important	  role	  in	  the	  physiology	  and	  pathology	  of	  the	  human	  reproductive	  system. CCR5	  is	  present	  in	  human	  endometrium	  throughout	  the	  menstrual	  cycle	  and	  the	  expression	  of	  CXCR1	  was	   found	   to	   reach	   a	   peak	   at	   the	   midsecretory	   phase	   179.	   In	   leiomyoma,	   the	  chemokine	   receptor	   CCR3	   was	   increased	   in	   the	   myometrium	   of	   patients	   with	  submucosal	   fibroids	   178	   and	   CXCR2,	   CXCR3	   and	   CXCR4	   were	   increased	   in	   human	  endometriosis	  samples	  180	  which	  may	  indicate	  a	  role	  in	  this	  condition.	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Among	   all	   the	   chemokine/chemokine	   receptors,	   CCL20/CCR6	  plays	   a	  major	   role	   in	  inducing	  migration	  of	  DCs,	  T	  and	  B	  cells181.	   In	  human	  parturition,	  CCL20	  is	   found	  in	  amniotic	   fluid	   and	   its	   concentration	   increases	   as	   term	   approaches.	   Spontaneous	  labour	   (term	   and	   preterm)	   is	   associated	   with	   increased	   bioavailability	   of	   amniotic	  fluid	  CCL20	  suggesting	  that	  an	  increase	  in	  CCL20	  may	  be	  part	  of	  the	  common	  pathway	  of	   human	   parturition182.	   Patients	   who	   had	   intra-­‐amniotic	   infection	   also	   had	   a	  dramatically	   elevated	   level	   of	   CCL20182.	   However,	   research	   on	   the	   role	   of	   DCs	   in	  human	  myometrium	  is	  limited.	  
Despite	   their	  role	   in	   the	   induction	  of	   inflammation,	  chemokine	  receptors	  have	  been	  shown	  to	  act	  as	  decoys,	  so	  regulating	  the	  activity	  of	  their	  ligands.	  	  Some	  specific	  non-­‐signalling	   decoy	   receptors	   have	   been	   shown	   to	   be	   expressed	   in	   fetal-­‐maternal	  interface	   and	   their	   dysregulation	   was	   suggested	   to	   result	   in	   fetal	   loss183,184.	   	   	   In	  addition,	  signalling	  receptors	  such	  as	  CCR1,	  CCR2	  and	  CCR5	  can	  act	  as	  decoys	  under	  specific	   circumstances185.	   However,	   currently	   it	   is	   not	   known	   how	   myometrial	  chemokine	   receptor	   expression	   changes	   through	   pregnancy	   and	   with	   the	   onset	   of	  labour.	  
1.4.5	  Regulations	  of	  chemokine/chemokine	  receptor	  	  It	   is	   well	   known	   that	   cytokines	   can	   induce	   the	   expression	   of	   chemokines.	   In	   rat	  myocardial	   cells,	   treatment	  with	  TNFα	   induced	  CXCL5	   expression,	  which	   suggested	  that	   the	   increase	   of	   chemokines	   being	   a	   down-­‐stream	   effect	   of	   inflammatory	  cytokines.	  This	  effect	  was	  via	  activated	  NF-­‐κB	  186,187.	   In	  human	  astrocytes,	  cytokines	  IL-­‐1β	  and	  TNFα	  increase	  the	  expression	  of	  chemokines	  CXCL8,	  CXCL10,	  CXCL9,	  CCL2	  and	  CCL5.	  However,	  IFN-­‐γ	  only	  increased	  CXCL9	  and	  CXCL10	  188.	  IL-­‐6	  had	  very	  little	  effect	  on	  these	  cells	  189.	  In	  myometrium,	  the	  expression	  of	  chemokines	  is	  up	  regulated	  by	   IL-­‐1β	   and	   TNFα	   at	   both	   the	   mRNA	   and	   protein	   level.	   IL-­‐1β	   also	   enhanced	   the	  chemotactic	  effect	  of	  these	  chemokines	  40.	  	  
Progesterone	   is	   a	   steroid	   hormone	   and	   plays	   essential	   roles	   in	   normal	   human	  physiology.	   It	   is	   one	   of	   the	   most	   important	   hormones	   in	   the	   development	   and	  maintenance	   of	   human	   pregnancy.	   In	   rodent	   models	   of	   pregnancy,	   labour	   is	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associated	  with	  progesterone	  withdraw	  190.	  As	  in	  the	  human,	  circulating	  progesterone	  levels	  do	  not	  decrease,	  the	  hypothesis	  that	  there	  is	  either	  a	  decline	  in	  local	  levels	  or	  a	  functional	   withdrawal	   of	   progesterone	   action	   in	   labour	   was	   proposed.	   There	   are	  several	  potential	  mechanisms	  which	  may	  be	  involved:	  changes	  in	  the	  number,	  affinity	  or	   distribution	   of	   progesterone	   receptors;	   production	   of	   an	   antiprogestin,	   which	  prevent	  the	  physiological	  action	  of	  progesterone;	  inactivation	  of	  progesterone	  in	  the	  target	   tissue	   before	   receptor	   interaction	   either	   by	   a	   change	   in	   local	   synthesis,	  metabolism	  or	  sequestration	  by	  a	  binding	  protein	  191.	  Progesterone	  is	  known	  to	  have	  anti-­‐inflammatory	   functions;	   it	   suppresses	   the	   expression	   of	   chemokines,	   such	   as	  CXCL8	   192.	  Progesterone	  also	  decreased	   the	   level	  of	  CCL5	  and	  CXCL12	  and,	   reduced	  the	  densities	  of	  CCR5	  and	  CXCR4	  193-­‐195.	  Further,	  progesterone	  reduced	  the	  migration	  of	   mast	   cells	   toward	   the	   chemokine	   CXCL12	   by	   decreasing	   its	   receptor	   CXCR4	  expression	  and	  reduces	  the	  calcium	  response	  to	  chemokines	  and	  Akt	  phosphorylation	  196.	  	  The	   activation	   of	   the	   myometrium,	   the	   switch	   from	   a	   state	   of	   relative	   quiescence	  during	   pregnancy	   to	   one	   of	   increased	   contractility	   associated	  with	   labour,	   involves	  increased	   sensitivity	   to	   endogenous	   uterotonins	   and	   results	   from	   the	   coordinated	  expression	   of	   ‘contraction-­‐associated	   proteins’	   (CAPs),	   including	   actin,	   myosin,	  connexin-­‐43,	  and	   the	   receptors	   for	  oxytocin	  and	  prostaglandins.	   In	  both	   the	  human	  and	   rat,	   a	   significant	   increase	   in	   myometrial	   prostaglandin	   F2α	   receptor	   mRNA	  expression	   is	   associated	   with	   labour	   at	   term	   and	   myometrial	   oxytocin	   receptor	  density	   increases	  markedly	  before	  parturition.	   PGF2a	   values	  were	   increased	  only	   at	  the	  time	  of	  term	  birth,	  but	  PGE2	  was	  elevated	  during	  both	  preterm	  and	  term	  labour	  197.	   
During	   pregnancy,	   the	   uterus	   is	   under	   constant	   stretch	   through	   the	   growth	   of	   the	  pregnancy	   (fetus,	   placenta	   and	   amniotic	   fluid).	   Other	   conditions,	   such	   as	   multiple	  pregnancy,	   polyhydramnios,	   or	   uterine	   abnormalities	   result	   in	   relative	   or	   absolute	  uterine	  overdistension	  198.	  Studies	  suggest	  that	  uterine	  distension	  is	  a	  major	  drive	  to	  uterine	  contractility	  199.	  The	  numbers	  of	  multiple	  gestations,	  arising	   from	  the	  use	  of	  assisted	   reproductive	   technologies	   or	   simply	   because	   the	   average	   maternal	   age	   is	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increasing,	  are	  associated	  with	  a	  56%	  risk	  of	  delivery	  before	  37	  weeks	  and	  a	  10-­‐15%	  risk	  of	  delivery	  before	  32	  weeks	  of	  gestation	  200.	  The	  uterus	  begins	  to	  contract	  when	  the	  ability	  of	  the	  uterus	  to	  accommodate	  the	  change	  in	  volume,	  through	  hyperplasia	  and	   hypotrophy,	   is	   exceeded	   and	   uterine	   wall	   tension	   begins	   to	   rise.	   The	   level	   of	  CXCL8	   and	   the	   activity	   of	   collagenase	   in	   fetal	   membrane	   is	   elevated	   when	   the	  membranes	   are	   stretched	   198.	   Similarly,	   when	   amnion	   and	   myometrial	   cells	   are	  stretched	   in	  vitro,	   the	  synthesis	  of	  prostaglandins	  is	   increased,	  which	  down	  regulate	  the	  expression	  of	  chemokines	  201,202.	  Mechanical	  stretch	  on	  rat	  myometrium	  smooth	  muscle	   cells	   induced	   a	   release	   of	   CCL2	   protein	   and	   enhanced	   the	   monocyte	  chemoattractant	  activity	  of	  CCL2	  166.	  	  
1.5	  Signaling	  pathways	  involved	  in	  human	  labour	  	  	  	  
1.5.1	  Nuclear	  factor	  kappa	  B	  	  NF-­‐κB	   is	   a	   protein	   complex	   that	   controls	   the	   transcription	   of	   DNA.	   	   NF-­‐κB	   family	  comprise	  five	  members,	  including	  NF-­‐κB1	  (P105/p50),	  NF-­‐κB2	  (P100/p52),	  p65	  (Rel	  A),	  c-­‐Rel	  and	  Rel	  B	  203.	  One	  of	  the	  NF-­‐κB	  pathways	  is	  called	  canonical	  pathway,	  which	  is	   triggered,	   by	   LPS	   and	  pro-­‐inflammatory	   cytokines,	   such	   as	  TNFα	   and	   IL-­‐1β.	   This	  effect	   involves	   IκB	   kinase	   (IKK)-­‐mediated	   phosphorylation	   IκBα	   204.	   IκK-­‐dependent	  phosphorylation	   targets	   IκBα	   for	   degradation	   by	   the	   proteasome.	   Once	   IκBα	   is	  degraded,	   p65	   is	   phosphorylated	   and	   the	   NF-­‐κB	   nuclear	   localization	   signals	   are	  unmasked,	  allowing	  the	  p50/p65	  dimer	  to	  translocate	  to	  the	  nucleus	  where	  it	  binds	  to	  NF-­‐κB	  response	  factors	  in	  the	  promoter	  of	  target	  genes.	  Degradation	  of	  p105	  may	  simultaneously	   occur,	   which	   releases	   more	   NF-­‐κB	   dimers,	   including	   p50/p65.	   The	  p105	   precursor	   may	   also	   be	   processed	   in	   response	   to	   cytokines	   to	   generate	  additional	   p50	   homodimers,	   which	   may	   take	   part	   in	   NF-­‐κB	   DNA	   binding	   or	   be	  displaced	   from	   DNA	   by	   transactivating	   dimers.	   In	   the	   nucleus,	   further	  phosphorylation	   and	   acetylation	   modifications	   of	   NF-­‐κB	   occur,	   promoting	   the	  recruitment	   of	   co-­‐activators,	   such	   as	   CREB-­‐binding	   protein	   to	   drive	   transcription.	  Termination	  of	  signaling	  occurs	  when	  newly	  synthesized	  IκBa	  displaces	  DNA-­‐bound	  NF-­‐κB	  and	  exports	  it	  back	  to	  the	  cytoplasm	  (Figure	  1.3)	  205-­‐207.	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complex (Tanaka et al. 1999, Rudolph et al. 2000) and
can involve the degradation of IkBa, IkBb and IkB1. The
p105 protein may also play a role in the canonical path-
way. In addition to the constitutive, cotranslational proces-
sing of p105 (Lin et al. 1998), which provides the resting
cell with the small amount of p50 required for its basal
needs (e.g. low-level transcription or repression of tran-
scription), IKK-dependent phosphorylation and ubiquitina-
tion of p105 may occur in response to pro-inflammatory
cytokines and LPS (Heissmeyer et al. 1999, Heissmeyer
et al. 2001). Such inducible targeting of the p105 precur-
sor can result in two distinct processes, which employ dis-
tinct ubiquitin ligases: there may be either complete
degradation or limited processing of the protein (Cohen
et al. 2004). Presumably processing of p105 will provide
solely p50 subunits whereas degradation may release a
variety of NF-kB subunits bound to the p105 ankyrin
repeats.
The non-canonical pathway is activated in response to a
subset of NF-kB inducers, such as lymphotoxin b, B-cell
activating factor, or the CD40 ligand, although these can
also trigger the canonical pathway. In the non-canonical
pathway, which is NEMO- and IKKb-independent (Clau-
dio et al. 2002, Dejardin et al. 2002), IKKa homodimers
phosphorylate p100 associated with RelB. This elicits the
processing of p100 to p52 and releases transcriptionally
Figure 3 Schematic model of the canonical NF-kB signalling pathway. Stimulation of the cell by tumour necrosis factor-a (TNFa), interleukin-1b
(IL-1b) or lipopolysaccharide (LPS) leads to the degradation of the small IkB proteins (classically IkBa), by the IKK complex. IKK-dependent
phosphorylation targets IkBa for ubiquitination (Ub) and degradation by the proteasome. Once IkBa is degraded, p65 is phosphorylated (P) and
the NF-kB nuclear localization signals are unmasked, allowing the p50/p65 dimer to translocate to the nucleus where it binds to NF-kB response
elements (kB) in the promoter of target genes. Induction of p105 degradation may simultaneously occur, thereby releasing further NF-kB dimers,
including p50/p65. The p105 precursor may also be processed in response to cytokines to generate additional p50 homodimers, which may take
part in NF-kB DNA binding or be displaced from DNA by transactivating dimers. In the nucleus, further phosphorylation and acetylation (A)
modifications of NF-kB occur, promoting the recruitment of co-activators, e.g. CREB-binding protein (CBP) to drive transcription. Termination of
signalling occurs when newly synthesized IkBa displaces DNA-bound NF-kB and exports it back to the cytoplasm.
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Figure 1.3 Schematic model of the canonical NF-κB signaling pathw y. 
Adopted from Tamsin M Lindstrom and Phillip R Bennett, The role of nuclear factor kappa B in human 
labour. Reproduction (2005) 130 569–581 	  NF-­‐κB	   plays	   a	   key	   r e	   in	   regulating	   the	   immune	   esponse	   to	   fection	   208.	   NF-­‐κB	  pathways	  are	  importa t	  for	  the	  cytokine	  stimulated	  CCL2	  and	  CCL7	  production	  209.	  It	  also	  regulates	  the	  chemoattractants	  such	  as	  CCL2	  and	  CXCL-­‐8	  210.	  The	  production	  of	  several	  pro-­‐inflammatory	  cytokines,	  such	  as	  TNFα,	  IL-­‐1β,	  IL-­‐6,	  IL-­‐17	  and	  IL-­‐23,	  which	  are	   all	   increased	   during	   labour,	   are	   NF-­‐κB-­‐dependent211-­‐213.	   Promoters	   of	   these	  cytokines	  contain	  NF-­‐κB	  response	  elements,	  which	  are	  essential	   for	   transcription	  of	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CXCL8	   gene	   in	   amnion	   and	   cervical	   cells	   214.	   On	   the	   other	   hand,	   NF-­‐κB	   is	   a	   highly	  inducible	  by	  pro-­‐inflammatory	  stimuli.	  LPS,	  TNFα	  and	  IL-­‐1β	  were	  shown	  to	  activate	  NF-­‐κB	   in	  uterus	   215-­‐217.	   In	   IL-­‐1β	  deficient	  mice,	  NF-­‐κB	  activity	  decreased	  due	   to	   the	  decline	   of	   cytokine	   production	   when	   treated	   with	   LPS	   218.	   	   	   Stretch	   also	   induces	  activation	  of	  NF-­‐κB	  in	  amnion	  cells,	  but	  not	  myometrial	  cells	  219.	  	  
Prostaglandins	   are	   involved	   in	   the	   process	   of	   labour,	   including	   cervical	   ripening,	  dilation	  and	  stimulating	  uterine	  contraction	  220.	  The	  promoter	  of	  COX-­‐2	  contains	  two	  NF-­‐κB	  binding	   sites.	  Blocking	   the	  nuclear	   translocation	  of	  NF-­‐κB	   inhibits	  TNFα	  and	  IL-­‐1β	  induced	  COX-­‐2	  expression	  in	  amnion	  and	  trophoblast	  cells	  217,221.	  
In	  early	  pregnancy,	  the	  suppression	  of	  NF-­‐κB	  activation	  by	  progesterone	  is	  important	  in	  maintaining	   the	   quiescence	   of	   the	   uterus	   222.	   During	   labour,	   NF-­‐κB	   activation	   is	  reported	  to	  occur	  in	  myometrium,	  cervix	  and	  amnion	  223-­‐225,226.	  Suggesting	  that	  NF-­‐κB	  activation	  is	  a	  key	  part	  of	  the	  onset	  and	  progression	  of	  labour.	  	  
1.5.2	  MAPK	  pathways	  	  Mitogen-­‐activated	  protein	  (MAP)	  kinases	  respond	  to	  extracellular	  stimuli	  (mitogens,	  heat	  shock	  and	  pro-­‐inflammatory	  cytokines)	  and	  regulate	  cellular	  activations,	  which	  involve	  differentiation,	  gene	  expression,	  proliferation	  and	  apoptosis	  227.	  Six	  groups	  of	  MAPKs	  have	  been	  defined	  in	  mammalian	  cells:	  	  extracellular	  signal-­‐regulated	  kinases	  (ERK1	   and	   ERK2),	   Jun	   N-­‐terminal	   kinases	   (JNK),	   which	   are	   crucial	   in	   regulating	  responses	  to	  various	  stresses	  and	  apoptosis	  and	  p38	  kinase	  isoforms,	  ERK5,	  ERK3/4	  and	  ERK7/8.	  Among	  the	  targets	  of	  MAPKs	  are	  several	  transcription	  factors,	  including	  NF-­‐κB,	  p53	  and	  activating	  transcription	  factor	  2	  (ATF2)	  that	  modulate	  the	  expression	  of	   genes	   encoding	   pro-­‐inflammatory	   cytokines	   228.	   Hypertrophy	   induced	   by	  mechanical	   stretch	   of	   the	   rat	   uterus	   stimulates	   myometrial	   cell	   activate	   MAPK	  cascades	   229,230.	   In	   rat	  myometrium,	  MAPKs	   are	   involved	   in	   inhibiting	   gap	   junction-­‐mediated	   cellular	   communication	   and	   stretch-­‐induced	   c-­‐fos	   expression	   231,232.	   In	  addition,	   the	   expression	   of	   MAPK	   p38	   and	   ERK-­‐1/2	   in	   conjunction	   with	   ATF2	  isoforms	  within	   the	   human	   uterine	   corpus	   during	   pregnancy	   and	   labor	   is	   likely	   to	  play	  a	  key	  role	  in	  preparation	  of	  the	  uterus	  for	  delivery	  233.	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In	  human	  myometrial	  cells,	  the	  MAPK	  pathways	  are	  also	  implicated	  in	  the	  induction	  of	   COX-­‐2	   expression	   and	   in	  mediating	   the	   effects	   of	  OT	   and	   corticotropin-­‐releasing	  hormone	  (CRH)	  202,234.	  CRH	  is	  a	  stress	  hormone,	  which	  has	  been	  suggested	  to	  play	  an	  important	  role	  in	  human	  parturition.	  The	  level	  of	  CRH	  increases	  in	  maternal	  plasma	  during	   the	   last	   weeks	   of	   pregnancy.	   Its	   receptors	   are	   highly	   expressed	   in	  choriodecidua,	   placenta	   and	   myometrium	   235.	   Moreover,	   the	   MAPK	   cascade	   is	  reported	  to	  be	  involved	  in	  PGF2α	  and	  endothelin-­‐1	  induced	  rat	  puerperal	  contraction	  236,237.	   MAPK	   activity	   increases	   in	   the	   rat	   myometrium	   from	   day	   15	   to	   day	   20	   of	  gestation	  and	  but	  intriguingly	  declines	  sharply	  just	  before	  parturition	  238.	  During	  the	  same	   interval,	   a	   shift	   in	   intracellular	   distribution	   of	   the	   Ras	   protein	   precedes	   the	  down-­‐regulation	   of	   membrane-­‐dependent	   mitogenic	   signaling	   and	   uterine	  hypertrophy	   as	   gestation	   approaches	   parturition	   239.	   ERK	   phosphorylation	   levels	  increase	   in	  a	   rat	  model	  of	  preterm	  delivery.	  After	  chronically	  being	   treated	  with	  an	  agent	  that	  prevents	  ERK	  activation,	  the	  onset	  of	  preterm	  labour	  of	  the	  rat	  is	  delayed	  240,241.	   The	   effect	   of	   oxytocin	   on	   human	   myometrium,	   which	   is	   mediated	   via	   a	   G-­‐protein	   linked	  receptor,	  activates	  MAPK	  pathways,	  and	  stimulates	   the	  expression	  of	  prostaglandins	  242.	  	  
1.5.3	  Protein	  kinase	  PKC	   constitute	   a	   family	   of	   enzymes,	   which	   may	   determine	   two	   essential	   uterine	  processes,	   contractility	   and	   proliferation.	   There	   are	   3	   subfamilies	   of	   PKC,	   the	  conventional	   PKC	   isoforms	   (α,	   βI,	   βII,	   and	   γ),	   the	   activation	   of	  which	   requires	   Ca2+,	  diacylglycerol,	  and	  a	  phospholipid	   for	  activation;	   the	  novel	  PKC	   isoforms	  (δ,	   ε,	  η,	  θ)	  that	  require	  DAG,	  but	  do	  not	  require	  Ca2+	  for	  activation	  and	  the	  atypical	  PKC	  isoform	  (protein	   kinase	  Mζ	   and	   ι	   /	   λ	   isoforms)	   require	   neither	   Ca2+	   nor	   diacylglycerol	   for	  activation.	  PKC	  is	  present	  in	  human	  myometrium	  and	  is	  required	  for	  proliferation	  of	  human	  myometrial	  cells	  243.	  Further,	  PKCs	  are	  thought	  to	  be	  involved	  in	  determining	  the	  balance	  between	  T	  helper	  (Th1)	  (pro-­‐inflammatory)	  and	  Th2	  (anti-­‐inflammatory)	  cytokine	   production	   that	   has	   been	   described	   at	   the	   time	   of	   parturition	   244	   and	   are	  important	   components	   of	   the	   TNFα/IL-­‐1β	   signaling	   pathway	   that	   controls	   NF-­‐κB	  activation.	  Such	  roles	  suggest	   that	  PKC	  may	  be	  critically	   important	   in	   the	  control	  of	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human	   labour.	   Further,	   the	   levels	   of	   PKC	   mRNA	   isoforms	   in	   pregnant	   human	  myometrium	  were	   greater	   than	   those	   in	   non-­‐pregnant	  myometrium	   244,245.	   In	   CHO	  cells	  that	  being	  transfected	  with	  rat	  OTR,	  PKC	  activation	  through	  G	  proteins	  and	  ERK2	  phosphorylation	   were	   shown	   to	   be	   vital	   steps	   in	   the	   process	   of	   OT	   stimulation	   of	  PGE2	  and	  c-­‐fos	  synthesis	  (Fig	  1.6)	  246.	  	  Another	   important	   kinase	   involved	   in	   human	   parturition	   is	   phospholipase	   C	   (PLC).	  PLC	   consists	   of	   a	   group	   of	   enzymes	   that	   cleaves	   the	   phospholipids	   just	   before	   the	  phosphate	   group	   and	   is	   involved	   in	   particular	   cell	   signal	   pathways.	   PLCβ1-­‐4	   is	   the	  well-­‐known	  mammalian	   phosphatidylinositide-­‐specific	   PLCβ	   subfamily.	   A	   pregnant	  human	   myometrial	   cell	   line	   expressed	   only	   PLCβ1	   and	   PLCβ3.	   PLCβ1,	   PLCβ2,	   and	  PLCβ3	   are	   presented	   in	   human	   myometrium	   247,248.	   Oxytocin-­‐mediated	   ERK1/2	  activation	  in	  human	  myometrial	  cells	  involves	  a	  PLC-­‐independent	  pathway	  234.	  In	  rat	  myometrium,	  PLC	  coupling,	  which	  involves	  in	  cAMP-­‐dependent	  phosphorylation,	  can	  exert	  a	  negative	  effect	  on	   the	  stimulation	  of	   IP3	   formation	  by	  oxytocin	  and	   thereby	  affect	   contraction/relaxation	   in	   the	   myometrium	   249.	   PLC	   is	   also	   involved	   in	   the	  prostaglandin-­‐induced	  increase	  in	  intracellular	  calcium	  levels	  in	  myometrial	  cells	  250.	  
cific for the ⌅, ⌃, and ⇥ isoforms of PKC, but it has
recently been shown that it also inhibits MAPKAP
kinase-1⌃ (Rsk-2) and p70 S6 kinase, both members of
the MAPK cascade (2). Because both these activities
are downstream from ERK2, it is more likely that the
inhibition of OT-stimulated ERK2 phosphorylation by
GF-109203X was due to the inhibition of PKC activity.
Inhibition of increases in [Ca2⇧]i with the Ca2⇧ sponges
partially blocked OT-stimulated ERK2 phosphoryla-
tion. Conversely, elevation of [Ca2⇧]i with Calcimycin
caused ERK2 phosphorylation, indicating that intracel-
lular Ca2⇧ is important in activating ERK2 in CHO-
OTR cells. The effects of Calcimycin on ERK2 were
blocked by PKC inhibition, suggesting that rather than
[Ca2⇧]i causing ERK2 phosphorylation via a PKC-
independent, p21ras-mediated process (14, 15), Ca2⇧
activates PKC.
The transcription factor Elk-1 (ternary complex factor-
1), which participates in formation of a ternary complex
with the serum response element allowing transcrip-
tion of c-fos, is phosphorylated by ERKs (19). Because
OT activated ERK2, it was not surprising that OT also
induced increases in c-fos mRNA levels. Indeed, OT
induction of c-fos mRNA was virtually eliminated by
pretreating CHO-OTR cells with the MEK1/2 inhibitor
PD-98059. AP1 activity often is induced by mitogens,
and the ERK pathway is generally considered to be
involved in cell proliferation or differentiation, depend-
ing on cellular context (12). However, OT had no effect
on [3H]thymidine incorporation by CHO-OTR cells,
unlike FBS or bFGF. Thus the role of OT-induced
synthesis of c-fos mRNA in CHO-OTR cells remains to
be determined. The phosphorylation of ERK2 is critical
for OT-induced PGE2 synthesis, as the
effects of OT on PGE2 were completely blocked by
PD-98059. Inhibition of ERK2 phosphorylation by PTX
and GF-109203X gave proportional effects on OT-
stimulated PGE2 release, indicating a clear causal
relationship betweenERK2 activation andPGE2 synthe-
sis. Although it has been demonstrated that MAPK is
involved in cPLA2 phosphorylation (23), there is evi-
dence to suggest that the rise in intracellular Ca2⇧, and
not phosphorylation of cPLA2, is essential for activation
of the arachidonic acid cascade in rat liver macro-
phages (5). In other studies, PD-98059 inhibited p42/
p44MAPK activation in thrombin-, collagen- and phorbol
ester-stimulated platelets, but did not interfere with
the release of arachidonic acid or with cPLA2 phosphor-
ylation (7). Our findings, which indicate a causal rela-
tionship between inhibition of ERK2 phosphorylation
and inhibition of PGE2 production, are more consistent
with the conclusions of other studies (34). In summary,
we have shown that PKC activation through G proteins
and ERK2 phosphorylation are vital steps in the pro-
cess ofOT stimulation of PGE2 and c-fos synthesis (Fig.
9). PKC-independent steps involving p21ras appear to
be less important in OT signaling in CHO-OTR cells
(Fig. 9). Our studies also establish these cells as a valid
model to study additional signaling pathways involved
in OT action.
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Fig. 9. OT signaling pathways in CHO-
OTR cells. Major route, indicated by
heavy arrows, involves Gi andGq activa-
tion of PLC and subsequently PKC.
Effects of OT on PGE2 synthesis and
c-fos expression are totally (or almost
totally, repectively) blocked by inhibi-
tion of ERK2 phosphorylation with PD-
98059. Potential pathways involving
activation of p21ras either by Ca2⇧ or by
Shc-Grb2-Sos formation, via tyrosine
kinase phosphorylation, appear to be
less important in this system (broken
arrows). Sites of action ofPTX, U-73122,
BAPTAand TMB, GF-109203X and PD-
98059 are also shown.












































Figure 1.4 OT signaling pathways in CHO-OTR cells.  
Adapted from Zuzana Strakova, John A. Copland, Stephen J. Lolait, and Melvyn s. Soloff, ERK2 mediates 
oxytocin-stimulated PGE2 synthesis. Am J Physiol Endocrinol Metab 274:634-641, 1998.      
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1.6	  Available	  human	  myometrial	  models	  
A	   number	   of	   studies	   have	   been	   performed	   on	   primary	   myometrial	   cells	   and	  myometrial	  cell	  lines,	  a	  viral-­‐based	  transformation	  of	  myometrial	  cells	  has	  been	  used	  by	  several	  laboratories251,252.	  	  Some	  have	  suggested	  that	  the	  phenotype	  of	  these	  cells	  might	   not	   reflect	   normal	   myometrial	   cell	   characteristics,	   however,	   after	   being	  transfected	  with	  an	  expression	  vector	  for	  the	  catalytic	  subunit	  of	  human	  telomerase,	  primary	  cells	  have	  been	  shown	  to	  maintain	  a	  normal	  karyotype	  and	  phenotype253,254.	  Anderson’s	   group	   recently	   developed	   three	   telomerase-­‐immortalized	   cell	   line	   from	  term-­‐pregnant	   human	   myometrium.	   These	   cells	   were	   shown	   to	   have	   a	   normal	  karyotype	  and	  were	  proved	  to	  be	  smooth	  muscle	  by	  a	  α-­‐actin	  staining255.	  Over	  the	  20	  years,	  most	  of	  the	  studies	  on	  myometrium	  were	  done	  on	  primary	  cultured	  cells,	  when	  used	  at	   low	  passage	  number	  these	  cells	  retain	  most	  of	   the	  characteristics	  of	  normal	  cells.	  Therefore,	  I	  used	  primary	  cultured	  cells	  in	  my	  studies.	  	  Human	  primary	  cultures	  cells	  can	  easily	  be	  treated	  to	  mimic	  physiological	  and	  pathological	  processes,	  however,	  these	   studies	   are	   limited	   by	   the	   absence	   of	   other	   cell	   types,	   the	   loss	   of	   the	   normal	  intracellular	   relationships	   and	   the	   homeostatic	   mechanisms	   present	   in	   the	   body.	  Consequently,	  although	  hypotheses	  can	  be	  generated	   in	  vitro,	  they	  need	  to	  be	  tested	  
in	   vivo	   by	   using	   appropriate	   animal	   models	   both	   to	   elucidate	   the	   mechanisms	   of	  labour	  and	  to	  investigate	  possible	  interventions	  to	  prove	  the	  outcomes.	  
1.7	  Mouse	  model	  	  	  	  
Despite	  some	  biological	  differences,	  mouse	  models	  are	  very	  important	  and	  frequently	  used	   in	   the	   study	   of	   human	   labour,	   since	   they	   can	   be	   used	   in	   large	   numbers	   and	  tolerate	   to	   surgery	   very	   well.	   They	   can	   be	   genetically	   altered	   to	   help	   define	   the	  pathways	  involved	  in	  parturition.	  Equally,	  there	  are	  differences	  between	  rodent	  and	  human	  pregnancy,	  for	  example	  progesterone	  withdrawal,	  which	  occurs	  before	  labour	  in	  rodent,	  does	  not	  happen	  in	  human.	  On	  the	  other	  hand,	  recent	  studies	  have	  shown	  that	  progesterone	  withdrawal	  might	  not	  be	  necessary	  for	  mouse	  preterm	  labour256,257.	  Inflammation	   represents	   a	   common	   biochemical	   pathway,	   in	   which	   the	   different	  causes	  of	  both	  preterm	  and	  term	  labour	  converge	  12.	  Intrauterine	  infection	  is	  thought	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to	  induce	  preterm	  labour	  through	  the	  interaction	  of	  bacterial	  products	  with	  the	  toll-­‐like	  receptors	   258,259.	  To	  mimic	   this	  process,	   inflammatory	  or	   infectious	  agents	  were	  introduced.	  The	  use	  of	  live	  bacteria	  may	  mimic	  such	  cases	  as	  human	  preterm	  labour	  in	  which	   culture	   of	   amniotic	   fluid	   test	   positive	   for	   bacteria.	   Killed	   bacteria,	   LPS	   or	  lipotechoic	   acid	   induced	   an	   inflammatory	   state	   without	   an	   overt	   infection.	   Studies	  have	   shown	   that	   a	  very	   low	  dose	  of	  LPS	   (1–10	  ng)	   injected	   in	  mice	   can	   specifically	  activate	  TLR-­‐4	  signaling,	   leading	  to	  dramatic	   increases	   in	  proinflammatory	  cytokine	  production	  260,261.	  Intrauterine	  injection	  of	  10	  μg	  LPS	  induced	  preterm	  delivery	  in	  all	  mice	   within	   16.8	   hours	   (54.7hours	   for	   saline	   injected	   mouse)	   262	   An	   intrauterine	  injection	  of	  TLR-­‐4-­‐grade	  LPS	  at	  doses	  between	  0.25	  and	  5μg	  on	  d17	  of	  pregnancy	  led	  to	   rapid	   preterm	   delivery	   within	   18	   hours	   and	   high	   pup	   mortality,	   whereas	   the	  induced	  preterm	  delivery	  of	  LPS	  injection	  at	  a	  dose	  of	  0.1	  μg	  on	  d	  16	  occurred	  within	  24	  hour	  which	  associated	  with	  a	  wider	  potential	  window	  for	  therapeutic	  intervention	  and	  with	   reduced	  mortality	   263.	   	   The	   level	   of	  TNFα,	   CCL2	   and	   IL-­‐6	   increased	   in	   the	  amniotic	  fluid	  3-­‐6	  hours	  after	  the	  i.p.	  injection	  of	  LPS,	  and	  the	  increase	  was	  greater	  in	  d17	  animals	  than	  in	  the	  d16.	  There	  was	  a	  robust	  response	   in	  the	  myometrium	  with	  up-­‐regulation	   of	   IL-­‐1β,	   MIP-­‐2,	   IL-­‐4,	   TNFα,	   IL-­‐6,	   and	   IL-­‐10	   mRNA	   264.	   However,	  pharmacological	  agents	  against	  IL-­‐1β	  or	  TNFα	  did	  not	  prevent	  inflammatory-­‐induced	  preterm	  delivery	  in	  mouse	  265.	  	  
CCL2	   and	   its	   receptor	   CCR2	   are	   essential	   for	  monocytes	   trafficking.	   In	   the	   rat,	   the	  expression	  of	  CCL2	  increases	  with	  advancing	  gestational	  age	  has	  and	  only	  decreases	  after	   labour	   166.	   However,	   whether	   there	   are	   differences	   of	   the	   expression	   of	  chemokine/chemokine	  receptors	  during	  pregnancy	  and	  labour	  between	  rat	  and	  mice	  remains	   unknown.	   	   CCR2	   knockout	   (CCR2KO)	  mouse	   has	   been	   used	   in	   parturition	  related	  studies,	  but	   it	  has	  been	  used	   in	  other	  models.	   In	  LPS	   induced	   lung	   infection,	  compare	  to	  wild	  type	  mice,	  CCR2KO	  mice	  showed	  lower	  macrophages	  accumulations	  in	  alveolar,	  which	  was	  accompanied	  by	  high	  level	  of	  CCL2	  in	  bronchoalveolar	  lavage	  fluid	   266.	   Similar	   results	   occurred	   in	   peritoneal	   macrophage	   numbers	   after	  thioglycollate	  injection	  267.	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CCR6	  is	  expressed	  on	  immature	  dendritic	  cells	  268-­‐270,	  memory	  T	  cells	  271,	  and	  B	  cells	  272,	   suggesting	   that	   CCR6	   plays	   an	   important	   role	   in	   adaptive	   immunity.	   CCR6	   has	  only	   one	   chemokine	   ligand,	   CCL20,	   although	   β-­‐defensin	   has	   been	   reported	   to	   bind	  CCR6	  with	  a	   lower	  affinity	   273.	  These	   characteristics	  of	  CCR6	  make	  CCR6	  knock	  out	  mouse	  a	  very	  good	  model	  in	  the	  study	  of	  chemokine/chemokine	  receptor	  in	  human.	  In	   a	   peritoneal	   cavity	   inflammation	   model,	   a	   CCR6-­‐/-­‐	   C57B/6	   mouse	   model	   had	  significantly	  lower	  numbers	  of	  macrophages	  and	  dendritic	  cells,	  but	  a	  higher	  number	  of	   B	   cells	   in	   the	   peritoneal	   cavity,	   as	   compared	   to	   wild	   type	   controls.	   After	   the	  injection	  of	  LPS,	  the	  level	  of	  chemokines	  and	  cytokines	  in	  peritoneal	  cavity	  in	  CCR6-­‐/-­‐	  mouse	  were	  significantly	  lower	  than	  the	  wild	  type	  ones,	  suggesting	  that	  the	  CCR6-­‐/-­‐	  mouse	  may	  be	  interesting	  to	  study	  in	  inflammation-­‐induced	  preterm	  labour	  274.	  
1.8	  Hypothesis	  and	  Objectives	  
1.8.1	  Hypotheses	  The	  expression	  of	  chemokines	  increases	  with	  the	  onset	  of	  labour.	  	  
Myometrial	  chemokine	  expression	  is	  regulated	  by	  cytokines,	  chemokines,	  stretch	  and	  pro-­‐labour	  factors.	  
CCL2/CCR2	  and	  CCL20/CCR6	  are	  essential	  for	  normal	  and	  LPS-­‐induced	  labour	  in	  the	  mouse.	  
1.8.2	  Objectives	  
1) To	   define	   human	  myometrial	   expression	   of	   chemokines	   and	   their	   receptors	  with	  advancing	  pregnancy	  and	  labour. 
2) To	  elucidate	  the	  role	  of	  inflammatory	  cytokines,	  labour-­‐associated	  factors	  (OT,	  PGs)	  and	  stretch	  in	  the	  regulation	  of	  the	  expression	  of	  myometrial	  chemokines	  and	  their	  receptors. 
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3) To	  investigate	  which	  pathways	  (PLC,	  PKC	  and/or	  PI3K)	  are	  involved	  in	  the	  PG	  and	  OT	  induced	  down-­‐regulation	  of	  myometrial	  chemokine	  expression. 
4) To	  use	  chemotaxis	  assays	  to	  identify	  whether	  the	  supernatants	  of	  myometrial	  and	   amnion	   cell	   cultures	   exposed	   to	   mechanical	   stretch	   and	   inflammatory	  cytokines	  stimulate	  chemotaxis	  and	  neutrophil	  activation. 
5) To	  investigate	  the	  effects	  of	  CCL20	  on	  pro-­‐labour	  gene	  expression	  in	  primary	  cultures	  of	  human	  myometrial	  cells. 
6) To	   define	   the	   patterns	   of	   expression	   of	   chemokines	   and	   their	   receptors	   in	  mouse	   myometrium	   during	   the	   oestrous	   cycle,	   pregnancy	   and	   parturition	  term	  and	  inflammation-­‐induced	  PTL. 
7) To	   investigate	  whether	   chemokine	   receptor	   deletion	   (CCR6	   and	   CCR2)	   alter	  the	  response	  to	  inflammation	  and	  delay	  normal	  LPS	  induced	  preterm	  labour	  in	  the	  mouse.	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2.1	  Materials	  
Chemicals,	  reagents	  and	  solvents	  
Absolute	  Ethanol:	   	   	   	   	   Fisher	  Scientific	  
Acrylamide:	   	   	   	   	   	   Roche	  
Agarose:	   	   	   	   	   	   Invitrogen	  
β-­‐Mercaptoethanol:	   	   	   	   	   Sigma-­‐Aldrich	  
Bench	  top	  protein	  marker:	   	   	   	   Promega	  
Bovine	  Serum	  Albumin:	   	   	   	   Sigma-­‐Aldrich	  
Bromophenol	  Blue:	   	   	   	   	   Bio-­‐Rad	  
Deoxynucleotide	  triphosphate	  (dNTP):	   	   Bio-­‐Rad	  
DNA	  Ladders:	  	   	   	   	   	   Invitrogen	  
Ethylenediaminetetraacetic	  Acid	  (EDTA):	   	   Sigma-­‐Aldrich	  
Fixation	  Buffer:	   	   	   	   	   eBiosciences	  
Isopropanol:	   	   	   	   	   	   Fisher	  Scientific	  
Methonal:	   	   	   	   	   	   Fisher	  Scientific	  
MgCl2:	  	   	   	   	   	   	   Sigma-­‐Aldrich	  
NaCl:	   	   	   	   	   	   	   Sigma-­‐Aldrich	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NaOH:	  	   	   	   	   	   	   	   Sigma-­‐Aldrich	  
Oligo-­‐dT	  random	  primers:	   	   	   	   	   Applied	  Biosysterems	  
Oligonucleotides	  and	  primers:	   	   	   	   Invitrogen	  
RNaseZap:	   Ambion	  
RIPA	  Buffer:	   Sigma-­‐Aldrich	  
Skimmed	  Milk	  Power:	   Marvel	  
SYNR	  Green	  Reagents:	   Applied	  Biosystems	  
SYBR	  Safe:	   Invitrogen	  
Tris	  Base:	   Sigma-­‐Aldrich	  
Tween	  20:	   Sigma-­‐Aldrich	  
Buffer,	  Solutions	  and	  Gels	   	  
TE	  buffer	  
100mM	  Tris-­‐Hcl,	  pH8.0	  
1mM	  EDTA,	  pH8.0	  
Complete	  protease	  inhibitor	  tablets	  (Roche)	  
FACS	  Wash	  Buffer	  
0.5%	  FCS	  in	  PBS	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Polyacrylamide	  stacking	  gels	  	  





Phosphate	  Buffered	  Saline	  (PBS)	  
140nM	  NaCl	  
2.5nM	  KCl	  
1.5mM	  KH2PO4,	  pH7.2	  
10mM	  Na2HPO4,	  pH7.2	  
Tris	  Buffered	  Saline	  (TBS)	  
130mM	  NaCl	  
20mM	  Tris-­‐HCl,	  pH	  7.6	  
Adjusted	  to	  pH7.4	  with	  HCl	  
TBS-­‐Tween	  20	  (TBS-­‐T)	  
0.1%	  Tween	  20	  in	  TBS	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Western	  Blocking	  Buffer	  
5%	  (w/v)	  non-­‐fat	  milk	  in	  TBS-­‐T	  
Solutions	  for	  genotyping	  
Solution	  1	  (pH	  12):	  
25mM	  NaOH	  
0.2mM	  EDTA	  Na2	  
47.48ml	  dH2O	  
Solution	  2	  (pH	  5.0):	  
40mM	  Tis-­‐HCL,	  pH8.0	  
48ml	  dH2O	  
Antibodies	  
Anti-­‐goat	  IgG:	  	   	   	   	   	   Daco	  
Anti-­‐mouse	  IgG,	  HRP-­‐linked	  Antibody:	   	   Cell	  Signaling,	  7076	  
Anti-­‐rabbit	  IgG,	  HRP-­‐likned	  Antibody:	   	   Cell	  Signaling,	  7074	  
Alexa	  Fluor	  647	  anti-­‐CD192:	   	   	   eBiosciences	  
Alexa	  Fluor	  647	  anti-­‐CD196:	   	   	   eBiosciences	  
APC	  anti-­‐CD181:	  	   	   	   	   	   eBiosciences	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APC	  anti-­‐CD182:	   	   	   	   	   eBiosciences	  
β-­‐actin	  :	   	   	   	   	   	   Abcam,	  Ab6276	  
COX-­‐2:	  	   	   	   	   	   	   Santa	  Cruz	  Biochemicals,	  SC-­‐1745	  
NF-­‐κB	  p65:	   	   	   	   	   	   Santa	  Cruz	  Biochemicals,	  SC-­‐8008	  
Phospho-­‐C/EBPβ:	   	   	   	   	   Cell	  Signaling	  
Phospho-­‐c-­‐Jun:	   	   	   	   	   Santa	  Cruz	  Biochemicals,	  
Phospho-­‐NF-­‐κB	  p65	  (Ser536):	   	   	   Cell	  Signaling3031	  
CD45	   	   	   	   	   	   	   eBiosciences	  
F4/80	   	   	   	   	   	   	   eBiosciences	  
CD11b	  	   	   	   	   	   	   eBiosciences	  
CD11c	  	   	   	   	   	   	   eBiosciences	  
Gr1	   	   	   	   	   	   	   eBiosciences	  
CCR2	  antibody:	   	   	   	   	   Abcam	  
CCR6	  antibody:	   	   	   	   	   Abcam	  
CXCR1	  antibody:	   	   	   	   	   Abcam	  
CXCR2	  antibody:	   	   	   	   	   Abcam	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Table 2.1 Primers for human chemokine/chemokine receptors used in real-time PCR 
Name	   Forward	  (F)	  and	  Reverse	  (R)	  primer	   Genebank/EMBL	  Accession	  no.	   Nucleotide	  no.	   Ct	  value	  
GAPDH	   F:	  5’-­‐TGATGACATCAAGAAGGTGGTGAAG-­‐3’	  R:	  5’-­‐TCCTTGGAGGCCATGTAGGCCAT-­‐3’	   BC014085	   1644-­‐1883	   15.56±1.12	  CXCL8	   F:	  5’-­‐GCCTTCCTGATTTCTGCAGC	  -­‐3’	  R:	  5’-­‐	  CGCAGTGTGGTCCACTCTCA	  -­‐3’	   NM000584	   136-­‐285	   14.98±1.63	  
CXCL1	   F:	  5’-­‐GAAAGCTTGCCTCAATCCTG-­‐3’	  R:	  5’-­‐GCCTCTGCAGCTGTGTCTCT-­‐3’	   NM001511	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   325-­‐498	   18.03±2.98	  
CCL5	   F:	  5’-­‐CCATATTCCTCGGACACCAC-­‐3’	  R:	  5’-­‐	  TGTACTCCCGAACCCATTTC-­‐3’	   NM002985	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   141-­‐321	   19.65±3.40	  
CCL2	   F:	  5’-­‐TCTGTGCCTGCTGCTCATAG	  R:	  5’-­‐AGATCTCCTTGGCCACAATG-­‐3’	   X14768	   74-­‐276	   17.84±2.38	  
CCL20	   F:	  5’-­‐TTTATTGTGGGCTTCACACG	  R:	  5’-­‐TGGGCTATGTCCAATTCCAT-­‐3’	   NM004591	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   91-­‐228	   20.56±3.86	  
CXCL5	   F:	  5’-­‐	  GTGTTGAGAGAGCTGCGTTG-­‐3’	  R:	  5’-­‐	  GGCTTCTGGATCAAGACAAA-­‐3’	   NM_002994	   201-­‐480	   16.82±2.47	  
CXCR1	   F:	  5’-­‐	  TTTGTTTGTCTTGGCTGCTG-­‐3’	  R:	  5’-­‐	  AGTGTACGCAGGGTGAATCC-­‐3’	   NM_000634	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  463-­‐686	   23.80±3.38	  
CXCR2	   F:	  5’-­‐	  ACATGGGCAACAATACAGCA-­‐3’	  R:	  	  	  5’-­‐TGAGGACGACAGCAAAGATG-­‐3’	   NM_001557	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  605-­‐783	   20.10±2.54	  
CCR2	   F:	  5’-­‐	  TGGCTGTGTTTGCTTCTGTC-­‐3’	  R:	  5’-­‐	  TCTCACTGCCCTATGCCTCT-­‐3’	   NM_000647	   501-­‐729	   15.84±4.04	  
CCR6	   F:	  5’-­‐	  GAGGTCAGGCAGTTCTCCAG-­‐3’	  R:	  5’-­‐	  CTGCCCAGAATGGGAGAGTA-­‐3’	   NM_004367	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  311-­‐581	   17.84±2.38	  
CCL20	   F:	  5’-­‐	  CAAGCTTAGGCTGCTCCATC-­‐3’	  R:	  5’-­‐	  TCAGTCCTCTTGCAGCCTTT-­‐3’	   NM_002989	   81-­‐481	   18.53±2.20	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Table 2.2 Primers for mouse chemokine/chemokine receptors used in real-time PCR Name	   Forward	  (F)	  and	  Reverse	  (R)	  primer	  sequence	  (5’-­‐3’)	   Genebank/EMBL	  Accession	  no.	   Nucleotide	  no.	   Ct	  value	  GAPDH	   F:5’-­‐ACTCCACTCACGGCAAATTC-­‐3’	  R:5’-­‐TCTCCATGGTGGTGAAGACA-­‐3’	  	   NM001001303	   201-­‐371	   17.52±2.89	  CCL2	   F:	  5’-­‐CCCACTCACCTGCTGCTACT-­‐3’	  R:	  5’-­‐TCTGGACCCATTCCTTCTTG-­‐3’	   NM_011333	   81-­‐481	   18.20±1.69	  CCL5	   F:	  5’-­‐	  CCCTCACCATCATCCTCACT-­‐3’	  R:	  5’-­‐	  CCTTCGAGTGACAAACACGA-­‐3’	   NM_013653	   51-­‐321	   17.84±2.38	  CXCL1	   F:	  5’-­‐	  GCCTATCGCCAATGAGCTG-­‐3’	  R:	  5’-­‐	  AAGGGAGCTTCAGGGTCAAG-­‐3’	   NM_008176	   71-­‐321	   18.10±1.26	  CCL20	   F:	  5’-­‐	  CGACTGTTGCCTCTCGTACA-­‐3’	  R:	  5’-­‐	  CACCCAGTTCTGCTTTGGAT-­‐3’	  
NM_016960	   59-­‐320	   19.84±2.45	  
CXCL5	   F:	  5’-­‐	  CGCTAATTTGGAGGTGATCC-­‐3’	  R:	  5’-­‐	  GTGCATTCCGCTTAGCTTTC-­‐3’	  
NM_009141	   161-­‐490	   20.56±1.09	  
Cell	  Culture	  materials	  and	  medium	  	  
Cell	  strainer	  (2	  mm):	  	   	   	   Falcon	  
Collagenase	  XI	  or	  1A:	   	   	   Sigma-­‐Aldrich	  
Dulbecco’s	  Modified	  Eagles’	  Medium:	   Sigma-­‐Aldrich	  
Fetal	  Bovine	  Serum:	   	   	   	   Sigma-­‐Aldrich	  
Filter	  Unit	  (0.20 μM):	   	   	   Sartorius	  
L-­‐glutamine:	   	   	   	   	   Sigma-­‐Aldrich	  
Nutrient	  Mixture	  F-­‐12	  Ham:	  	   	   Sigma-­‐Aldrich
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Penicillin/Streptomycin:	   	   	   Sigma-­‐Aldrich	  
Tissue	  Culture	  Plastic-­‐ware:	  	   	   Corning,	  Falcon,	  Orange	  
Trypsin/EDTA:	   	   	   	   Sigma-­‐Aldrich	  
6-­‐well	  Flexible-­‐bottom	  plates:	   	   Flexcell	  International	  Corp.	  
Enzymes	  
Ampli-­‐Tag	  Gold	  DNA	  Polymerase:	   	   Applied	  Biosystems	  
DNase	  I	  (RNase-­‐free):	   	   	   Qiagen	  
MuL	  V	  reverse	  transcriptase:	   	   Applied	  Biosystems	  
Inhibitors	  and	  Treatments	  
Complete	  Protease	  Inhibitors:	   	   	   Roche	  
ERK	  Inhibitor	  U0126:	   	   	   	   Sigma-­‐Aldrich	  
Halt	  Phosphatase	  Inhibitor	  Single-­‐Use	  Cocktail:	   Thermo	  
IKK-­‐2	  Inhibitor	  TPCA-­‐1:	   	   	   	   Sigma-­‐Aldrich	  
Interleukin	  1β:	   	   	   	   	   Sigma-­‐Aldrich	  
JNK	  Inhibitor	  SP600125:	   	   	   	   Sigma-­‐Aldrich	  
p38	  Inhibitor	  SB203580:	   	   	   	   Sigma-­‐Aldrich	  
PGE2:	   	   	   	   	   	   	   Sigma-­‐Aldrich	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PGF2α:	  	   	   	   	   	   	   Sigma-­‐Aldrich	  
TNFα:	   	   	   	   	   	   	   Sigma-­‐Aldrich	  
Kits	  
cDNA	  synthesis	  and	  SYBR	  Green	  for	  qPCR:	   Applied	  Biosystems	  
GenElut	  Gel	  Extration	  Kit:	   	   	   	   Qiagen	  
QIA	  quick	  PCR	  perification	  Kit:	   	   	   Qiagen	  
RNeasy	  mini	  Kit:	   	   	   	   	   Qiagen	  
SDS-­‐PAGE	  electrophoresis	  and	  Westerm	  Blotting	  materials	  
Cell	  Lysis	  buffer:	   	   	   	   	   	   Cell	  Signaling	  
ECL	  Plus	  Western	  Blotting	  Detection	  System:	   	   GE	  Healthcare	  
ECL	  hperfilm:	  	   	   	   	   	   	   Amersham	  Biosciences	  
Hybond	  ECL	  Nitrocellulose	  membrane:	   	   	   Amersham	  Biosciences	  
Novex	  Sharp	  Pre-­‐stained	  Protein	  Standard:	   	   Invitrogen	  
NuPAGE	  LDS	  Samples	  buffer:	   	   	   	   Invitrogen	  
NuPAGE	  MOPS	  SDS	  running	  buffer:	  	   	   	   Invitrogen	  
SDS	  PAGE	  pre-­‐cast	  gels:	   	   	   	   	   Invitrogen	  
Supersignal	  West	  Pico	  Chemiluminescent	  Substrate:	   Pierce	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Transfer	  buffer:	   	   	   	   	   	   Bio-­‐Rad	  
2.2	  Methods	  
2.2.1	  In vitro	  studies	  
Tissue	  specimens	  All	   procedures	   involving	   paired	   upper	   and	   lower	   segment	   human	  myometrial	   tissues	  were	   conducted	   in	   compliance	  with	   the	   Institution	  Review	  Board	   of	   the	  University	   of	  Cincinnati	  (Cincinnati,	  OH,	  USA).	  Informed	  consent	  was	  obtained	  from	  all	  women	  before	  any	   tissue	   collection.	   Human	   myometrial	   samples	   were	   taken	   from	   four	   groups	   of	  women	  (mean	  gestational	  age	  ±	  SD	  in	  each	  case),	  at	  preterm	  no	  labour	  (PTNL:	  31.5	  ±	  3.5	  wks;	  mean	  ±	  SD;	  n=8),	  preterm	  labour	  (PTL:	  32.3	  ±	  4.1	  wks;	  n=8),	  term	  no	  labour	  (TNL:	  38.0	  ±	  1.2	  wks;	  n=8)	  or	   term	   labour	  (TL:	  39.4	  ±	  0.5	  wks;	  n=8)(Table	  2.3).	  Labour	  was	  defined	  as	  the	  presence	  of	  regular	  uterine	  contractions	  (every	  3-­‐4	  minutes)	  resulting	  in	  cervical	   effacement	   and	   dilation.	   Myometrial	   samples	   were	   removed	   from	   the	   upper	  margin	  of	  the	  incision	  made	  in	  the	  lower	  uterine	  segment,	  and	  for	  the	  upper	  segment,	  an	  Allis	  clamp	  was	  used	  to	  group	  a	  small	  segment	  (1.0x0.5	  cm)	  of	  myometrium	  below	  the	  fundus	  and	  tissue	  excised	  using	  Mayo	  scissors	  (this	  included	  the	  serosal	  surface	  but	  not	  the	   endometrium).	   Haemostasis	   was	   obtained	   using	   a	   single	   figure	   of	   size	   8	   sutures.	  Tissues	  were	  flash	  frozen	  in	  liquid	  nitrogen	  prior	  to	  storage	  at	  -­‐	  70°C.	  The	  indications	  for	  caesarean	   section	   included:	   failure	   to	   progress	   (n=4),	   fetal	   distress	   (n=8),	   previous	  uterine	   surgery	   (n=12),	   malpresentation	   (n=5),	   severe	   pre-­‐eclampsia	   (n=5),	   placenta	  praevia	  (n=1)	  and	  gestational	  diabetes	  (n=1).	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Table 2.3 The demographic data of paired upper and lower segment myometrial samples 
 PTNL (n=8) PTL (n=8) TNL (n=8) NL (n=8) 
Gestational age 32.3 (26-35.3) 33.3 (26.2-36.3) 38.4 (37-39.5) 39.3 (37.3-40.6) 
Reason for LSCS     
FTP - - - 3 
NRFHT 2 2 - 2 
PUS - 3 5 3 
Malpresentation - 3 1 - 
PET 4 - 1 - 
Placenta praevia 1 - - - 
GDM 1 - - - 
FTP, failure to progress; NRFHT, non-assuring fetal heart trace; PET, pre-eclampsia; GDM, gestational diabetes. 	  The	   myometrial	   samples	   for	   cell	   culture	   were	   collected	   in	   Chelsea	   and	   Westminster	  Hospital	  (London,	  United	  Kingdom).	  Tissue	  samples	  were	  taken	  from	  the	  upper	  margin	  of	   lower	  uterine	   segment	   incision	  at	   the	   time	  of	  TNL	   caesarean	   sections.	  The	   samples	  were	   	  	   placed	   	  	   in	   	  	   Dulbecco’s	  modified	   Eagle’s	  Medium	   (DMEM,	   Invitrogen)	  medium,	  which	   contains	   100mU/ml	   	  	   penicillin	   	  	   and	   100	   μg/ml	   streptomycin.	   	  Samples	   were	  stored	  at	  40C	  for	  no	  more	  than	  3h	  before	  the	  cell	  preparation	  for	  culture.	  The	  study	  was	  approved	  by	  the	   local	  Ethics	  Committee	  (RREC3663)	  and	  all	  specimens	  were	  obtained	  after	  written	  patient	  consent.	  	  
Primary	  cell	  culture	  	  Myometrial	   tissue	  was	  washed	   in	   phosphate-­‐buffered	   saline	   (PBS)	   after	   obtained	   and	  finely	   dissected.	   Cut	   tissue	   was	   then	   digested	   for	   45minutes	   at	   370C	   in	   a	   mixture	   of	  collagenase	   solution	   containing	   1	   mg/ml	   collagenase	   1A	   (Sigma)	   and	   1	   mg/ml	  collagenase	   XI	   in	   a	   mixed	   medium	   (50%	   DMEM	   and	   50%	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Dulbecco’s	   	  	  Modified	   	  	  Eagle’s	   	  	  Medium/Nutrient	   	  	  Mixture	   	  	  F-­‐12	  Ham).	  Tissue	  pieces	  were	  filtered	  through	  a	  cell	  strainer	  (70	  mm	  mesh)	  using	  a	  Pasteur	  pipette.	  Cells	  were	  then	   centrifuged	   at	   179g	   for	  5	  min	   and	   re-­‐suspended	  with	  DMEM	  medium	  containing	  10%	   fetal	   calf	   serum,	   L-­‐glutamine	   and	   100mU/ml	   penicillin	   and	   100mg/ml	  streptomycin.	  Cells	  then	  were	  cultured	  in	  T25	  in	  an	  atmosphere	  of	  5%	  CO2:	  95%	  air	  at	  370C.	   Myometrial	   cells	   from	   passage	   1-­‐4	   were	   washed	   using	   PBS	   and	   trypsinised	   in	  0.25%	   trypsin	   and	   cultured	   in	   6-­‐well	   plates	  with	   stripped	  medium	   (5%	  Charcoal	   and	  Dextran-­‐stripped	  fetal	  calf	  serum,	  L-­‐glutamine	  and	  100	  mU/ml	  penicillin	  and	  100	  mg/ml	  streptomycin).	  	  For	   mechanical	   stretch,	   cells	   were	   subjected	   to	   a	   static	   stretch	   of	   16%	   for	   different	  period	  of	  time	  using	  6-­‐well	  flexible-­‐bottom	  plates,	  which	  pre-­‐coated	  with	  collagen	  type	  I	  (Flexcell	   International	   Corp.,	   McKeesport,	   PA).	   Unstretched	   cells	   grown	   in	   the	   same	  stretch	   plates	   were	   used	   as	   controls.	   To	   determine	   the	   expression	   of	  chemokine/chemokine	   receptors	   with	   cytokines	   and	   pro-­‐labour	   genes,	   cells	   were	  incubated	  with	  IL-­‐1β,	  TNFα,	  IL-­‐6,	  IL-­‐8,	  PGE2,	  PGF2α	  and	  oxytocin	  respectively	  for	  1,	  6	  and	  24	   hours.	   A	   lower	   serum	  medium	   containing	   1%	   fetal	   calf	   serum	  was	   used	   to	   serum	  starve	  the	  cells	  12	  hours	  prior	  to	  each	  treatments.	  
Protein	  extraction	  from	  cultured	  cells	  Cell	  Lysis	  Buffer	  (Cell	  Signaling)	  containing	  protease	  inhibitor	  and	  phosphatase	  inhibitor	  was	   used	   to	   prepare	   protein	   samples	   from	   cultured	   cells.	   Cell	   lysate	  was	   obtained	   by	  using	  a	  cell	  scraper	  and,	  supernatant	  was	  taken	  from	  a	  centrifugation	  at	  13,000	  ×g	  for	  30	  min	   at	   40C.	   The	   concentration	   of	   protein	   was	   determined	   by	   Protein	   assay	   (Bio-­‐Rad	  Laboratories,	  USA).	  Bovine	  serum	  was	  used	  as	  standards.	  Samples	  were	  then	  aliquot	  and	  stored	  at	   -­‐70oC.	  Before	  western	  blotting,	  protein	   samples	  were	  denatured	   in	  heater	  at	  70oC	  for	  10	  min.	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Quantitative	  RT-­‐PCR	   	  Total	  RNA	  was	  extracted	  and	  purified	  from	  cell	  or	  tissue	  samples	  using	  RNeasy	  mini	  kit	  (Qiagen	  Ltd,	  UK)	  according	  to	  manufacturer’s	  protocol.	  After	  quantification,	  1.0	  µg	  was	  reverse	   transcribed	   with	   oligo	   dT	   random	   primers	   using	  MuLV	   reverse	   transcriptase	  (Applied	   Biosystems	   Ltd,	   UK).	   Primer	   sets	   for	   chemokine/chemokine	   receptors	   were	  designed	   and	  obtained	   from	   Invitrogen.	   These	  primer	   sets	   produced	   amplicons	   of	   the	  expected	   size	   (Table	   1).	   Assays	  were	   validated	   for	   all	   primer	   sets	   by	   confirming	   that	  single	   amplicons	   of	   appropriate	   size	   and	   sequence	   were	   generated	   according	   to	  predictions.	   Quantitative	   PCR	   was	   performed	   in	   the	   presence	   of	   SYBR	   Green	   (Roche	  Diagnostics	   Ltd,	   UK),	   and	   amplicon	   yield	   was	   monitored	   by	   Rotor	   Gene	   R-­‐G	   3000	  (Corbett	   Research,	   Australia)	   that	   continually	   measures	   fluorescence	   caused	   by	   the	  binding	  of	  the	  dye	  to	  double-­‐stranded	  DNA.	  Pre-­‐PCR	  cycle	  was	  7	  min	  at	  95℃	  followed	  by	  35	  cycles	  of	  95℃	  for	  10	  s	  and	  72℃	  for	  10	  s	  followed	  by	  final	  extension	  at	  72℃	  for	  1	  min.	  The	  cycle	  in	  which	  fluorescence	  reached	  a	  preset	  threshold	  (cycle	  threshold)	  was	  used	  or	  quantitative	  analyses.	  The	  cycle	  threshold	  in	  each	  assay	  was	  set	  at	  a	  level	  where	  the	  exponential	   increase	   in	   amplicon	   abundance	   was	   approximately	   parallel	   between	   all	  samples.	  	  The	  melt	  curve,	  which	  is	  a	  post	  PCR	  analysis	  used	  to	  test	  the	  integrity	  of	  the	  cDNA	  and	  the	   purity	   of	   the	   amplified	   samples	   and	   thus	   ensure	   that	   one	   is	   analysing	   the	   correct	  product.	  	  	  In	   order	   to	   correct	   the	   variations,	   data	   were	   expressed	   relative	   to	   the	   amount	   of	  constitutively	   expressed	   housekeeping	   gene.	   Our	   group	   tested	   the	   use	   of	   several	  commonly	   used	   housekeeping	   genes,	   including	   GAPDH,	   β-­‐actin,	   18sRNA,	   Calponin,	  HGRP	  and	  L19.	  It	  was	  found	  GAPDH	  was	  the	  best	  one	  to	  use	  to	  study	  myometrial	  cells.	  Conventional	   PCR	   was	   performed	   using	   Ampli-­‐Taq	   Gold	   DNA	   polymerase	   (Applied	  Biosystems	  Ltd).	  Pre-­‐PCR	  cycle	  was	  10	  min	  at	  95℃	   followed	  by	  35	  cycles	  of	  95℃	   for	  1	  min,	  56-­‐60℃	  for	  1	  min	  and	  72℃	  for	  1	  min	  followed	  by	  final	  extension	  72℃	  for	  10	  min.	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DNA	  electrophoresis	  and	  purification	  
1.5%	   agarose	   gels	   were	   prepared	   by	   dissolving	   agarose	   in	   1×tris-­‐borate-­‐EDTA	   (TBE)	  buffer	   and	   was	   heated	   until	   boiling.	   After	   cooling	   down,	   SYBR	   safe	   DNA	   gel	   stain	  (Invitrogen)	   was	   added	   to	   the	   solution,	   which	   was	   then	   poured	   into	   an	   appropriate	  mould.	  PRC	  products	  and	  restriction	  fragments	  were	  electrophoresed	  in	  1×TBE	  at	  100-­‐120V.	   The	   size	   of	   DNA	   fragments	   was	   estimated	   by	   comparing	   with	   the	   markers	  (Invitrogen).	  Target	  DNA	  fragments	  were	  cut	  and	  purified	   from	  agarose	  gel	  by	  Wizard	  SV	  Gel	  and	  PCR	  Clean-­‐Up	  System	  (Promega)	  according	  to	  manufacturer’s	  protocol.	  
Western	  blot	  analysis	  
Denatured	  protein	  samples	  (40-­‐60ug)	  were	   loaded	  in	  10-­‐15	  well	  gels	  (Invitrogen)	  and	  run	   on	   80-­‐130	   volts.	   After	   that,	   an	   electrophoretic	   transfer	   onto	   a	   Hybond	   ECL	  nitrocellulose	  membrane	   (Amersham	  Pharmacia	   Biotech)	  was	   performed.	  Membranes	  were	  blocked	  in	  washing	  buffer	  (5M	  NaCL,	  Tris-­‐HCL	  and	  Tween)	  containing	  5%	  milk	  for	  1	   h	   at	   room	   temperature,	  washed	   in	  washing	   buffer	   and	  hybridized	  with	   the	   primary	  antibody	   over	   night	   at	   4℃.	   Membranes	   were	   washed	   again	   and	   then	   incubated	   with	  secondary	   antibody	   at	   a	   dilution	   of	   1:2000	   for	   2	   h	   at	   room	   temperature.	   SuperSignal	  West	   Pico	   Chemiluminescent	   Substrate	   (Pierce,	   USA)	   was	   used	   for	   detection.	   Protein	  band	  size	  was	  determined	  using	  Novex	  Sharp	  Pre-­‐stained	  Protein	  Standard	  (Invitrogen).	  
ELISA	  
Cell	  culture	  medium	  was	  collected	  24	  hours	  after	  cells	  were	  stretch	  by	  16%,	  or	  treated	  with	  IL-­‐1β	  and	  oxytocin.	  Before	  the	  supernatant	  was	  collected,	  cell	  culture	  medium	  was	  spun	  at	  13.3RPM	  for	  20	  minutes.	  All	  supernatant	  was	  diluted	  5-­‐100	  fold	  before	  use.	  IL-­‐8	  ELISA	   kit	   was	   used	   (R&D	   Systems).	   The	   assay	   was	   performed	   following	   the	  manufacturer’s	   protocol.	   50ml	   of	   standards	   and	   samples	   were	   used	   in	   this	   assay.	   A	  
	   Chapter	  2.	  Materials	  and	  Methods	   	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  	  	  
44	  
miroplate	   reader	  was	   used	   to	   determine	   the	   density.	   Reading	  was	   performed	   at	   both	  450nm	  and	  540nm	  to	  correct	  for	  optical	  imperfections	  in	  the	  plate.	  
Transfection	  All	   steps	   were	   performed	   in	   a	   tissue	   culture	   cabinet,	   with	   the	   exception	   of	   the	  electroporation	   step.	   L1.2	   cells	   (a	   murine	   B	   cell	   line)	   were	   counted	   using	   a	  haemocytometer.	  1.5x107	  cells	  were	  transferred	  to	  a	  sterile	  50	  ml	  tube,	  and	  centrifuged	  at	   1200	   RPM,	   21°C,	   for	   5	   minutes.	   The	   vector	   pCDNA3	   containing	   CCR2	   or	   CXCR2	  constructs	  were	  used.	  50μg	  (10.5mg/ml)	  tRNA	  and	  1	  μg	  DNA	  per	  1x106	  cells	  were	  added	  to	  the	  bottom	  of	  a	  sterile	  cuvette	  (BTX	  Harvard	  Apparatus,	  USA).	  The	  supernatant	  of	  the	  centrifuged	   cells	   was	   decanted,	   and	   the	   pelleted	   cells	   resuspended	   in	   800μl	   simple	  Roswell	  Park	  Memorial	  Institute	  medium	  (RPMI),	  transferred	  to	  cuvette,	  and	  incubated	  at	   room	  temperature	   for	  20	  minutes.	  The	  cuvette	  was	  placed	   in	  a	  BioRad	  Gene-­‐pulser	  (BioRad,	  USA),	  electroporated	  at	  330	  volts,	  975	  μF,	  and	  incubated	  at	  room	  temperature	  for	   20	  minutes.	   The	   contents	   of	   the	   cuvette	  were	   transferred	   to	   a	   T-­‐75	   tissue	   culture	  flask	   containing	   15	  ml	   complete	   RPMI,	   and	   incubated	   for	   5	   hours	   at	   37°C.	   150	   μl	   1M	  sodium	  butyrate	  was	  added	  to	  the	  flask	  to	  give	  a	  final	  concentration	  of	  10	  mM,	  and	  the	  cells	  incubated	  overnight	  at	  37°C.	  The	  expressions	  of	  CCR2	  and	  CXCR2	  on	  transfected	  L	  1.2	  cells	  were	  detected	  by	  FACS	  before	  the	  chemotaxis	  assay	  be	  performed.	  	  	  
Chemotaxis	  Assay	  The	   chemotaxis	   assay	   was	   performed	   on	   transfected	   L1.2	   cells.	   Once	   expression	   had	  been	  confirmed	  by	  staining	  and	  flow	  cytometry,	  a	  96	  well	  chemotaxis	  plate	  (Neuroprobe,	  USA)	  was	  blocked	  by	  adding	  30	  μl	  1%	  BSA	  (0.1	  g	  in	  10	  ml	  simple	  RPMI)	  to	  each	  well,	  and	  incubating	  at	  room	  temperature	  for	  30	  minutes,	  which	  prevented	  the	  chemokines	  from	  sticking	  to	  the	  plastic	  of	  the	  wells.	  Supernatant	  from	  myometrium	  cell	  culture	  was	  used,	  and	  was	  diluted	   to	  1:2,	  1:4	  and	  1:8.	  The	  1%	  BSA	  was	  removed	   from	  the	  plate	  and	   the	  chemokine	  stocks	  added.	  31	  μl	  0.1%	  BSA	  was	  added	  to	  the	  first	  well	  as	  a	  buffer	  control,	  then	  31	  μl	  of	  different	  dilution	  of	  supernatant	  to	  the	  next	  well,	  and	  so	  on.	  The	  wells	  were	  filled	  in	  duplicate.	  The	  membrane	  of	  the	  chemotaxis	  plate	  was	  carefully	  attached	  to	  the	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fluid	  in	  each	  well.	  20	  μl	  of	  cells	  (at	  10x106/ml)	  were	  pipetted	  onto	  the	  contact	  point	  on	  the	  membrane.	  The	  lid	  of	  the	  plate	  was	  closed,	  and	  the	  plate	  was	  placed	  in	  a	  humidified	  box	   and	   incubated	   for	   5	   hours	   at	   37°C.	   After	   incubation,	   the	   lid	   and	  membrane	  were	  removed,	   and	   the	   cells	   scraped	   off	   the	  membrane.	   Cells,	   which	  migrated	   through	   the	  membranes	  into	  the	  supernatant	  in	  each	  well,	  were	  counted	  by	  using	  a	  microscope.	  
Flow	  cytometry	  Primary	   cultured	  myometrial	   cells	   were	   pre-­‐treated	   with	   oxytocin	   (10nM/ml)	   for	   24	  hours.	   Cells	   were	   lifted	   by	   cell	   dissociation	   solution	   (Sigma-­‐Aldrich)	   and	   washed	   by	  FACS	  wash	  buffer	  (PBS	  containing	  0.5%	  bovine	  serum	  albumin).	  None	  treated	  cells	  were	  harvested	   as	   controls.	   Cells	  were	   suspended	   in	  wash	   buffer	   and	  mixed	  with	   different	  antibodies	   for	   60	   minutes.	   Cells	   were	   incubated	   with	   the	   following	   antibodies:	   Alexa	  Fluor	   647	   anti-­‐CD192	   (CCR2),	   Alexa	   Fluor	   647	   anti-­‐CD196	   (CCR6),	   APC	   anti-­‐CD181	  (CXCR1)	  and	  APC	  anti-­‐CD182	  (CXCR2),	   respectively.	  Mouse	   IgG2b	  and	   IgG1	  antibodies	  (R&D	  systems)	  were	  used	  as	  isotype	  control.	  After	  incubated	  on	  ice	  for	  45	  minutes,	  cells	  were	  washed	  and	  re-­‐suspended	  FACS	  wash	  buffer.	  Flow	  cytometry	  was	  performed	  on	  a	  BD	   FACSCalibur	   flow	   cytometry	   system.	   A	   minimum	   of	   10,000	   events	   were	   counted.	  Data	  were	  analysed	  using	  FACSCalibur	  software.	  	  
2.2.2	  In vivo	  studies	  
Animals	  Animal	   studies	   were	   performed	   under	   UK	   Home	   Office	   License	   70/6906	   and	   in	  accordance	  with	  the	  UK	  Animals	  (Scientific	  Procedures)	  Act	  of	  1986.	  Virgin	  female	  and	  stud	  male	  CD1	  outbred	  mice	  were	  purchased	   from	  Charles	  River	   (Margate,	  UK)	  at	  6-­‐8	  weeks	  of	  age.	  Female	  CCR2	  knockout	  (KO)	  and	  CCR6	  KO	  mice	  on	  a	  C57BL/6	  background	  were	  purchased	  from	  the	  Jackson	  Laboratory	  (Bar	  Harbor	  Maine,	  USA).	   	  All	  mice	  were	  maintained	   in	  open	  cages	  at	  21	  ±	  1°C,	  with	  ad	  libitum	  access	  to	   food	  (RM1	  diet,	  Lillico	  Biotechnology,	   UK)	   and	   water,	   and	   a	   12:12	   light/dark	   cycle	   regimen.	   All	   mice	   were	  
	   Chapter	  2.	  Materials	  and	  Methods	   	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  	  	  
46	  
acclimatised	  for	  a	  minimum	  of	  72	  hours	  before	  undergoing	  any	  regulated	  procedure	  or	  mating.	  
Outbreeding	  of	  transgenic	  strains	  To	  add	  genetic	  variation	  to	  these	  strains	  and	  allow	  comparison	  with	  our	  inflammation-­‐induced	  preterm	  labour	  model	  in	  CD1	  mice	  (see	  section	  1.2),	  KO	  female	  mice	  (classed	  as	  the	   F0	   generation)	   were	   mated	   with	   CD1	   outbred	   males.	   Heterozygous	   pups	   (F1	  generation)	   from	  different	   litters	  were	  mated	   together,	  producing	  a	  heterogeneous	  F2	  generation	   (25%	   KO,	   50%	   heterozygous	   and	   25%	  wild	   type	   litters).	   Genotyping	   was	  performed	  to	  determine	  between	  KO,	  heterozygous	  and	  wild	  type	  animals.	  The	  resulting	  KO	   F2	   generation	   (males	   and	   females)	   were	   interbred	   to	   expand	   the	   colony	   for	  experimentation.	  	  
Timed-­‐mating	  Timed	  mating	  was	  employed	  to	  enable	  accurate	  timing	  of	  intrauterine	  injections.	  Female	  mice	   (CD1;	   CCR2-­‐/-­‐	   or	   CCR6-­‐/-­‐)	   were	   mated	   with	   a	   stud	   CD1	   male	   overnight.	   The	  presence	  of	  a	  copulatory	  plug	  in	  the	  vagina	  of	  the	  female	  indicated	  successful	  mating	  and	  was	  classed	  as	  E0	  (day	  0)	  of	  gestation.	  	  
Mouse	  model	  of	  localized	  intrauterine	  inflammation	  and	  preterm	  delivery	  Intrauterine	   administration	   of	   LPS	   to	   rodents	   has	   been	   described	   by	   Elovitz275.	   An	  adapted	   version	   of	   this	  model	   has	   subsequently	   been	   established	   in	   our	   group263	   and	  further	  optimized	  for	  this	  study.	  	  A	  laparotomy	  was	  performed	  on	  day	  16	  (E16)	  of	  gestation	  with	  anaesthesia	  induced	  and	  maintained	  using	  isoflurane	  (need	  to	  look	  up	  supplier).	  Morphine	  analgesia	  (2.5mg/kg)	  was	   administered	   subcutaneously	   30	   minutes	   prior	   to	   surgery.	   Pregnant	   mice	   were	  swabbed	  with	   povidone	   iodine	   (Ecolab,	   UK)	   before	   a	   1.5cm	   incision	  was	  made	   in	   the	  lower	   abdomen	   between	   the	   last	   two	   sets	   of	   nipples.	   Both	   uterine	   horns	   were	  exteriorised	  and	  wrapped	  in	  PBS	  saturated	  surgical	  swabs	  (MidMed) whilst	  the	  number	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of	   live	   fetuses	   per	   horn	   was	   determined.	   	   10μg/dam	   (in	   a	   total	   volume	   of	   25μl)	   of	  
Escherichia	  coli	  LPS	  serotype	  0111:B4	  (Sigma)	  or	  sterile	  PBS	  was	  then	  infused	  into	  the	  upper	   right	  uterine	  horn	  between	   the	   first	  and	  second	  sacs	  with	  care	  not	   to	  enter	   the	  amniotic	  cavity.	  	  If	  this	  was	  not	  possible	  because	  there	  were	  less	  than	  two	  fetuses	  in	  the	  right	  uterine	  horn,	  then	  the	  left	  horn	  was	  injected.	  The	  wound	  was	  closed	  in	  two	  layers	  (the	   muscle	   layer	   by	   continuous	   suture	   and	   the	   skin	   by	   simple	   interrupted	   sutures	  (MidMed,	   UK).	   Mice	   were	   allowed	   to	   recover	   in	   a	   heating	   chamber	   at	   30ºC	   for	   30	  minutes	  before	  returning	  to	  their	  home	  cage.	  	  
Tissue	  Collection	  Tissue	  collections	  were	  performed	  at	  3h,	  7h	  and	   the	  onset	  of	   labour	  after	   intrauterine	  injection	  of	  PBS	  or	  LPS.	  Delivery	  of	  the	  first	  pup	  was	  considered	  as	  the	  onset	  of	  labour.	  Maternal	  serum,	  plasma,	  myometrium,	  cervix,	  placentas	  and	  fetal	  brains	  were	  collected.	  Tissue	  was	  snap	  frozen	  on	  dry	  ice	  for	  molecular	  studies.	  Maternal	  myometrium	  and	  fetal	  brains	   were	   also	   fixed	   overnight	   in	   10%	   neutral-­‐buffered	   formalin	   (Sigma)	   at	   room	  temperature	  and	  then	  transferred	  into	  70%	  ethanol	  the	  next	  day.	  	  
RNA	  extraction	  	  Mouse	   tissues	   were	   snap	   frozen	   on	   dry	   ice	   after	   collection.	   30mg	   tissue	   from	   each	  sample	   was	   used.	   RNA	   extraction	   was	   performed	   using	   RNAesy	   Kit	   and	   Qiashredder	  (Qiagen).	  The	  concentration	  of	   	   	  RNA	  in	  each	  sample	  was	  measured	  by	  NanoDrop.	  2ug	  RNA	  was	  used	  in	  cDNA	  synthesis.	  	  
Protein	  extraction	  	  Mouse	   tissues	   were	   snap	   frozen	   on	   dry	   ice	   after	   collection.	   Samples	   were	   weighed	  before	   extraction.	   2ml	   of	   RIPA	   Buffer	   (Sigma)	   containing	   protease	   inhibitor	   and	  phosphatase	  inhibitor	  was	  added	  into	  per	  100mg	  frozen	  tissue	  and	  homogenized	  for	  30	  seconds.	   Lysate	   was	   sonicated	   and,	   supernatant	   was	   taken	   from	   a	   centrifugation	   at	  13,000	  ×g	   for	  30	  min	  at	  40C.	  The	  concentration	  of	  protein	  was	  determined	  by	  Protein	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assay	   (Bio-­‐Rad	   Laboratories,	   USA)	   and	   bovine	   serum	  was	   used	   as	   standards.	   Samples	  were	  then	  aliquot	  and	  stored	  at	  -­‐80oC.	  Protein	  samples	  were	  denatured	  in	  heater	  at	  70oC	  for	  10	  min	  before	  western	  blotting.	  	  
Genomic	  DNA	  extraction	  and	  genotyping	  PCR	  The	  ear	  clips	  from	  tested	  mice	  were	  taken	  and	  put	  in	  75µl	  of	  solution	  1,	  then	  vortex.	  The	  solution	   containing	   ear	   clips	   were	   heated	   afterwards	   to	   95	   oC	   for	   10min	   and	   cooled	  down	  to	  4	  oC.	  Solution	  2	  was	  added	  and,	  the	  whole	  solution	  was	  vortexed	  and	  spun	  down.	  	  4µl	  of	   final	   solution	  was	  used	  and	  mixed	  with	  PCR	  reaction	  mix	  which	  containing	  2	  µl	  PCR	  Buffer(×10),	  2	  µl	  dNTP’s	  (2mM),	  0.6	  µl	  Mgcl2	  (50mM),	  1	  µl	  of	  primer	  F	  (10µM),	  1	  µl	  of	  primer	  R	  (10µM),	  4	  µl	  of	  DNA,	  9.3	  µl	  dH2O	  and	  0.1	  µl	  Taq	  (5U/	  µl).	  Genotyping	  PCR	  thermocycler	  condition	  for	  CCR2	  KO	  was	  95	  oC	  for	  5min,	  95	  oC	  for	  30sec,	  65	  oC	  for	  1min,	  72	   oC	   for	   2min	   and,	   after	   35	   cycles	   heated	   75	   oC	   for	   10min	   and	   4	   oC	   for	   10min.	  	  Genotyping	  PCR	  thermocycler	  condition	  for	  CCR6	  KO	  was	  95	  oC	  for	  5min,	  95	  oC	  for	  30sec,	  69	  oC	   for	  1min,	  72	  oC	   for	  1min	  and,	  after	  35	  cycles	  heated	  72	  oC	   for	  10min	  and	  4	  oC	   for	  10min.	  	  
Table 2.4 Primers for genotyping PCR Name	   Forward	  (F)	  and	  Reverse	  (R)	  primer	  sequence	  (5’-­‐3’)	   Size	  CCR2	  WT	   F:	  5’-­‐CCACAGAATCAAAGGAAATGG-­‐3’	  R:	  5’-­‐CCAATGTGATAGAGCCCTGTG-­‐3’	   424bp	  CCR2	  KO	   F:	  5’-­‐	  CTTGGGTGGAGAGGCTATTC-­‐3’	  R:	  5’-­‐	  AGGTGAGATGACAGGAGATC-­‐3’	   280bp	  CCR6	  WT	   F:	  5’-­‐	  GGGTGGGATTAGATAAATGCCTGCTCT-­‐3’	  R:	  5’-­‐	  CCCTAGAAGAGGTCAGAAACTTCAC-­‐3’	   228	  CCR6	  KO	   F:	  5’-­‐	  AAAACCCAAGTGTTGGTGGCATGAG-­‐3’	  R:	  5’-­‐	  CCCTAGAAGAGGTCAGAAACTTCAC-­‐3’	   442	  
Cell	  preparation	  Uteri	   were	   dissected	   free	   of	   decidua	   in	   ice-­‐cold	   PBS.	  Minced	   and	  weighed	   tissue	  was	  enzymatically	   dissociated	   in	   PBS	   containing	   collagenase	   X	   (Sigma,	   UK)	   and	   30	   μg/ml	  DNase	   I	   (Roche)	   for	   30	   minutes	   at	   37°C	   with	   intermittent	   trituration	   and,	   filtered	  through	  a	  70-­‐μm	  cell	  strainer.	  Cells	  were	  washed	  twice	  in	  FACS	  wash	  buffer	  containing	  5	  mM	  EDTA.	  Live	  pup	  brains	  were	  harvested	  3h	  post	  operation,	  and	  gently	  homogenized	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in	  1ml	  fixation	  buffer	  for	  10	  seconds.	  After	  1	  min	  incubation	  in	  room	  temperature,	  15ml	  FACS	  wash	   buffer	   was	   added	   to	   stop	   fixation.	   Fixed	   cells	   were	   then	  washed	   twice	   in	  FACS	  wash	  buffer.	  
Flow	  cytometry	  Inflammatory	   cell	   suspensions	   were	   prepared	   for	   ﬂow	   cytometry	   analysis.	   Samples	  were	   stained	   with	   ﬂuorophoreconjugated	   anti-­‐mouse	   antibodies	   for	   CD45,	   CD11c,	  CD11b,	   Gr-­‐1,	   F4/80	   (eBiosciences,	   UK)	   and	   then	   analyzed	   using	   a	   FACSCalibur	  cytometer	   with	   CellQuest	   (Becton	   Dickinson,	   Oxford,	   UK)	   and	   FlowJo	   (Tree	   Star,	  Ashland,	  OR)	  software.	  Cells	  were	  quantiﬁed-­‐using	  microsphere	  counting	  beads	  (Caltag	  Medsystems,	  Buckingham,	  UK).	  	  
Statistical	  analysis	  
All	  data	  were	  initially	  tested	  for	  normality	  using	  a	  Kolmogorov-­‐Smirnoff	  test.	  Normally	  distributed	   data	  were	   analyzed	   using	   a	   Student	   t	   test	   for	   2	   groups	   and	   an	   analysis	   of	  variance	   (ANOVA)	   followed	   by	   a	   Dunnett	   or	   Bonferroni	  post	  hoc	   test	   for	   3	   groups	   or	  more.	  Data	  that	  were	  not	  normally	  distributed	  were	  analyzed	  using	  a	  Wilcoxon	  matched	  pairs	  test	  for	  paired	  data,	  Mann	  Whitney	  test	  for	  unpaired	  data	  and	  when	  comparing	  3	  groups	   or	  more	   a	   Friedman’s	   Test,	  with	   a	  Dunn's	  Multiple	   Comparisons	   post	  hoc	  test.	  p<0.05	  was	  considered	  statistically	  significant.	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3.1	  Introduction	  
Preterm	  delivery	  accounts	   for	  up	   to	  70%	  of	  neonatal	  deaths	  and	  75%	  of	  neonatal	  morbidity	   and	   complicates	   between	   5	   and	   11%	   of	   pregnancies	   1.	   Preterm	   labour	  (PTL)	   is	   the	   most	   important	   cause	   of	   preterm	   delivery.	   Current	   concepts	   of	   PTL	  implicate	   infection	   and	   inflammation	   as	   the	   main	   causative	   factors.	   The	  inflammatory	  process	  in	  human	  parturition	  is	  associated	  with	  a	  marked	  neutrophil	  and	   macrophage	   infiltration	   of	   the	   cervix	   and	   myometrium	   17,	   resulting	   in	   an	  increase	  in	  myometrial	  cytokines.	  The	  primary	  role	  of	  leukocytes	  is	  in	  host	  defence	  against	   pathogenic	   microorganisms,	   however,	   within	   tissues,	   leukocytes	   acquire	  other	   critical	   functions,	   regulating	   cell	   growth,	   development	   and	   function	   276.	  Human	   labour	   is	   critical	   as	   the	   activated	   leucocytes	   release	   potent	   inflammatory	  cytokines	  that	  drive	  prostaglandins	  synthesis	  and	  the	  increase	  in	  the	  contractility	  of	  myometrial.	  	  
Chemokines	  must	   be	   involved	   in	   the	   process	   of	   human	   labour,	   since	   they	   are	   the	  main	   regulator	   of	   leukocyte	  migration,	   tissue	   infiltration	   and	   activation.	   A	   recent	  study	  reported	  that	  human	  myometrial	  expression	  of	  the	  chemokines	  CCL2,	  CCL20,	  CXCL1,	  CXCL5	  and	  CXCL8	  was	  greater	   in	  samples	  obtained	  after	   the	  onset	  of	   term	  labour	   than	   before	   167.	   Further,	   levels	   of	   various	   chemokines,	   including	   CCL5	   in	  amniotic	  fluid	  are	  increased	  with	  both	  preterm	  and	  term	  labour	  and	  these	  increases	  are	   greater	   in	   the	   presence	   of	   infection	   169,171,182,277.	   The	   greater	   increase	   in	   the	  presence	   of	   infection	   is	   probably	   explained	   by	   the	   activation	   of	   the	   toll-­‐like	  receptors	  (TLR),	  key	  players	   in	   the	   innate	  response	   to	   infections,	   linked	  to	  NF-­‐κB,	  the	   archetypal	   inflammatory	   transcription	   factor	   that	   known	   to	   drive	   chemokine	  expression	  in	  human	  myometrium	  278.	  However,	  which	  factor	  (s)	  are	  responsible	  for	  the	   increase	   in	  myometrial	   chemokine	  expression	  with	   spontaneous	   labour	   is	  not	  certain	  and	  whether,	  as	  suggested	  above,	  the	  inflammatory	  infiltration	  is	  important	  in	  the	  onset	  and	  progression	  of	  labour	  or	  is	  simply	  a	  consequence	  of	  labour	  is	  also	  debated.	   However,	   in	   a	   rat	   model	   of	   human	   pregnancy	   and	   labour,	   CCL2,	   a	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chemokine	   that	   involved	   in	   the	   recruitment	   and	   activation	   of	   macrophages,	  increases	  both	  before	   and	  with	   the	  onset	  of	  parturition	   279.	   Interestingly,	   the	  pre-­‐parturition	  increase	  is	  driven	  by	  mechanical	  stretch	  279	  although	  other	  studies	  have	  shown	   that	   CCL2	   is	   also	   increased	   by	   both	   IL-­‐1β	   and	   the	   TLR-­‐4	   agonist	   LPS	   165.	  	  These	  data	  suggest	  that	  in	  the	  rat	  at	  least	  the	  inflammatory	  infiltration	  precedes	  the	  on	  set	  of	  labour	  and	  may	  be	  involved	  in	  its	  onset.	  	  
In	   this	   study,	   in	   order	   to	   understand	   whether	   the	   increases	   in	   myometrial	  chemokines	  are	  important	  in	  the	  onset	  and	  progression	  of	  preterm	  and	  term	  labour,	  or,	   as	   others	   suggest,	   only	   increased	   in	   response	   to	   the	   process	   of	   labour	   I	   have	  investigated	  (1)	  the	  pattern	  of	  myometrial	  chemokine	  expression	  during	  pregnancy	  and	  with	  the	  onset	  of	   labour	  both	  before	  and	  at	  term;	  (2)	  the	  factors	  that	  regulate	  myometrial	   chemokine	   expression;	   and	   (3)	   the	   potential	   intracellular	   signalling	  pathways	  involved.	  
3.2	  Results	  
3.2.1	  Myometrial	  expression	  of	  chemokines	  in	  pregnancy	  and	  labour	  In	  TL	  samples,	  CCL2	  and	  CXCL8	  mRNA	   levels	  were	   increased	  significantly	   in	  both	  upper	  and	  lower	  uterine	  segments	  and	  CXCL1	  mRNA	  significantly	  increased	  in	  the	  upper	   segment	   only	   (Fig.3.1a-­‐c).	   In	   PTL	   samples,	   CCL5,	   CXCL5	   and	   CCL20	  mRNA	  expression	  was	  only	  significantly	  increased	  in	  the	  lower	  segment	  (Fig.3.1d-­‐g).	  I	  find	  a	  consistent	  relationship	  between	  chemokine	  mRNA	  and	  advancing	  gestation	  only	  when	  I	  included	  all	  of	  the	  samples	  (upper	  and	  lower	  segments,	  labouring	  and	  non-­‐labour)	  (Fig.	  3.2a-­‐f).	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Figure 3.1 Gene expression of CCL2, CCL5, CCL20, CXCL1, CXCL3, CXCL5 and CXCL8 in upper 
and lower PTL, PTNL, TL and TNL myometrium.  
Paired upper and lower segment human myometrial samples were obtained from four groups of 
women (mean gestational age ± SD in each case), at preterm no labour (PTNL; 31.5 ± 3.5 wks; mean 
± SD; n=8), PTL (32.3 ± 4.1 wks; n=8), term no labour (TNL; 38.0 ± 1.2 wks; n=8) or TL (39.4 ± 0.5 
wks; n=8). See Table 2.3 for details regarding the phenotype of the samples. The gene expressions 
were measured by quantitative rtPCR. n=8 for this experiment. Comparisons were made between 
groups using a Mann Whitney test. * indicates p<0.05.	  
	   Chapter	  3.	  Myometrial	  chemokine	  expression	  and	  regulations	   	  
	   	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  	  	  
56	  






































	   Chapter	  3.	  Myometrial	  chemokine	  expression	  and	  regulations	   	  
	   	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  	  	  
57	  




































	   Chapter	  3.	  Myometrial	  chemokine	  expression	  and	  regulations	   	  
	   	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  	  	  
58	  

















































Figure 3.2 Correlations between gestational age and myometrial chemokine expressions 
Paired upper and lower segment human myometrial samples were obtained from four groups of women 
(mean gestational age ± SD in each case), at preterm no labour (PTNL; 31.5 ± 3.5 wks; mean ± SD; 
n=8), PTL (32.3 ± 4.1 wks; n=8), term no labour (TNL; 38.0 ± 1.2 wks; n=8) or TL (39.4 ± 0.5 wks; 
n=8). The gene expressions were measured by quantitative rtPCR. n=8 for this experiment. Non-
parametric correlation test was performed between gestational age and myometrial chemokine 
expression, spearman r was shown. a semilog line was drawn base on the nonlinear regression. NL, 
stands for non-labour, TNL stands for term non-labour, PTNL stands for preterm non-labour. * 
indicates p<0.05. ** indicates p<0.01, *** indicates p<0.001 
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3.2.2	  Cell	  culture I	  found	  that	  myometrial	  chemokine	  mRNA	  expression	  did	  not	  change	  in	  prolonged	  culture	  at	  6,	  24	  and	  54	  hours	  (Appendix	  1).	  	  
3.2.3	  Stretch	  induced	  myometrial	  chemokine	  expression	  Chemokine	  mRNA	   expression	   in	   cultured	  myometrial	   cells	   in	   response	   to	   stretch	  was	  assessed	  after	  the	  application	  of	  16%	  stretch	  for	  1,	  3,	  6	  hours.	  CCL2,	  CXCL8	  and	  CXCL1	  mRNA	   levels	  were	   significantly	   increased	   at	   the	   6	   hours,	   CCL5	  mRNA	  was	  significantly	  increased	  at	  3	  and	  6	  hours	  and	  CCL20	  mRNA	  at	  3	  hours	  only	  (Fig.3.3a-­‐f).	   The	   increase	   in	   CXCL5	  mRNA	   did	   not	   quite	   reach	   significance	   in	   this	   series	   of	  experiments,	   but	   did	   in	   later	   studies.	   The	   levels	   of	   all	   of	   the	   chemokines	   above,	  including	   CXCL5,	   were	   significantly	   increased	   in	   the	   culture	   supernatant	   after	   6	  hours	  stretch	  (Fig.3.3g).	  
It	   is	   reported	   that	   chemokine	   expressions	  were	   primarily	   regulated	   by	  NF-­‐κB	   278,	  but	  previously	  using	  EMSA	  our	  group	  had	   failed	   to	   find	  any	  evidence	  of	  a	  stretch-­‐induced	   activation	   of	   NF-­‐κB	   activity	   219.	   Since	   stretch	   enhanced	   chemokine	  expression,	   I	   re-­‐assessed	   the	   impact	   of	   stretch	   on	   NF-­‐κB	   activation,	   using	   p65	  phosphorylation	  and	   found	   that	   stretch	   increased	  phospho-­‐p65.	  The	   increase	  was	  detectable	  by	  5	  minutes,	  persisted	  until	  30	  minutes	  and	  could	  be	  blocked	  by	  an	  IκK	  inhibitor	  (TPCA-­‐1,	  Fig.3.4).	  	  
Since	  previously	  our	  group	  found	  that	  stretch	  drove	  both	  CXCL8	  and	  COX-­‐2	  mRNA	  expression	  via	  MAPK	  280,	  I	  pre-­‐incubated	  myometrial	  cells	  with	  both	  MAPK	  and	  IκK	  inhibitors	   and	   found	   that	   the	   6	   hour	   stretch-­‐induced	   increase	   in	   CCL2,	   CXCL8,	  CXCL1	  and	  CCL20	  mRNA	  expression	  was	  inhibited	  by	  pre-­‐incubation	  of	  myometrial	  cells	  with	  the	  ERK-­‐inhibitor	  U0126,	  and	  the	  IKK-­‐2	  inhibitor	  TPCA-­‐1.	   In	  the	  case	  of	  CCL5,	  pre-­‐incubation	  with	   the	   JNK	   inhibitor	  SP600125	  and	  TPCA-­‐1	  and	   for	  CXCL5	  pre-­‐incubation	   with	   TPCA-­‐1	   only	   blocked	   the	   stretch–induced	   increase	   in	   mRNA	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Figure 3.3 a-g Stretch induced the expression of myometrial chemokines. 
a-f: Human myometrial cells were exposed to 16% stretch for 0, 1, 3 and 6 hours. mRNA was extracted 
and measured using quantitative rtPCR, n=6. Data were analysed using an ANOVA followed by a 
Dunnett’s post test or with a Friedman’s Test followed by a Dunn’s post test depending on the data 
distribution. CCL2, ANOVA=0.0257, Dunnett’s p<0.05 at 6 hours, Fig.2a; CXCL8, ANOVA=0.0027，
Dunnett’s p<0.01 at 6 hours, Fig.2b; CXCL1, ANOVA=0.0325，Dunnett’s p<0.05 at 6 hours, Fig2c; 
CCL5 , ANOVA p=0.0027，Dunnett’s p<0.01 at 3 and 6 hour, Fig. 2d; CCL20, ANOVA=0.0325, 
Dunnett’s p<0.05 at 3 hours, Fig. 2F. Data are shown as the median, the 25th and 75th percentiles and the 
range. * indicates p<0.05. ** indicates p<0.01. g: Human uterine smooth muscle cells were exposed to 
16% stretch for 0 and 6 hours. The supernatant collected and chemokine levels measured by ELISA. Data 
are expressed as median and range, n=8 and analysed using a paired t test or Wilcoxon matched pairs test 
depending on data distribution. CCL2, Wilcoxon=0.0078, Dunnett’s p<0.01; CXCL8, Paired t test=0.0017, 
Dunnett’s p<0.01; CXCL1, Paired t test=0.0029, Dunnett’s p<0.01, Fig.2i; CCL5 and CXCL5, 
Wilcoxon=0.0313, Dunnett’s p<0.05; CCL20, Paired t test=0.0143, Dunnett’s p<0.05, Fig. 2l, and * 
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Figure 3.4 Stretch induced the expression of myometrial chemokines. 
Myometrial cells were treated with or without TPCA-1, after stretch, whole cell protein was extracted. 
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Table 3.1 The effects of MAPK and NF-κB P65 inhibitors on stretch induced chemokine expression 
(percentage changes compared to stretch alone) 
	  
Stretch increased chemokines expressions (data not shown). Data were shown as percentage of stretch 
treatment alone, ANOVA Test was used if data were parametric, and Friedman’s Test if data were non-
parametric, with a Dunn's Multiple Comparisons post hoc test. N=6 for each experiment. * indicates 
p<0.05. ** indicates p<0.01, *** indicates p<0.001. 
	  
3.2.4	  Cytokines	  induced	  myometrial	  chemokine	  expression	  IL-­‐1β	  (10ng/ml)	  and	  TNFα	  (10ng/ml)	  induced	  marked	  increases	  in	  the	  expression	  of	   CCL2,	   CXCL1	   and	  CXCL8	  mRNA	   (Fig.3.5a-­‐c)	   and	   a	   less	   pronounced	   response	   in	  CCL5,	   CXCL5	  and	  CCL20	  mRNA	  expression	   (Fig.3.5d-­‐f).	   IL-­‐1β	   also	   induced	   similar	  increases	   in	   culture	   supernatant	   chemokine	   levels	   (Fig.3.6).	   TPCA-­‐1	   blocked	   the	  cytokine-­‐induced	   increases	  chemokine	  mRNA	  expression	  and	   this	  effect	  was	  most	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Figure 3.5 a-f Cytokines induced the expression of chemokines.  
a-f: Human myometrial cells were incubated with or without 10ng/mL IL-1β or TNFα for 1, 6 and 24 
hours. At the end of incubation RNA was extracted and converted to cDNA. The expressions of 
chemokine, including CCL2, CCL5, CCL20, CXCL1, CXCL5, CXCL8 were measured by quantitative 
RTPCR. n=6 for this experiment, data analyzed using ANOVA Test if data were parametric, and 
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Friedman’s Test if data were non-parametric, with a Dunn's Multiple Comparisons post hoc test. For IL-1β 
treatment, CCL2, Friedman<0.0001, Dunnett’s p<0.001 at 6 hours, p<0.05 at 24 hours, Fig.3a; CXCL8, 
ANOVA<0.0001, Dunnett’s p<0.001 at 6 hours, p<0.01 at 24 hours, Fig.3b; CXCL1, Friedman=0.0007, 
Dunnett’s p<0.01 at 6 hours, Fig3c; CCL5 , Friedman=0.0015, Dunnett’s p<0.05 at both 6 and 24 hours, 
Fig. 3d; CXCL5, Friedman=0.0015, p<0.05 at 24 hours Fig. 3e; CCL20, ANOVA=0.0019, Dunnett’s 
p<0.05 at 1 hour, Fig. 3f. For TNFα treatment, CCL2, ANOVA<0.0001, Dunnett’s p<0.001 at 6 and 24 
hours, Fig.3a; CXCL8, Friedman=0.0006, Dunnett’s p<0.01 for 6 hours, p<0.05 for 24 hours, Fig.2b; 
CXCL1, ANOVA<0.0001, Dunnett’s p<0.001 at 1 hours, Fig2c; CCL5 , Friedman=0.0007, Dunnett’s 
p<0.05 at 1 hour, Fig. 2d; CXCL5, Friedman<0.0001, Dunnett’s p<0.05 at 6 hours, p<0.001 at 24 hours, 
Fig. 3e; CCL20, ANOVA=0.0004, Dunnett’s p<0.001 at 1 hour, p<0.05 at 6 hour, Fig. 2f. Data are shown 
as the median, the 25th and 75th percentiles and the range, and * indicates p<0.05. ** indicates p<0.01, 
*** indicates p<0.001.  
	   	  
Figure 3.6  Cytokines induced the expression of chemokines.  
Human myometrial cells were pre-incubated with IL-1β for 0 and 24 hours. The supernatant was collected, 
and the protein levels of chemokines in stretched cell culture medium were measured by ELISA. Data are 
expressed as median and range, n=8 for this experiment. Wilcoxon matched pairs test was performed. 
CCL2, Wilcoxon=0.0313, Dunnett’s p<0.05; CXCL8, Paired t test<0.0001, Dunnett’s p<0.001; CXCL1, 
Paired t test<0.0001, Dunnett’s p<0.001; CCL5, Paired t test=0.0125, Dunnett’s p<0.05; CXCL5, Paired t 
test=0.0435, Dunnett’s p<0.05, CCL20, Wilcoxon=0.0156, Dunnett’s p<0.05and * indicates p<0.05. ** 
indicates p<0.01, *** indicates p<0.001 
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Cytokines increased chemokine expression at various time points (data not shown). Data were shown as 
percentage of IL-1β/TNFα treatment alone, ANOVA Test was used if data were parametric, and 
Friedman’s Test if data were non-parametric, with a Dunn's Multiple Comparisons post hoc test. Data are 
shown as the median, the 25th and 75th percentiles and the range. * indicates p<0.05. ** indicates p<0.01, 
*** indicates p<0.001. 
 
3.2.5	  The	  effects	  of	  pro-­‐labour	  protein	  on	  chemokines	  expression	  on	  
myometrium	  Treatment	  of	  myometrial	   cells	  with	  PGE2,	  PGF2α	   and	  oxytocin	   (100nM/ml)	  had	  an	  inhibitory	  effect	  on	  chemokine	  mRNA	  expressions,	  being	  most	  marked	  for	  oxytocin	  treatment	   and	   least	   for	   PGE2	   (Fig.	   3.7a-­‐f).	   Incubation	   with	   oxytocin	   (100nM/ml)	  also	  reduced	  the	  levels	  of	  chemokines	  in	  the	  culture	  supernatant	  (Fig.3.8).	  	  
Table 3.1 The effects of MAPK and NF-κB P65 inhibitors on cytokines induced chemokine 
expression (percentage changes compared to IL-1β or TNFα treatment alone in 1, 6 and 24 hours, 
respectively) 
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Figure 3.7 a-f The effect of pro-labour protein on chemokine expression.  
a-f: Human myometrial cells were incubated with or without 10nM PGE2, PGF2a and 100nM oxytocin for 
1, 6 and 24 hours. At the end of incubation RNA was extracted and converted to cDNA. Copy numbers of 
chemokine, including CCL-2, CCL5, CCL20, CXCL1, CXCL5, CXCL8 were measured by quantitative 
rtPCR. n=6 for this experiment, data analysed using ANOVA Test if data were parametric, and Friedman’s 
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Test if data were non-parametric, with a Dunn's Multiple Comparisons post hoc test. CCL2, 
ANOVA<0.0001, Dunnett’s p<0.001 at PGE2 6 hours, p<0.05 at PGF2α 1 hour, oxytocin 1, 6 and 24 hours, 
Fig. 4a; CXCL8, Friedman=0.0007, Dunnett’s p<0.01 at PGE2 24 hours, oxytocin 24 hours and PGF2α 24 
hours, p<0.05 for both PGF2α at 6 hour and oxytocin at 24 hours Fig.4b; CXCL1, Friedman=0.0003, 
Dunnett’s p<0.05 for both PGE2 1 hour and oxytocin 24 hours, p<0.001 for PGF2α at 1,6 and 24 hours, 
Fig.4c; CCL5, Friedman=0.002, Dunnett’s p<0.05 for both PGE2 and oxytocin at 1 hour, Fig.4d; CXCL5, 
ANOVA<0.0001, Dunnett’s p<0.001 for all time points of PGF2α and oxytocin treatments, Fig.4e; CCL20, 
ANOVA<0.0001, Dunnett’s p<0.001 for PGF2α 24 hours, p<0.01 for oxytocin 1 hour, Fig.4f. Data are 
shown as the median, the 25th and 75th percentiles and the range, and * indicates p<0.05. ** indicates 
p<0.01, *** indicates p<0.001. 	  
	  	   	  
Figure 3.8  The effect of pro-labour gene on chemokine expression. 
Human myometrial cells were pre-incubated with IL-1β for 0 and 24 hours. The supernatant was collected, 
and the protein levels of chemokines in cell culture medium were measured by ELISA. Data are expressed 
as median and range, n=8 for this experiment. Wilcoxon matched pairs test was performed. CCL2, Paired t 
test=0.0005, Dunnett’s p<0.001, Fig.4g; CXCL8, Wilcoxon=0.0078, Dunnett’s p<0.01; CXCL1, Paired t 
test=0.0003, Dunnett’s p<0.001; CCL5, Paired t test=0.0498, Dunnett’s p<0.05; CXCL5, Paired t 
test=0.0229, Dunnett’s p<0.05; CCL20, Wilcoxon=0.0156, Dunnett’s p<0.05, and * indicates p<0.05. ** 
indicates p<0.01, *** indicates p<0.001. 
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3.2.6	  The	  migration	  of	  L1.2	  cells	  (B	  cell	  line)	  into	  IL-­‐1β	  treated	  myocytes	  
culture	  medium	  To	  determine	  whether	  the	  chemokines	  released	  by	  myometrial	  cells	  were	  bioactive,	  chemotaxis	  assays	  was	  performed	  using	  CCR2	  and	  CXCR1	  transfectants	  and	  a	  series	  of	   dilutions	   of	   IL-­‐1β	   treated	   myometrial	   cells	   culture	   medium.	   Both	   sets	   of	  transfectants	  migrated	  to	  the	  diluted	  supernatants	  with	  the	  typical	  bell-­‐shaped	  dose	  response	   curves,	  while	  naive	   cells	  which	  were	  not	   transfected	  were	  unresponsive	  (Fig.9a&b)	  suggesting	  that	  the	  CCR2	  and	  CXCR2-­‐specific	  chemokines	  detected	  in	  the	  supernatant	  by	  ELISA	  (CCL2,	  CXCL1,	  CXCL5	  and	  CXCL8)	  were	  biologically	  active	  and	  able	  to	  recruit	  leukocytes.	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Figure 3.9 Chemotaxis assay.   
Primary cultured myometrial cells were incubated with 1ng/mL IL-1β, supernatant was harvested after 24 
hours. The ability of L1.2 transfectants expressing CCR2 (a) or CXCR2 (b) and negative controls to 
migrate in response to a series of dilutions of the supernatant was subsequently assessed by chemotaxis. 
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3.3	  Discussion	  
This	   study	   shows	   that	   human	   myometrial	   chemokine	   expression	   generally	  increases	  with	  the	  advancing	  gestation	  and	  again	  at	   the	  onset	  of	   labour,	  CCL2	  and	  CXCL8	  increasing	  with	  term	  labour	  in	  both	  upper	  and	  lower	  uterine	  segments	  and	  CCL5,	  CXCL5	  and	  CCL20	  in	  preterm	  labour	  in	  the	  lower	  uterine	  segment	  only.	  These	  changes	   might	   be	   driven	   by	   inflammation	   and	   mechanical	   stretch	   since	   in	  myometrial	   cultures,	   stretch,	   IL-­‐1β	   and	  TNFα	   all	   increased	   chemokine	   expression	  via	  both	  NF-­‐κB	  and	  MAPK	  pathways.	  In	  contrast,	  the	  pro-­‐labour	  proteins,	  PGF2α	  and	  oxytocin,	  decreased	  the	  expression	  of	  myometrial	  chemokines.	  These	  data	  suggest	  that	  myometrial	  chemokine	  expression	  increases	  before	  the	  onset	  of	  human	  labour,	  potentially	  in	  response	  to	  stretch	  and/or	  inflammatory	  cytokines	  and	  may	  therefore	  play	  an	  important	  role	  in	  its	  onset	  and	  progression.	  
Both	  PTL	  and	  TL	  in	  the	  human	  is	  characterised	  by	  a	  marked	  increased	  myometrial	  inflammatory	   infiltration	   composed	   of	   macrophages,	   neutrophils	   and	   T-­‐lymphocytes	   17.	   The	   primary	   role	   of	   the	   infiltration	   is	   still	   not	   clear,	   but	   may	  contribute	  to	  the	  onset	  of	  labour	  or	  to	  uterine	  remodelling	  after	  delivery.	  I	  focussed	  on	   the	   chemokines	  previously	   found	   to	  be	   increased	   in	   a	   study	  of	   term	   labouring	  myometrium167,	   and	   found	   two	   distinct	   patterns.	   CCL2	   and	   CXCL8	   mRNAs	   were	  elevated	   in	   the	   upper	   and	   lower	   segments	   of	   TL	   only	   (the	   expression	   of	   CXCL1	  mRNA	   followed	   a	   similar	   pattern,	   but	   did	   not	   reach	   significance	   in	   the	   lower	  segment	   samples	  because	  of	   one	  outlying	   sample),	  while	  CCL5,	  CCL20	  and	  CXCL5	  mRNA	   were	   increased	   in	   PTL	   lower	   segment	   myometrium	   only.	   It	   is	   clear	   that	  different	  subsets	  of	  chemokines	  may	  attract	  specific	  inflammatory	  cells,	  determined	  by	   their	   chemokine	   receptor	   expression.	   For	   example,	   Th2	   cells	   mainly	   express	  CCR4,	  while	  Th1	  cells	  express	  high	  level	  of	  CCR5,	  which	  will	  be	  attracted	  by	  CCL5,	  CCL3	   and	   CCL4281,	   which	   bind	   to	   CCL2,	   CCL5	   and	   CCL17.	   Consequently,	   I	   might	  expect	  to	  see	  different	  subtypes	  of	  inflammatory	  cells	  in	  TL	  and	  PTL,	  but	  this	  has	  yet	  to	   be	   studied.	   The	   distinct	   patterns	   of	   chemokine	   expression	   in	   TL	   and	   PTL	  may	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reflect	   differences	   in	   aetiology	   and/or	   role,	   for	   example,	   in	   PTL	   the	   inflammatory	  infiltration	  may	  contribute	   to	   the	  onset	  of	   labour,	  while	   in	  TL,	   its	  role	  might	  be	   to	  remodel	   the	   uterus	   after	   labour.	   I	   then	   investigate	   which	   factors	   regulate	  myometrial	  chemokine	  expression	  and	  then	  to	  define	  which	  intracellular	  pathways	  were	  involved	  to	  see	  if	  either	  approach	  could	  explain	  the	  differential	  expression	  of	  the	  chemokines	  in	  term	  and	  preterm	  labour.	  
Pathway	   analysis	   of	   a	   human	   labour	   gene	   array	   data	   suggested	   that	   the	   onset	   of	  human	  labour	  was	  initiated	  by	  inflammatory	  stimulation,	  rather	  than	  either	  of	  the	  other	  two	  alternatives	  that	  were	  considered,	  functional	  progesterone	  withdrawal	  or	  oxytocin	   receptor	   activation	   282.	   Consistent	   with	   this	   idea,	   our	   group	   found	  previously	   that	   IL-­‐1β	   and	   IL-­‐6	  mRNA	  expression	  was	   increased	  with	   the	   onset	   of	  labour	  in	  lower	  segment	  myometrium,	  interestingly,	  although	  CXCL8	  increased	  with	  advancing	  gestation	  in	  this	  study,	  the	  expression	  of	  IL-­‐1β	  and	  IL-­‐6	  did	  not	  103.	  These	  data	   suggest	   that	   chemokine	   expressions	   increase	   first	   followed	   by	   an	   influx	   of	  inflammatory	   cells,	  which	   then	   increase	   local	   cytokine	   levels.	  These	   Inflammatory	  cytokines	  may	  then	  act	  to	  increase	  myometrial	  contractility	  directly	  and/or	  through	  increased	  PG	  synthesis.	  In	   this	   study,	   I	   found	   that	   incubating	   myometrial	   cells	   with	   IL-­‐1β	   and	   TNFα	  markedly	   increased	   CXCL1,	   CCL2	   and	   CXCL8	   mRNA	   expression,	   but	   had	   a	   lesser	  effect	  on	  CXCL5,	  CCL5	  and	  CCL20	  mRNA	  expression.	  This	  is	  similar	  to	  the	  pattern	  I	  observed	   in	   labouring	  myometrium,	  where	  CCL2,	   CXCL8	   and	  CXCL1	  mRNAs	  were	  increased	   in	   the	  upper	  and	   lower	  myometrial	   segments	  with	  TL	  and	  CXCL5,	  CCL5	  and	  CCL20	  mRNAs	  were	  only	  elevated	  in	  the	  lower	  uterine	  segment	  in	  PTL.	  Further,	  I	  found	  that	  the	  IκK-­‐2	  inhibitor,	  TPCA-­‐1,	  which	  reduces	  NF-­‐κB	  activation,	  markedly	  blocked	   cytokine-­‐driven	   CCL2,	   CXCL8	   and	   CXCL1	   mRNA	   expression.	   These	   data	  suggest	   that	   the	  chemokine	  expression	  of	  TL	   is	  driven	  by	   inflammation	   in	  general	  and	   the	   activation	   of	   NF-­‐κB	   specifically.	   These	   data	   are	   consistent	   with	   previous	  reports	   of	   increased	   NF-­‐κB	   activity	   with	   human	   labour	   226,283	   and	   previous	   data	  from	  group,	  which	  showed	  that	  p65	  over-­‐expression,	  drove	  chemokine	  expression	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278.	  Although	  these	  data	  show	  clearly	   that	  chemokine	  expression	  can	  be	  driven	  by	  inflammatory	   cytokines,	   it	   is	   clear	   that	   the	   inflammatory	   cytokines	   only	   increase	  with	   the	   onset	   of	   labour	   and	   not	   with	   advancing	   gestation	   103.	   Therefore,	   which	  process	  initiates	  the	  increase	  in	  myometrial	  chemokine	  expression,	   is	  unclear.	  The	  withdrawal	  of	  progesterone	  suppression	  is	  one	  possible	  explanation,	  however	  some	  studies	   analysis	   suggests	   that	   progesterone	   withdrawal	   is	   secondary	   to	  inflammation	   and	   not	   vice	   versa	   282.	   During	   pregnancy,	   the	   growing	   conceptus	  distends	  the	  uterus,	  subjecting	  the	  myometrium	  to	  progressively	  greater	  degrees	  of	  stretch,	  which	  our	  group	  have	  previously	   found	  to	  up-­‐regulate	   the	  expression	  and	  synthesis	  of	  various	  labour	  associated	  genes	  including	  COX-­‐2	  and	  CXCL8	  284,285	  in	  a	  MAPK-­‐dependent	  manner	  280.	  Uterine	  stretch	  has	  also	  been	  shown	  to	  be	  responsible	  for	   the	  pre-­‐parturition	   increase	   in	  CCL2	   in	  myometrium	   in	   rats279.	   In	   this	   study,	   I	  found	  that	  stretch	  of	  myometrial	  cells	  increased	  the	  mRNA	  expression	  and	  synthesis	  of	   several	   chemokines.	   It	   is	   possible	   that	   increased	   uterine	   stretch	   caused	   by	   the	  growing	  conceptus	  would	  drive	  the	  increase	  in	  myometrial	  chemokine	  expressions	  and	   induce	   an	   inflammatory	   infiltration	   279	   so	   reversing	   the	   pro-­‐gestational	  dominance	  and	  ultimately	  bringing	  about	  the	  onset	  of	  labour.	  	  Finally,	   I	   investigated	   whether	   pro-­‐labour	   proteins	   could	   drive	   chemokine	  expression,	  since	  I	  reasoned	  that	  if	  the	  inflammatory	  infiltration	  promoted	  uterine	  remodelling	   in	   the	   post	   partum,	   then	   the	   process	   of	   labour	   could	   be	   expected	   to	  drive	  chemokine	  expression.	  	  However,	  I	  found	  that	  oxytocin	  and	  PGF2α	  in	  virtually	  all	  cases	  decreased	  the	  mRNA	  expression	  of	  chemokines,	  suggesting	  that	  the	  labour	  associated	   increase	   in	   chemokine	   expression	   is	   not	   induced	   by	   oxytocin,	   PGE2	   or	  PGF2α.	  Interestingly,	  oxytocin	  has	  been	  reported	  to	  have	  an	  anti-­‐inflammatory	  effect	  in	   humans,	   reducing	   the	   endotoxin-­‐induced	   increase	   in	   plasma	   cytokines	   and	  chemokines	  286.	  	  This	   study	   highlights	   an	   intriguing	   differential	   expression	   of	   chemokines	   in	   term	  labour	  and	  preterm	  labour.	  This	  study	  suggests	  that	  uterine	  stretch	  may	  initiate	  the	  elevation	  in	  chemokine	  expression	  leading	  to	  the	  infiltration	  of	  the	  myometrium	  by	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activated	   inflammatory	   cells.	   These	   in	   turn	   release	   cytokines,	  which	  drive	   further	  chemokine	   expressions	   creating	   a	   positive	   feedback	   loop	  which	   culminates	   in	   the	  onset	   of	   labour.	   Given	   the	   key	   role	   played	   by	   NF-­‐κB	   p65	   in	   both	   stretch	   and	  inflammatory	   cytokine-­‐induced	   chemokine	   expression	   agents	   that	   modulate	   its	  activity	   might	   be	   of	   potential	   therapeutic	   benefit	   in	   the	   management	   of	   preterm	  delivery.	   Indeed,	   inhibition	  of	  NF-­‐κB	  p65	  activity	  through	  various	  means	  has	  been	  shown	  to	  successfully	  prevent	  preterm	  delivery	  in	  some	  animal	  models	  263,287,288.	  It	  remains	  to	  be	  seen	  whether	  inhibition	  of	  NF-­‐κB	  activity	  is	  of	  therapeutic	  benefit	  in	  human	  preterm	  delivery.	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4.1	  Introduction	  
Labour	  is	  characterized	  by	  an	  marked	  inflammatory	  cells	  into	  the	  myometrium	  and	  cervix	   9-­‐13.	   Leukocytes	   migrate	   to	   sites	   of	   inflammation	   in	   response	   to	  chemokines139,	  which	  act	  through	  seven-­‐transmembrane	  domain	  G	  protein-­‐coupled	  receptors	  termed	  chemokine	  receptors.	  Seven	  CXC	  (CXCR1–7),	  ten	  CCR	  (CCR1–10),	  one	  CX3CR	  (CX3CR1),	  and	  one	  CR	  (XCR1)	  chemokine	  receptor	  has	  been	   identified	  140.	   The	   CC	   chemokines	   mainly	   interact	   with	   lymphocytes,	   macrophages,	   and	  monocytes	  141.	  Neutrophils	  express	  a	  very	  limited	  number	  of	  chemokine	  receptors	  142-­‐144,	  predominantly	  receptors	  of	  the	  CXC	  or	  CX3C	  family,	  in	  particular	  CXCR1	  and	  CXCR2	   145	   and	   consequently,	   with	   the	   exception	   of	   CXCR1/CXCR2	   ligands,	   the	  majority	  of	  chemokines	  have	  no	  functional	  effect	  on	  human	  neutrophils	  146.	  It	  is	  not	  yet	   known	   which	   chemokine	   receptor	   interactions	   trigger	   which	   corresponding	  intracellular	   pathway.	   It	   is	   suggested	   that	   when	   bound	   by	   the	   same	   chemokine	  different	  receptors	  may	  elicit	  distinct	  functional	  responses.	  For	  example,	  CXCR1	  and	  CXCR2	  mediate	  changes	   in	  Ca+2,	   release	  of	  granule	  enzymes	  and	  chemotaxis	  when	  bound	  by	  CXCL8.	  However,	  CXCR1	  also	  specifically	  activates	  phospholipase	  D	  147,148.	  Prior	   to	   and	   during	   labour	   it	   is	   likely	   that	   specific	   subsets	   of	   pro-­‐inflammatory	  chemokines	   direct	   uterine	   and	   cervical	   leukocyte	   homing	   and	   control	   their	  behaviour	  on	  arrival.	  CXC	  chemokines	  CXCL1,	  CXCL2,	  CXCL3,	  CXCL5	  and	  CXCL8,	  CC	  chemokines	  CCL2,	  CCL5	  and	  CCL20	  are	  up	  regulated	  in	  myometrium	  in	  term	  labour	  (Chapter	   3).	   It	   is	   suggested	   that	   the	   CXC	   chemokines	   exert	   their	   effect	   via	   CXCR1	  and	  CXCR2	  on	  neutrophils	  expressed	  and	   that,	  CC	  chemokines	  act	  via	  CCR1,	  CCR2	  and	   CCR6	   to	   recruit	   monocytes	   as	   observed	   in	   the	   myometrium	   of	   spontaneous	  labour	  and	  LPS-­‐induced	  preterm	  labour	  165,167.	  
Chemokine	   receptors	   are	   expressed	   in	   the	  uterus,	  where	   they	  are	  held	   to	  play	   an	  important	  role	  in	  the	  physiology	  and	  pathology	  of	  the	  human	  reproductive	  system	  178.	  CCR5	  was	  found	  in	  human	  endometrium	  throughout	  the	  menstrual	  cycle	  while	  the	  expression	  of	  CXCR1	  was	  reported	  to	  reach	  a	  peak	   in	  the	  mid-­‐secretory	  phase	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4.2	  Results	  
4.2.1	  Myometrial	  expression	  of	  chemokines	  in	  pregnancy	  and	  labour	  During	   pregnancy,	   only	   CXCR1	   declined	   with	   advancing	   gestation	   (-­‐0.4683,	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Figure 4.1 Gene expression of CCR2, CXCR1 and CXCR2 in upper and lower PTL, PTNL, TL and 
TNL myometrium.  
a-c:Paired upper and lower segment human myometrial samples were obtained from four groups of women 
(mean gestational age ± SD in each case), at preterm no labour (PTNL; 31.5 ± 3.5 wks; mean ± SD; n=8), 
PTL (32.3 ± 4.1 wks; n=8), term no labour (TNL; 38.0 ± 1.2 wks; n=8) or TL (39.4 ± 0.5 wks; n=8). See 
Table 2.3 for details regarding the phenotype of the samples. Messenger RNA expression was measured by 
quantitative rtPCR. n=8 for this experiment. Comparisons were made between groups using a Wilcoxon 
c	  
d	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test. * indicates p<0.05. ** indicates p<0.01. d: Non-parametric correlation test was performed between 
gestational age and myometrial chemokine expression, spearman r was shown. a semilog line was drawn 
base on the nonlinear regression. 
4.2.2	  Mechanical	  stretch	  increased	  myometrial	  chemokine	  receptor	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Figure 4.2 Stretch induced the expression of myometrial chemokine receptors.  
Human uterine smooth muscle cells were exposed to 16% stretch for 0, 1, 3 and 6 hours. mRNA was 
extracted and measured using quantitative rtPCR, n=6. Data were analysed using a Paired T-test or with a 
Wilcoxon Test depending on the data distribution. CCR2, p=0.0313 at 1 and 6 hours, Fig.2a; CXCR1, 
p=0.0046 at 6 hours, Fig.2b. Data are shown as the median, the 25th and 75th percentiles and the range. * 
indicates p<0.05. ** indicates p<0.01.  
4.2.3	  Cytokines	  reduce	  the	  expression	  of	  myometrial	  chemokine	  
receptors	  Chemokine	   receptor	  mRNA	   expression	  was	   assessed	   after	  myometrial	   cells	   were	  exposed	  to	  TNFα	  (10ng/ml),	  IL-­‐1β	  (10ng/ml)	  and	  CXCL8	  (10ng/ml)	  for	  1,	  6	  and	  24	  hours.	   CCR2	   mRNA	   expression	   was	   reduced	   by	   CXCL8	   (10ng/ml)	   at	   24	   hours	  (p<0.05,	  Fig.3a)	  and	  CXCR2	  reduced	  by	  IL-­‐1β	  at	  24	  hours	  (p<0.01,	  Fig.3c),	  by	  TNFa	  at	  1	  and	  24	  hours	  (both	  p<0.05,	  Fig4.3c)	  and	  CXCL8	  at	  1	  and	  6	  hours	  (p<0.01	  and	  0.05	  respectively,	  Fig4.3c).	  	  
There	  was	  a	  relationship	  between	  the	  myometrial	  mRNA	  expression	  of	  CXCL8	  and	  both	   CXCR1	   (r=-­‐31,	   p=0.04)	   and	   CXCR2	   (r=-­‐0.33,	   p=0.03),	   but	   not	   between	   CCL2	  and	  CCR2	  (r=-­‐0.19,	  p=0.15)	  in	  labouring	  upper	  and	  lower	  segment	  samples.	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Figure 4.3 Cytokines reduced the expression of chemokine receptors. 
 4.3a-4.3c: Human uterine smooth muscle cells were incubated with or without 1ng/mL IL-1β, TNFα or 
IL-8 for 1, 6 and 24 hours. At the end of incubation RNA was extracted and converted to cDNA. Copy 
numbers of chemokine receptor mRNA were measured by quantitative rtPCR. n=6 for this experiment, 
data analysed using ANOVA Test if data distribution was parametric, and Friedman’s Test if data 
distribution was non-parametric, with a Dunn's Multiple Comparisons post hoc test. CCR2, 
Friedman<0.0001, Dunnett’s p<0.05 at 24 hours with IL-8 treatment, Fig.3a; CXCR2, Friedman<0.0001, 
Dunnett’s p<0.01 at 24 hours with IL-1β treatment, p<0.05 at 1 and 24 hours with TNFα treatment, p<0.01 
at 1 hour and p<0.05 at 6hours with IL-8 treatment, Fig.3b. Data are shown as the median, the 25th and 
75th percentiles and the range, and * indicates p<0.05. ** indicates p<0.01, *** indicates p<0.001. 
4.2.4	  Prostaglandins	  and	  oxytocin	  reduce	  the	  expression	  of	  myometrial	  
chemokine	  receptors	  Chemokine	   receptor	  mRNA	   expression	  was	   assessed	   after	  myometrial	   cells	   were	  exposed	  to	  PGE2,	  PGF2αand	  oxytocin	  (100nM).	  CCR2	  mRNA	  expression	  was	  reduced	  by	   PGF2α	   at	   6	   and	   24	   hours	   (p<0.05	   and	   p<0.01	   respectively,	   Fig4.4a)	   and	   by	  oxytocin	   at	   1,	   6	   and	  24	  hours	   (for	   all	   p<0.001,	   Fig4.4a).	   CXCR1	  mRNA	  expression	  was	   reduced	   by	   PGE2	   at	   24	   hours	   (p<0.05,	   Fig4.4b),	   by	   PGF2α	   at	   6	   and	   24	   hours	  (p<0.05	   and	   p<0.01	   respectively,	   Fig4.4b)	   and	   by	   oxytocin	   at	   24	   hours	   (p<0.01,	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Figure 4.4 The effect of pro-labour gene on chemokine receptors expression.  
Human uterine smooth muscle cells were incubated with or without 10nM PGE2, PGF2a and 100nM 
oxytocin for 1, 6 and 24 hours. At the end of incubation mRNA was extracted and converted to cDNA. 
Copy numbers of chemokine receptor mRNA were measured by quantitative rtPCR. n=6 for this 
experiment, data analysed using ANOVA Test if data distribution was parametric, and Friedman’s Test if 
data distribution was non-parametric, with a Dunn's Multiple Comparisons post hoc test. CCR2, 
Friedman<0.0001, Dunnett’s p<0.05 at PGF2a 6 hour, p<0.01 at PGF2a 24 hour, p<0.001 at oxytocin 1, 6 
and 24 hours, Fig. 4a; CXCR1, Friedman<0.0001, Dunnett’s p<0.05 at PGE224 hours and PGF2a 6 hours, 
p<0.01 for both PGF2a at 24 hour and oxytocin at 24 hours, Fig.4b; CXCR2, Friedman<0.0001, Dunnett’s 
p<0.05 for PGF2a 24 hours, p<0.001 for PGE2 and oxytocin at 24 hours, Fig.4c. Data are shown as the 
median, the 25th and 75th percentiles and the range, and * indicates p<0.05. ** indicates p<0.01, *** 
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indicates p<0.001. 4.4d: Human uterine smooth muscle cells were incubated with or without 1ng/mL IL-
1β, TNFα or IL-8, 10nM PGF2a and 100nM oxytocin for 1, 6 and 24 hours. At the end of incubation 
protein was extracted. Protein expression of CCR2 was measured by Western blot. n=4 for this experiment, 
densitometry was measured and analysed using Paired t-test, p<0.05 at 6 hours and p<0.01 at 24 hours with 
PGF2a and oxytocin. Data are shown as mean±SEM, and * indicates p<0.05. ** indicates p<0.01. 4.4e-
4.4g: Human uterine smooth muscle cells were pre-incubated with oxytocin for 0 and 24 hours. Cells were 
collected, and the CCR2 on cell surface was measured by FACS. n=4 for this experiment.  
4.2.5	  PGF2α	  and	  oxytocin	  down-­‐regulate	  myometrial	  chemokine	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Figure 4.5 Pro-labour protein reduced chemokine receptor expressions via PLC.   
Human uterine smooth muscle cells were incubated with or without 10nM PGF2a, 100nM oxytocin,  PGF2a 
+PLC inhibitor or oxytocin+ PLC inhibitor for 6 and 24 hours. At the end of incubation mRNA was 
extracted and converted to cDNA. Copy numbers of chemokine receptor mRNA were measured by 
quantitative rtPCR. n=6 for this experiment, data analysed using ANOVA Test if data distribution was 
parametric, and Friedman’s Test if data distribution was was non-parametric, with a Dunn's Multiple 
Comparisons post hoc test. CCR2, Friedman＝ 0.0018, Dunnett’s p<0.05 at oxytocin 6 hours, 
oxytocin+PLC inhibitor 24 hours and PGF2a +PLC inhibitor 6 hours, p<0.01 at oxytocin 24 hours and 
PGF2a +PLC inhibitor 24 hours, p<0.001 at PGF2a 6 and 24 hours, Fig. 5a and 5d; CXCR1, 
Friedman=0.0022, Dunnett’s p<0.05 at oxytocin+PLC inhibitor 6 hours, PGF2a +PLC inhibitor 6 hours and 
24 hours, p<0.01 for both PGF2a at 6 and 24 hour, p<0.001 for oxytocin at 6 and 24 hours, Fig.5b and 5e; 
CXCR2, Friedman=0.0022, Dunnett’s p<0.05 for PGF2a +PLC inhibitor 24 hours, p<0.01 for oxytocin 6 
hours, oxytocin+PLC inhibitor 24 hours and PGF2a 6 hours, p<0.001 for oxytocin at 24 hours, Fig.5c and 
5f. Data are shown as the median, the 25th and 75th percentiles and the range, and * indicates p<0.05. ** 
indicates p<0.01, *** indicates p<0.001 when comparing gene expression under PGF2a alone with PGF2a 
+PLC inhibitor at the same time point; # indicates p<0.05 when comparing control with PGF2a alone.  
f	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4.3	  Discussion	  
In	   this	   study,	   I	   found	   that	   the	   expression	   of	   the	  myometrial	   chemokine	   receptors	  CCR2	  CXCR1	  and	  CXCR2	  was	   reduced	  with	  TL,	  but	  unaffected	  by	  PTL.	  My	   in	  vitro	  studies	   showed	   that	   both	   oxytocin	   and	   PGF2a	   reduced	   chemokine	   receptor	  expression	  in	  cultured	  myometrial	  cells	  via	  PLC,	  while	  inflammatory	  cytokines	  had	  less	   marked,	   but	   still	   negative	   effect	   and	   mechanical	   stretch	   tended	   to	   increase	  expression.	   Previously,	   our	   group	   has	   shown	   that	   CXCR1/2	   are	   functional	   and	   in	  this	  study	  I	  found	  that	  CXCL8	  reduced	  the	  expression	  of	  CXCR2	  consistent	  with	  the	  negative	   relationship	   observed	   between	   the	   expression	   of	   CXCL8	   and	   CXCR2	   in	  labouring	   myometrial	   samples.	   The	   reduction	   in	   chemokine	   receptor	   expression	  with	   the	   onset	   of	   labour	   suggests	   that	   these	   receptors	  may	   act	   as	   decoys	   during	  pregnancy,	  limiting	  the	  response	  to	  myometrial	  chemokines.	  	  
In	  an	  earlier	  chapter,	  I	  reported	  that	  a	  distinct	  pattern	  of	  expression	  of	  myometrial	  chemokine	   mRNA	   in	   relation	   to	   TL	   and	   PTL	   existed	   (Chapter	   3),	   TL	   was	  characterised	  by	  an	  increase	  in	  CXCL8	  and	  CCL-­‐2	  in	  both	  upper	  and	  lower	  segments,	  while	   PTL	  was	   associated	  with	   increases	   in	   CCL5,	   CXCL5	   and	  CCL20	   in	   the	   lower	  segment	  myometrium	   only.	   In	   this	   study,	   the	   expression	   of	   chemokine	   receptors	  was	  reduced	  in	  TL	  upper	  segment	  samples	  only,	  although	  there	  was	  a	  trend	  for	  the	  expression	  to	  be	  reduced	  in	  TL	  lower	  segment	  samples	  too.	  In	  contrast,	  PTL	  was	  not	  associated	  with	  any	  change	  in	  chemokine	  receptor	  expression,	  demonstrating	  again	  distinct	  patterns	  in	  TL	  and	  PTL.	  .	  Interestingly,	  in	  chapter	  3,	  I	  found	  that	  both	  CCL2	  and	   CXCL8	   were	   increased	   in	   TL	   only	   24	   and	   in	   this	   study	   I	   found	   that	   their	  respective	   receptors,	   CCR2	   for	   CCL2	   and	   CXCR1	   and	   CXCR2	   for	   CXCL8,	  were	   also	  reduced	   in	   term	   labour	   only.	   Furthermore,	   there	   was	   a	   negative	   correlation	  between	   myometrial	   CXCL8	   levels	   and	   those	   of	   CXCR1	   and	   CXCR2,	   but	   in	   vitro,	  CXCL8	   only	   down	   regulated	   CXCR2	   mRNA	   expression.	   So,	   while	   the	   increase	   in	  CXCL8	  may	   play	   a	   role	   in	   the	   reduction	   in	   CXCR2,	   it	   seems	   likely	   that	   PGF2α	  and	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oxytocin	  are	  the	  prime	  drivers	  for	  the	  repression	  of	  chemokine	  receptor	  expression	  acting	  via	  PLC.	  	  
CXCR1	  and	  CXCR2	  have	  both	  been	  suggested	  to	  act	  as	  decoys	  for	  their	  ligand,	  which	  is	   CXCL8	   291.	   If	  myometrial	   chemokine	   receptors	   functioned	   in	   this	  manner,	   then	  their	   relatively	   high	   expression	   during	   pregnancy	   would	   limit	   the	   effect	   of	   any	  locally	  produced	  chemokines	  and	   the	   inverse	  when	   they	  decline	  with	   the	  onset	  of	  labour.	  This	  would	  be	  consistent	  with	   the	  marked	   inflammatory	   infiltration	  of	   the	  myometrium	   seen	   with	   the	   onset	   of	   human	   labour17.	   In	   addition,	   besides	   being	  central	   to	   the	   inflammatory	   process,	   chemokines	   also	   regulate	   cell	   proliferation,	  migration	   and	   angiogenesis	   292.	   Indeed,	   CXCL8	   has	   been	   suggested	   to	   act	   as	   an	  autocrine	  growth	  factor,	  increasing	  the	  proliferation	  of	  endometrial	  stromal	  cells	  293	  and	   fibroids	   294.	   Consequently,	   CXCL8	   may	   promote	   myometrial	   growth	   during	  pregnancy,	   however,	   with	   the	   onset	   of	   labour,	   myometrial	   cells	   would	   need	   to	  differentiate	   into	   a	   contractile	   phenotype	   and	   the	   reduction	   in	   the	   expression	   of	  both	  CXCR1/2	  may	  play	  a	  role	  in	  this	  process.	  	  	  
The	  uterus	  is	  subjected	  to	  progressively	  greater	  stretch	  longitudinally.	  In	  chapter	  3,	  I	   found	   that	   myometrial	   stretch	   induced	   the	   expression	   of	   several	   pro-­‐labour	  proteins,	  such	  as	  CXCL8,	  oxytocin	  receptor,	  COX-­‐2	  and	  several	  chemokines	  202,219,284.	  In	  this	  study,	   I	   found	  that	  stretch	   induced	  the	  expression	  of	  myometrial	  CCR2	  and	  CXCR1	   mRNA	   expression,	   suggesting	   that	   it	   does	   not	   play	   a	   role	   in	   the	   labour	  associated	   decline	   in	   chemokine	   receptor	   expression.	   	   Similarly,	   the	   effect	   of	   the	  cytokines	  was	   inconsistent,	   in	   the	   case	   of	   CXCR1;	   they	  had	  no	   effect,	  while	   in	   the	  case	  of	  CXCR2	  both	   IL-­‐1β	   and	  TNFα	   reduced	   its	   expression.	   Since	  both	   IL-­‐1β	  and	  TNFα	  increase	  in	  labour	  103	  they	  may	  contribute	  to	  the	  decline	  in	  CXCR2	  expression,	  interestingly,	   TNFα	   has	   been	   reported	   to	   down-­‐regulate	   CXCR1	   and	   CXCR2	  expression	  in	  other	  cell	  types	  295.	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I	  have	  shown	  that	  chemokine	  receptors	  decline	  with	  the	  onset	  of	  labour,	  probably	  in	  response	   primarily	   to	   increased	   levels	   of	   oxytocin	   and	   PGF2α  , but	   with	   a	   less	  important	  effect	  of	  the	  inflammatory	  cytokines.	  In	  the	  case	  of	  CXCR2,	  the	  increased	  expression	   of	   CXCL8	   may	   also	   repress	   its	   expression.	   The	   decline	   in	   myometrial	  chemokine	   receptor	   expression	   may	   increase	   the	   effect	   of	   locally	   produced	  chemokines	  or	  even	  promote	  the	  generation	  of	  a	  contractile	  phenotype.	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Chapter	  5. The	  effects	  of	  LPS	  on	  E16	  mouse	  
regarding	  pregnancy	  outcome	  and	  molecular	  













	   Chapter	  5.	  The	  effects	  of	  LPS	  on	  E16	  mouse	  regarding	  pregnancy	  outcome	  and	  molecular	  indicators	  of	  tissue	  inflammation.	   	  	   	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  	  	  
103	  
5.1	  Introduction	  
Since	   labour	   is	  an	   inflammatory	  process	  chemokines	  should	  be	   involved.	  Different	  chemokines	  act	  to	  recruit	  specific	  immune	  cells	  into	  areas	  of	  inflammation,	  so	  that	  chemokine	   (C-­‐C	   motif)	   ligand	   2	   (CCL2),	   also	   known	   as	   monocyte	   chemotactic	  protein-­‐1	   (MCP-­‐1)	  mainly	   recruits	  monocytes,	  memory	  T	   cells	   and	   dendritic	   cells	  296,297,	  and	  the	  CXC	  or	  CX3C	  chemokines	  recruit	  neutrophils	  primarily	  via	  CXCR1	  and	  CXCR2	  145.	  It	  seems	  likely	  that	  specific	  chemokines	  will	  increase	  prior	  to	  the	  onset	  of	  parturition	   to	   direct	   uterine	   and	   cervical	   leukocyte	   recruitment	   and	   activation.	  Indeed,	  CXC	  chemokines	  CXCL1,	  CXCL2,	  CXCL3,	  CXCL5	  and	  CXCL8,	  CC	  chemokines	  CCL2,	   CCL5	   and	   CCL20	   have	   all	   be	   shown	   to	   be	   up-­‐regulated	   in	   myometrium	  obtained	  at	  the	  time	  of	  term	  human	  labour	  167	  and	  are	  probably	  responsible	  for	  the	  labour	  associated	  neutrophil	  and	  monocyte	  myometrial	  infiltration.	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5.2	  Results	  


















































	   Chapter	  5.	  The	  effects	  of	  LPS	  on	  E16	  mouse	  regarding	  pregnancy	  outcome	  and	  molecular	  indicators	  of	  tissue	  inflammation.	   	  	   	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
































































































	   Chapter	  5.	  The	  effects	  of	  LPS	  on	  E16	  mouse	  regarding	  pregnancy	  outcome	  and	  molecular	  indicators	  of	  tissue	  inflammation.	   	  	   	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  

























































































Figure 5.1 CD1 mouse myometrial chemokine expression.  
a-e: Mice were sacrificed before pregnancy (non-pregnant), on days 6, 11, 16 and 18 of pregnancy 
(E6,11,16,18), in labour (after the birth of the first pup) or 36 hours post delivery (T36). Myometrium from 
both of the right and left horns was harvested, put on dry ice and stored at -70oC until RNA extraction. 
Myometrial chemokine mRNA expression was subsequently measured by rt-PCR and expressed as 
d 
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median, interquartile range and range. In all cases except CCL20, chemokine expression declined between 
non-pregnant and E6 samples, and then rose to a peak at E18 and thereafter remained static in samples 
obtained during labour and 36 hours after delivery. Data were compared to E6 levels using ANOVA 
followed by Dunn’s post test. * indicates a difference of p<0.05, ** of p<0.01, *** of p<0.001, n=6 at each 
time point. 






































Figure 5.2 Inflammatory cells in non-pregnant and E18 mice myometrium.  
At each time point, mice were sacrificed and myometrium harvested and stored in PBS at 4℃. 
Subsequently, myometrium was digested using collagenase and then incubated with different antibodies. 
Positive cells were detected by FACS and numbers compared between myometrium obtained from non-
pregnant mice and pregnant mice on day 18 of pregnancy. The numbers of macrophages (labelled by 
CD45+/F4/80+/Gr1-) and monocytes (labelled CD45+/F4/80+/Gr1+) in E18 myometrium were 
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significantly higher (p<0.05), neutrophils (labelled CD45+/F4/80-/Gr1+) did not reach significance. Data 
were analyzed using Mann Whitney test. Data were presented as Mean with SEM, n=3-6. * indicates a 
significant difference of p<0.05.    







































Figure 5.3 Time of labour.  
After intrauterine PBS injection mean time to delivery was 66.3±6. hours and after LPS 13.9±3.9 hours 
(p<0.001, Fig.5.3a). n=6 for this experiment.   
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5.2.4	  Myometrial	  chemokine	  and	  cytokine	  mRNA	  expression	  in	  
response	  to	  LPS	  Myometrial	  samples	  were	  taken	  at	  7	  hours	  and	  in	  labour	  after	  LPS	  or	  PBS	  injection	  and	   chemokine	   and	   cytokine	  mRNA	   expression	   compared.	   In	   the	   right	   (injected)	  horn	   at	   7	   hours,	   the	   expression	   of	   the	   chemokines	   CCL2	   (p<0.05,	   Fig5.4a),	   was	  increased	   in	   the	   LPS	   injected	   as	   compared	   to	   PBS	   injected	   controls.	   In	   labouring	  samples,	  the	  expression	  of	  the	  chemokines	  CCL2,	  CCL5,	  CCL20	  and	  CXCL1	  and	  of	  the	  cytokines	  IL-­‐1β	  and	  IL-­‐6	  was	  increased	  (p<0.05-­‐0.01,	  Fig5.4b).	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Figure 5.4 Myometrial chemokine and cytokine mRNA expression in response to LPS.  
Mice were sacrificed at 7 hours after injection of LPS or PBS and at the time of labour (after the birth of 
the first pup). Myometrium was harvested, put on dry ice and stored at -70oC until RNA extraction. 
Myometrial chemokine mRNA expression was subsequently measured by rt-PCR and expressed as 
median, interquartile range and range. In the right (injected) horn at 7 hours in the LPS injected as 
compared to PBS injected controls, the expression of the chemokines CCL2 (p<0.05, Fig5.4a) was 
increased; in labouring samples, the expression of all chemokines and cytokines was increased (all p<0.05, 
Fig5.4b). In the left (non-injected) horn at 7 hours post LPS injection, the expression of the chemokines, 
CCL5, CXCL1, CXCL5 (all p<0.05, Fig5.4c), was increased; in labouring samples, the expression of all 
chemokines and of IL-1β and IL-6 was increased (all p<0.05, Fig5.4d). Data were analyzed using 





	   Chapter	  5.	  The	  effects	  of	  LPS	  on	  E16	  mouse	  regarding	  pregnancy	  outcome	  and	  molecular	  indicators	  of	  tissue	  inflammation.	   	  	   	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  	  	  
112	  
5.2.5	  The	  effect	  of	  LPS	  on	  the	  phosphorylation	  of	  ERK1/2,	  p65	  and	  c-­‐jun	  
and	  the	  levels	  of	  COX	  in	  myometrium	  (left	  horn).	  	  
1.	   Non-­‐pregnant	  and	  day	  16	  of	  pregnant	  mice.	  
The	  phosphorylation	  of	  ERK1/2	  and	  the	  levels	  of	  COX-­‐2	  were	  increased	  (p<0.01	  for	  all),	  while	  the	  phosphorylation	  of	  c-­‐jun	  was	  reduced	  (p<0.01)	  and	  of	  p65	  unchanged	  in	  the	  day	  16	  myometrial	  samples	  compared	  to	  the	  NP	  samples	  (Fig.5.5a).	  	  
2.	  	   LPS	  vs.	  PBS	  injected	  at	  7	  hours	  and	  in	  labour	  
At	   7	   hours	   post	   injection,	   LPS	   administration	   increased	   the	   phosphorylation	   of	  ERK1/2	  and	  p65	  (p<0.001	  and	  p<0.01	  respectively,	  Fig5.5b).	  The	  phosphorylation	  of	   c-­‐jun	   and	   COX-­‐2	   levels	   were	   unaffected	   (Fig5.5b).	   In	   labouring	   samples,	   LPS	  administration	  increased	  the	  phosphorylation	  of	  ERK1/2	  and	  COX-­‐2	  levels	  (p<0.01	  and	   p<0.001	   respectively,	   Fig5.5c).	   The	   phosphorylation	   of	   c-­‐jun	   and	   p65	   were	  unaffected	  (Fig5.5c).	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Figure 5.5 a-c The effect of LPS on the phosphorylation of ERK1/2, NF-κB and c-jun and the levels 
of COX in myometrium (left horn).  
Mice were sacrificed before pregnancy (non-pregnant), on day 16 before and after injection (7 hours or, in 
labour [after the birth of the first pup]). Myometrium of the left horn was harvested, put on dry ice and 
stored at -70oC until protein extraction. In comparison to non-pregnant samples, myometrium obtained on 
day 16 of pregnancy showed increased phosphorylation of ERK1/2 (p<0.01 for ERK1, p<0.001 for ERK2) 
and the level of COX-2 (p<0.01), phosphorylation of c-jun decreased (p<0.01), and levels of 
phosphorylated NF-κB showed no change (Fig.5.5a). At 7 hours post injection, the myometrial samples 
obtained from mice after LPS administration showed increased phosphorylation of ERK1/2 and NF-κB 
(p<0.001 and p<0.01 respectively, Fig5.5b), while the phosphorylation of c-jun and COX-2 levels were 
unaffected (Fig5.5b). In labouring samples, LPS administration increased the phosphorylation of ERK1/2 
and COX-2 levels (p<0.01 and p<0.001 respectively, Fig5.5c). The phosphorylation of c-jun and NF-κB 
were unaffected (Fig5.5c). Data are presented as mean + SEM and were analysed using an unpaired t test, 
n=6 for this experiment. * indicates a significant difference of  p<0.05, ** indicates p<0.01, *** indicates 
p<0.001.    
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Figure 5.6 The maternal IL-6 response to PBS and LPS intrauterine injection.  
4 groups of animals, non-pregnant, untreated mice on day 16 of pregnancy and mice injected on day 16 
with PBS or LPS injected were sacrificed and maternal plasma was collected. There was no difference 
between the circulating levels of IL-6 in NP, day 16 and spontaneously labouring mice. PBS or LPS 
significantly increased circulating levels of IL-6 at 3 hours post injection (p<0.001). The elevation in IL-6 
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levels continued until the onset of labour in mice injected with LPS, but declined in mice injected with 
PBS, although it remained elevated at the time of labour compared to the levels found in normal labouring 
mice (p<0.001). Data are presented as mean+SEM and were analyzed using an unpaired t test, n=6 for this 
experiment. §§§ indicates a significant difference of p<0.001 between E16 and 3 hours. *** indicates a 
significant difference of p<0.001 between PBS and LPS group. ### indicates a significant difference of 
p<0.001 between normal and PBS labouring groups. 
5.2.7	  Pup	  brain	  chemokine	  and	  cytokine	  mRNA	  expression	  in	  response	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Figure 5.7 a-c Pup brain chemokine and cytokine mRNA expression in response to LPS.  
Mice were sacrificed at 3 hours, 7 hours and labour after injection of LPS or PBS. Pup brains were 
harvested, put on dry ice and stored at -70oC until RNA extraction. Pup brain chemokine mRNA 
expression was subsequently measured by rt-PCR and expressed as mean+SEM, and were analyzed using 
an unpaired t test, n=6 for this experiment. Pup brains were collected from pups in the left (non-injected) 
horn. There were no differences in chemokine or cytokine mRNA expression between PBS and LPS 
injected mice at 3 and 7 hours (Figure a&b). CCL2, IL-1β and TNFα were increased in labour (p<0.05, 
Fig.5.7c). * indicates a significant difference of  p<0.05. 
b	  
c	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5.2.8	  Placental	  chemokine	  and	  cytokine	  mRNA	  expression	  in	  response	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Figure 5.8 a-c Placental chemokine and cytokine mRNA expression in response to LPS 
Mice were sacrificed at 3 hours, 7 hours and labour after injection of LPS or PBS. Placentae were 
harvested, put on dry ice and stored at -70oC until RNA extraction. Chemokine mRNA expression was 
subsequently measured by rt-PCR and expressed as mean+SEM. Placentae were collected from the left 
(non-injected) horn. At 3 hours, with the exception of CCL20, the mRNA expression of all chemokines 
b	  
c	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was increased by LPS (p<0.05 for each); cytokine mRNA expression was not significantly increased 
(Figure 5.8a). At 7 hours, CXCL1, TNFα and IL-6 were increased by LPS (p<0.05, Figure 5.8b). At the 
time of labour, CCL5 (p<0.05), CCL20 (p<0.001), CXCL1 (p<0.01), CXCL5 (p<0.05) and IL-
1β (p<0.05) were increased by LPS (Figure 5.8c). * indicates a significant difference of  p<0.05, ** 
indicates p<0.01, *** indicates p<0.001., n=6. 
5.2.9	  The	  effect	  of	  LPS	  on	  placental	  phosphorylation	  of	  ERK1/2,	  p65	  and	  
c-­‐jun	  and	  the	  levels	  of	  COX-­‐2.	  	  At	  3	  hours	  post	  injection,	  LPS	  administration	  increased	  the	  phosphorylation	  of	  p65	  and	   the	   levels	   of	   COX	   (p<0.01	   and	   p<0.05	   respectively,	   Fig5.9a).	   The	  phosphorylation	   of	   c-­‐jun	   and	   ERK1/2	   were	   unaffected	   (Fig5.9a).	   In	   labouring	  samples,	  LPS	  administration	  increased	  the	  phosphorylation	  of	  ERK1/2	  (p<0.05	  and	  p<0.01	  respectively)	  and	  of	  p65	  (p<0.01,	  Fig5.9b).	  The	  phosphorylation	  of	  c-­‐jun	  and	  the	  levels	  of	  COX-­‐2	  were	  unaffected	  (Fig5.9b).	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Figure 5.9 a&b The effect of LPS on the phosphorylation of ERK1/2, NF-κB and c-jun and the levels 
of COX in the placenta (left horn).  
Mice were sacrificed at 3 hours and labour after injection of LPS or PBS. Placentae were harvested, put on 
dry ice and stored at -70oC until protein extraction. At 3 hours, the placentae obtained from mice after LPS 
administration showed increased phosphorylation of NF-κB and COX levels (p<0.01 and p<0.05 
respectively), while the phosphorylation of ERK1/2 and c-jun were unaffected. During labour, 
phosphorylation of ERK1 (p<0.05), ERK2 (p<0.01) and NF-κB (p<0.01) were increased. Data are 
presented as mean + SEM and were analysed using an unpaired t test, n=6 for this experiment. * indicates a 
significant difference of  p<0.05, ** indicates p<0.01.    
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5.3	  Discussion	  
LPS	  has	  been	  used	  to	  induce	  pregnancy	  loss	  or	  PTL	  in	  various	  models.	  The	  dosage	  and	   serotype	   used	   has	   varied	  widely	   and	   in	   rodent	  models,	   it	   varies	   from	   0.1	   to	  500µg	   258,263,264,298-­‐300	  and	   the	  site	  of	  administration,	   intra-­‐uterine,	  between	  sacs	  1	  and	  2,	  258	  or	  intraperitoneal	  264.	  In	  those	  models	  where	  LPS	  is	  administered	  preterm,	  the	  impact	  on	  pregnancy	  outcomes	  seems	  to	  be	  similar,	  although	  the	  occurrence	  or	  interval	   to	   the	   onset	   of	   labour	   appears	   to	   be	   shorter	   the	   higher	   the	   dosage	   used	  258,263,264.	  Pup	  mortality	  is	  typically	  100%	  by	  the	  time	  of	  labour	  onset,	  although	  again	  this	  varies	  with	  dosage	  258,263,264.	  However,	  the	  process	  leading	  to	  pup	  death	  is	  not	  clear	  but	  has	  been	  assumed	  to	  be	  due	  to	  pup	  inflammation	  263.	  Certainly,	  previous	  studies	  found	  that	  there	  was	  phosphorylation	  of	  p65	  and	  c-­‐jun	  in	  the	  pup	  brain	  after	  intra-­‐uterine	   LPS	   injection	   263	   and	   of	   fetal	   cytokine	   levels	   in	   the	   circulation	   and	  expression	  in	  the	  brain,	  lung,	  intestine	  and	  liver	  after	  intra-­‐peritoneal	  injection	  264.	  Given	   the	   primary	   role	   of	   inflammation	   in	   human	   PTL	   and	   importance	   of	  chemokines	   in	   all	   inflammatory	   processes	   the	   mouse	   model	   of	   LPS-­‐induced	   PTL	  was	  chosen	  to	  investigate	  the	  impact	  of	  various	  chemokine	  knockout	  mice.	  However,	  before	   using	   the	   model	   the	   expression	   of	   chemokines	   and	   cytokines	   in	   normal	  pregnancy	  and	  in	  the	  LPS	  model	  were	  studied.	  
In	   general,	   the	   expression	   of	   chemokines	   in	   the	   mouse	   myometrium	   during	  pregnancy	   initially	   declined	   rapidly	   from	   the	   non-­‐pregnant	   state	   to	   day	   6	   of	  pregnancy,	  around	  the	  time	  of	  embryo	  implantation,	  and	  then	  rose	  to	  day	  18	  prior	  to	  the	  onset	  of	  parturition.	  There	  was	  no	  change	  in	  chemokine	  expression	  between	  day	   18	   and	   the	   onset	   of	   parturition,	   or	   between	   parturition	   and	   36	   hours	   later,	  suggesting	   that	   chemokine	   expression	   increases	   prior	   to	   the	   onset	   of	   parturition	  and	  is	  not	  a	  consequence	  of	  parturition.	  Given	  the	  increase	  in	  chemokine	  expression	  with	  advancing	  gestation	  Iexpected	  to	  see	  increased	  activation	  of	  NF-­‐κB	  and/or	  AP-­‐1	   transcription	   factors	   as	   MAPK	   and	   NFκB	   were	   shown	   to	   drive	   chemokine	  expression	  (Chapter	  3).	  However,	  although	  ERK1/2	  phosphorylation	  was	  increased,	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the	   phosphorylation	   of	   c-­‐jun	  was	   reduced	   and	   NFκB	   unchanged	   in	   samples	   from	  non-­‐pregnant	  and	  day	  16	  pregnant	  mice.	  	  Interestingly,	  COX-­‐2	  levels	  were	  increased	  in	   these	   samples	   suggesting	   that	   prostaglandin	   (PG)	   synthesis	   is	   increased.	  However,	   since	  PGs	   can	  act	   to	  promote	  myometrial	  quiescence	  or	   contraction	   the	  overall	  effect	  will	  be	  dependent	  on	  down	  stream	  PG	  synthetic	  enzyme	  activity.	  
The	   effects	   of	   the	   increased	   chemokine	   expression	   on	  monocyte	   and	  macrophage	  myometrial	   infiltration	   were	   studied	   and	   found	   that	   both	   increased	   in	   day	   18	  compared	   to	   non-­‐pregnant	   myometrium	   consistent	   with	   observations	   in	   the	   rat	  166,301,302.	   In	   the	   human,	   the	   increase	   in	   myometrial	   inflammatory	   cells	   seems	   to	  occur	   only	   after	   the	   onset	   of	   labour	   17.	   Similar	   observations	   have	   been	   made	   in	  human	   decidua	   302.	   In	   human	   cervical	   tissues,	   the	   numbers	   of	   neutrophils	   and	  monocytes	  increased	  at	  term	  and	  did	  not	  increase	  further	  with	  the	  onset	  of	  labour	  9.	  Similarly,	   in	   the	   present	   study,	   the	   increases	   in	   myometrial	   inflammatory	   cell	  infiltration	  were	   seen	  prior	   to	   the	  onset	   of	   labour.	  The	  observations	  made	   in	   this	  study	  support	  the	  idea	  that	  the	  increase	  in	  chemokines	  and	  the	  resultant	  increase	  in	  myometrial	  inflammatory	  cell	  infiltration	  precede	  the	  onset	  of	  labour	  and	  therefore	  may	  have	  a	  role	  in	  its	  causation.	  	  	  
LPS	   increased	  maternal	   IL-­‐6	   levels	   as	  has	  previously	  been	   reported	   275,303.	   In	   fact,	  laparotomy	   and	   PBS	   injection	   also	   increased	  maternal	   circulating	   IL-­‐6	   levels	   that	  remained	   elevated	   until	   the	   onset	   of	   labour	   some	  56	   hours	   post	   laparotomy.	   The	  myometrial	   response	  was	   interesting,	   in	   the	   right	   horn	   (injected)	   at	   7	   hours	  post	  injection	   there	   was	   no	   increase	   in	   inflammation	   as	   judged	   by	   the	   comparison	   of	  chemokine	   and/or	   cytokine	   expression	   between	   LPA	   and	   PBS	   injected	   tissues.	  However,	   in	   contrast,	   in	   the	   left	   horn	   (non-­‐injected),	   chemokine	   expression	   was	  increased	  at	  7	  hours	  suggesting	  that	  the	  local	  response	  to	  the	  PBS	  injection	  masked	  any	  LPS-­‐induced	  increase	  in	  chemokines	  in	  the	  right	  horn,	  but	  that	  these	  were	  clear	  in	   the	   left.	   In	   labouring	   samples,	   in	   both	   horns,	   the	   expression	   of	   all	   of	   the	  chemokines	   and	   of	   IL-­‐1β	   and	   IL-­‐6	   in	   the	   right	   and	   of	   IL-­‐6	   only	   in	   the	   left	   was	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increased.	  These	  data	  suggest	  that	  in	  the	  left	  horn	  chemokine	  expression	  increased	  first	  followed	  by	  increases	  in	  cytokine	  expression.	  This	  would	  be	  consistent	  with	  the	  observations	  of	  Young	  et	  al,	  who	  localised	  myometrial	  cytokine	  mRNA	  to	  infiltrating	  inflammatory	  cells	  in	  spontaneous	  labour	  104.	  Together	  these	  data	  support	  the	  idea	  that	  the	  increased	  myometrial	  cytokine	  production	  is	  dependent	  on	  the	  chemokine-­‐induced	  inflammatory	  cell	  infiltration.	  In	  terms	  of	  transcription	  factor	  activation,	  at	  7	   hours	   post	   injection	   in	   the	   left	   horn,	   ERK1/2	   and	   p65	   phosphorylation	   was	  increased,	  while	   c-­‐jun	   phosphorylation	   and	   COX-­‐2	   levels	  were	   unchanged.	   By	   the	  onset	  of	  parturition,	  although	  the	  phosphorylation	  of	  ERK1/2	  remained	  greater,	  the	  phosphorylation	   of	   p65	   and	   c-­‐jun	  was	   similar	   in	   PBS	   and	   LPS-­‐injected	  mice.	   The	  levels	   of	   COX-­‐2	   were	   greater.	   These	   data	   are	   consistent	   with	   those	   reported	   by	  Pirianov	  et	  al,	  who	  showed	  that	  LPS	  increased	  myometrial	  p65,	  c-­‐jun	  and	  cPLA2	  (an	  ERK1/2	  substrate)	  phosphorylation	  263.	  	  
The	   high	   rates	   of	   pup	   death	   have	   been	   associated	   with	   increased	   pup	   brain	  inflammation	   263	   and	   this	   has	   been	   suggested	   to	   be	   the	  main	   cause	   of	   pup	   death.	  However,	  in	  this	  study	  there	  was	  no	  evidence	  of	  pup	  brain	  inflammation	  until	  after	  pup	  death.	  This	  contrast	  with	  earlier	  work	  from	  our	  own	  group	  263	  and	  the	  evidence	  from	  Elovitz	  et	  al,	  who	  showed	   that	   intrauterine	  LPS	   results	   in	  marked	  pup	  brain	  inflammation	  298.	  The	  difference	  may	  be	  related	  to	  the	  different	  types	  of	  LPS	  used,	  Elovitz	   uses	   serotype	   O55	   and	   Piranov	   used	   a	   salmonella	   derived	   LPS,	   as	   the	  different	  oligosaccharides	   in	  each	   form	  of	  LPS	  may	  alter	  placental	   transfer	  and	  so	  the	  fetal	  inflammatory	  response.	  In	  the	  current	  study,	  there	  was	  no	  evidence	  of	  fetal	  brain	  inflammation.	  Consistent	  with	  this	  observation,	   in	  arat	  study	  using	  the	  same	  type	  of	  LPS	   labelled	  with	   I125,	  none	  was	  detected	   in	   the	   fetus,	   suggesting	   that	  LPS	  0111,	  does	  not	  cross	  the	  placenta	  304.	  	  
Consequently,	   to	   understand	  whether	   placental	   dysfunction	  might	   be	   responsible	  for	   pup	   death,	   I	   studied	   the	   effect	   of	   LPS	   on	   placental	   inflammation.	   In	   addition,	  since	  some	  pups	  were	  dead	  by	  7	  hours,	   I	  used	  the	  earlier	  time	  point	  of	  3	  hours	  to	  
	   Chapter	  5.	  The	  effects	  of	  LPS	  on	  E16	  mouse	  regarding	  pregnancy	  outcome	  and	  molecular	  indicators	  of	  tissue	  inflammation.	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assess	  placental	  changes.	  Chemokine	  expression	  was	  increased	  at	  3	  and	  7	  hours	  and	  markedly	  elevated	  in	  the	  labouring	  samples.	  In	  terms	  of	  the	  inflammatory	  cytokines,	  IL-­‐6	   expression	   was	   increased	   at	   all	   3	   time	   points,	   but	   like	   the	   chemokines	   the	  increase	  was	  greatest	  in	  labouring	  samples.	  TNFα	  mRNA	  expression	  was	  increased	  at	   7	   hours	   only	   and	   IL-­‐1β	   in	   labouring	   samples	   only.	   These	   data	   suggest	   that	  placental	   chemokine	   mRNA	   expression	   increased	   initially	   followed	   by	   the	  inflammatory	  cytokines.	  The	  time	  course	  of	  placental	  inflammation	  was	  different	  in	  rats	   treated	  with	   approximately	   4µg	   of	   the	   same	   type	   of	   LPS,	   the	   levels	   of	   TNFα	  were	  elevated	  at	  2	  hours	  only,	  of	  IL-­‐1β	  at	  4	  hours	  and	  8	  hours	  and	  of	  IL-­‐6	  at	  8	  hours	  only,	  maternal	  serum	  levels	  showed	  acute	  increases	  in	  TNFα	  at	  2	  hours,	  IL-­‐1β	  at	  4	  hours	   and	   IL-­‐6	   at	   both	   time	   points	   304.	   The	   significance	   of	   the	   increase	   in	  chemokines	  and	  cytokines	  in	  terms	  of	  their	  role	  in	  pup	  demise	  is	  difficult	  to	  assess.	  In	   the	   rat	   studies,	   perfusion	   was	   markedly	   reduced	   at	   45	   minutes	   post	   LPS	   and	  infusion	  of	  the	  IL-­‐1receptor	  antagonist	  protected	  the	  pups	  from	  the	  adverse	  effects	  of	   maternal	   LPS	   305.	   This	   suggests	   that	   the	   maternal	   inflammation	   induced	   the	  reduction	   in	  placental	  perfusion	  and	  pup	  death.	   In	  my	   study,	  maternal	   IL-­‐6	   levels	  were	   markedly	   elevated	   by	   3	   hours	   and	   placental	   chemokine	   expression	   was	  increased	  at	  3	  hours,	  but	  peaked	  in	  the	  labouring	  samples,	  at	  least	  7	  hours	  after	  pup	  demise.	   At	   3	   hours,	   p65	   phosphorylation	   and	   COX-­‐2	   levels	   were	   significantly	  increased,	   the	   changes	   in	   ERK1/2	   and	   c-­‐jun	   phosphorylation	   didn’t	   reach	  significance,	   only	   in	   labouring	   samples	   was	   ERK1/2	   and	   p65	   phosphorylation	  significantly	  increased.	  	  
These	  observations	  do	  not	  help	  us	   to	  understand	   the	  mechanisms	  responsible	   for	  pup	   death	   in	   this	  model.	   It	   seems	   unlikely	   that	   pup	   inflammation	   has	   a	   role,	   but	  whether	   there	   is	   a	   decline	   in	   maternal	   blood	   pressure	   that	   reduces	   placental	  perfusion	   or	   placental	   inflammation	   which	   restricts	   blood	   flow	   is	   uncertain.	  Although	  many	  groups	  have	  used	  and	  are	  currently	  using	  LPS	  to	  induce	  damage	  in	  the	  developing	  fetal	  brain,	  the	  mechanisms	  responsible	  for	  this	  damage	  are	  far	  from	  clear	  and	  need	  to	  be	  defined	  as	  a	  matter	  of	  urgency.	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Chapter	  6. CCR2	  knockout	  improves	  pup	  survival	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6.1	  Introduction	  
Inflammation	   is	   the	   first	   response	   to	   tissue	   injury	   and	   is	   driven	   by	   a	   chemokine-­‐dependent	   infiltration	   of	   immune	   cells	   into	   the	   area	   of	   injury.	   Labour	   is	   an	  inflammatory	   process,	   with	   a	   marked	   myometrial	   infiltration	   of	  monocytes/macrophages.	  The	  chemokine	  (C-­‐C	  motif)	   ligand	  2	   (CCL2),	  also	  known	  as	  monocyte	  chemotactic	  protein-­‐1	  (MCP-­‐1),	  is	  a	  CC	  chemokine	  that	  mainly	  recruits	  monocytes,	  memory	   T	   cells	   and	   dendritic	   cells	   to	   the	   sites	   of	   inflammation296,297.	  CCL2	   has	   also	   been	   implicated	   in	   the	   pathogenesis	   of	   other	   diseases	   that	   involve	  monocyte	   infiltration.	   Its	   effects	   are	  mediated	   through	   the	   cell	   surface	   chemokine	  receptors	  CCR2	  and	  CCR4,	  of	  the	  two,	  CCR2,	  is	  the	  prime	  mediator	  of	  the	  effects	  of	  CCL2	  and	  as	  such	  has	  been	  suggested	  to	  be	  an	  important	  therapeutic	  target306.	  The	  level	  of	  CCL2	  increases	  with	  the	  onset	  of	  labour	  suggesting	  that	  CCL2	  may	  be	  one	  of	  the	  key	  mediators	  of	   this	  effect.	   Increased	  amniotic	   fluid	  CCL2	   levels	  are	   found	   in	  preterm	  and	  term	  labouring	  samples168,307.	  In	  contrast,	  in	  rat	  studies,	  progesterone	  suppressed	   the	   expression	   of	   CCL2	   and	   conversely,	   RU486,	   an	   anti-­‐progestin,	  increased	  in	  CCL2	  mRNA	  expression	  and	  induced	  preterm	  delivery308.	  Collectively,	  these	  data	  suggest	  that	  CCL2	  could	  play	  a	  key	  role	  in	  the	  onset	  and	  progression	  of	  labour.	  	  	  
Several	   small	   molecule	   CCR2	   antagonists	   exist;	   however,	   CCR2	   knockout	   is	   an	  alternative	   approach	   to	   blocking	   CCR2	   for	   in	   vivo	   studies.	   The	   CCR2	   knockout	  mouse	   model	   has	   been	   used	   mainly	   in	   studies	   of	   respiratory	   system,	   where	   the	  CCR2	  defect	  markedly	  impaired	  macrophage	  recruitment	  to	  the	  site	  of	  inflammation.	  In	   CCR2-­‐/-­‐	  mice,	   after	   a	  mycobacterium	  bovin	   challenge,	   IFN-­‐γ	   producing	   cells	   in	  draining	  lymph	  node	  were	  70%	  lower	  309.	  Knockout	  of	  CCR2	  also	  impaired	  dendritic	  cell	  trafficking	  and	  activation/maturation,	  again	  shown	  after	  mycobacterium	  bovine	  antigen	   challenge,	   when	   dendritic	   cells	   had	   lower	   MHCII	   and	   CD40	   expression.	  Macrophage	   infiltration	  of	   the	   injected	  site	  decreased	  50%.	   	  Nelson’s	  group	   found	  that	  CCR2	  knockout	  had	  no	  impact	  on	  pregnancy	  outcomes,	  which	  was	  of	  a	  normal	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duration,	  with	  similar	  litter	  sizes,	  and	  fetal	  and	  placenta	  weight	  in	  CCR2-­‐/-­‐	  and	  wild	  type	  (CD1)	  mice.	  However,	  on	  day	  18	  of	  pregnancy,	  CCR2	  -­‐/-­‐	  mice	  did	  not	  display	  the	   increase	   in	   F4/80	   transcripts	   observed	   in	   the	   wild	   type	   mice,	   suggesting	  defective	  macrophage	  trafficking,	  however,	  similar	  levels	  of	  Gr-­‐1	  (granulocytes)	  was	  observed	  between	  wild	  type	  and	  CCR2-­‐/-­‐310.	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6.2	  Results	  














































a	   CCL2 mRNA expression in CCR2-/- mouse 
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CCL5 mRNA expression in CCR2-/- mouse 
CCL20 mRNA expression in CCR2-/- mouse 
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Figure 6.1 CCR2-/- mouse myometrial chemokine expressions.  
CCR2-/- mice were put under anaesthetic and sacrificed before and after pregnancy and on specific days 
during pregnancy. Myometrium was harvested and put on dry ice. RNA was extracted and the level of 
d	  
e	  
CXCL1 mRNA expression in CCR2-/- mouse 
CXCL5 mRNA expression in CCR2-/- mouse 
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mouse chemokine mRNA expression measured by rt-PCR. CCL20 increased at E6 compare to non-
pregnant and start to decrease at E11, E16, E18, labouring; CXCL1 increase at E16 compare to E6.  n=6 
for this experiment. Data were analyzed using ANOVA with Dunn’s post-test, and presented as median, 
interquartile range and range,  * indicates a significant difference p<0.05, **indicates p<0.01 
 
6.2.2	  NF-­‐κB	  p65	  and	  ERK	  activations	  on	  E16,	  resulting	  the	  increase	  of	  
COX-­‐2	  in	  left	  horn	  myometrium.	  Are	  the	  wild	  type	  and	  CCR2-­‐/-­‐	  the	  
same?	  NF-­‐κB	  and	  MAPK	  pathways	  were	  activated	  in	  CD1	  mice	  (wild	  type)	  with	  advancing	  gestation	  (Chapter	  5).	  In	  CD1	  mice,	  the	  phosphorylation	  of	  ERK1/2	  and	  the	  levels	  of	  COX-­‐2	  were	  increased,	  while	  the	  phosphorylation	  of	  c-­‐jun	  was	  reduced	  and	  of	  p65	  unchanged	  in	  the	  day	  16	  myometrial	  samples	  compared	  to	  the	  NP	  samples.	  In	  order	  to	  assess	  the	  impact	  of	  CCR2	  knockout,	  I	  sacrificed	  CCR2-­‐/-­‐	  mice	  before	  pregnancy	  and	   at	   the	   E16	   stage	   and	   extracted	   protein	   from	   myometrium.	   On	   E16,	   in	  comparison	   to	   NP	   samples,	   both	   p65	   and	   ERK	   were	   activated	   and	   this	   was	  associated	  with	  increased	  COX-­‐2	  synthesis	  in	  the	  CCR2-­‐/-­‐	  mice	  (Fig.6.2a,	  p<0.01	  for	  all	  3);	  c-­‐jun	  phosphorylation	  was	  reduced	  at	  the	  same	  time-­‐point	  (Fig.6.2a,	  p<0.01).	  	  
I	   then	  compared	  the	  myometrial	  samples	  from	  NP	  and	  E16	  wild	  type	  and	  CCR2-­‐/-­‐	  mice	   and	   found	   in	   NP	   samples	   that	   p65	   phosphorylation	   and	   COX-­‐2	   levels	   were	  similar	   (Fig.6.2.b),	   but	   that	   ERK1/2	   phosphorylation	   was	   marginally	   greater	  (p<0.05,	  Fig.6.2.b).	  On	  day	  16,	  the	  difference	  in	  ERK1/2	  phosphorylation	  persisted,	  but	  was	   associated	  with	   increased	   COX-­‐2	   levels	   (p<0.05	   and	   p<0.01	   respectively,	  Fig.6.2.c).	  Again,	  levels	  of	  c-­‐jun	  phosphorylation	  were	  reduced	  (p<0.01,	  Fig.6.2.c).	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Figure 6.2 The phosphorylation of myometrial NF-κB (p65), c-jun and ERK1/2 and COX-2 levels in 
CCR2-/- and CD1 mice.  Non-­‐pregnant	   and	   E16	   CD1	   and	   CCR2-­‐/-­‐	   mice	   were	   sacrificed.	   Myometrium	   was	   harvested	   and	  protein	  was	  extracted	   from	  the	   left	  horn.	  a.	  Comparing	  NP	  to	  E16	  samples	   from	  CCR2-­‐/-­‐	  mice,	   the	  phosphorylation	   of	   both	   NF-κB (p65) and ERK1/2 and COX levels were increased and the 
phosphorylation of c-jun reduced. b. In NP myometrial samples, phosphorylation of ERK1/2 was increased 
in samples from CCR2-/- compared with samples from CD1 mice. c. In E16 myometrial samples, ERK1/2 
phosphorylation and COX levels were increased and c-jun phosphorylation reduced in samples from 
CCR2-/- compared with samples from CD1 mice. Data	  were	  analysed	  using	  unpaired	   t	   tests,	  n=6	   for	  this	  experiment.	  Data were presented as mean with SEM. * indicates a significant difference of p<0.05, ** 
indicates p<0.01, *** indicates p<0.001.    
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6.2.3	  Leukocyte	  infiltrated	  into	  myometrium.	  Non-­‐pregnant	   and	   E18	   CCR2-­‐/-­‐	   and	   CD1	   mice	   were	   sacrificed	   and	   myometrium	  harvested	  and	  stored	  in	  PBS	  at	  4℃.	  Tissue	  was	  processed	  within	  24	  hour	  as	  follows,	  samples	  were	  digested	  by	  collagenase	  and	  then	  incubated	  with	  different	  antibodies	  in	   order	   to	   define	   whether	   CCR2-­‐/-­‐	   would	   prevent	   monocyte	   infiltration.	   After	  incubation,	  leukocytes	  were	  sorted	  by	  FACS.	  In	  an	  earlier	  chapter,	  leukocyte	  (CD45+	  cells)	  numbers	  were	  greater	  in	  E18	  samples	  obtained	  from	  CD1	  mice	  (Chapter	  5).	  	  
In	   CCR2-­‐/-­‐	   mice	   compared	   with	   NP	   animals,	   I	   found	   that	   on	   E18	   macrophages,	  labelled	   as	   CD45+/F4/80+/Gr1-­‐	   and	  monocytes,	   labelled	   as	   CD45+/F4/80+/Gr1+	  were	   significantly	   increased	   (p<0.05,	   Fig.	   6.3a).	   Neutrophils,	   labelled	   as	  CD45+/F4/80-­‐/Gr1+,	   tended	   to	   be	   higher	   as	   well	   (Fig.	   6.3a).	   	   There	   were	   fewer	  neutrophils	   in	   the	  myometrium	   of	   non-­‐pregnant	   CCR2-­‐/-­‐	  mice	   (p<0.01,	   Fig.6.3b).	  The	   number	   of	   monocytes	   and	   macrophages	   was	   similar	   in	   the	   myometrium	  obtained	   from	   non-­‐pregnant	   CD1	   and	   CCR2-­‐/-­‐	   mice	   (Fig6.3b).	   In	   the	   samples	  obtained	   at	   E18,	   there	  were	   fewer	  macrophages	   in	   the	  CCR2-­‐/-­‐	  myometrium,	   but	  more	  monocytes	  (p<0.05,	  Figure	  6.3b).	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Figure 6.3 Inflammatory cells in NP and E18 myometrium from CD1 and CCR2-/- mice. 
Myometrium was harvested and stored in PBS at 4 . Tissues were digested with collagenase and then 
incubated with different antibodies. Positive cells were detected by FACS. a. When samples from CCR2-/- 
NP and E18 mice were compared, the density of macrophages (labelled by CD45+/F4/80+/Gr1-) and 
monocytes (labelled CD45+/F4/80+/Gr1+) in E18 myometrium were higher in E18 samples. Neutrophils 
(labelled CD45+/F4/80-/Gr1+) also tended to be increased in E18. b. There were no differences in the 
densities of monocytes or macrophages between NP CD1 and CCR2-/- mice, but less neutrophils in non-
pregnant CCR2-/- mice. In E18 samples, the density of macrophages was greater in CD1 samples, but the 
density of monocytes was higher in CCR2-/- samples. Data were analyzed using unpaired t test. Data were 
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6.2.4	  Time	  of	  labour	  after	  LPS	  treatment	  and	  pup	  survival	  After	   LPS	   administration,	   the	   time	   of	   delivery	   of	   CD1	   and	   CCR2-­‐/-­‐	   mice	   were	  observed.	  There	  is	  no	  difference	  between	  the	  two	  genotypes	  (Figure	  6.4).	  At	  the	  two	  time	   points	   (7	   hours	   and	   labour),	   the	   numbers	   of	   live	   or	   barely	   alive	   pups	  were	  recorded.	   	  At	  7	  hours,	  6%	  of	   the	  CD1	  pups	  were	  alive,	  29%	  were	  barely	  alive	  and	  65%	  were	  dead;	  57%	  of	   the	  CCR2-­‐/-­‐	  pups	  were	  alive,	  36%	  were	  barely	  alive	  and	  7%	  were	   dead	   (Chi-­‐square	   p<0.0001).	   At	   the	   time	   of	   labour,	   all	   of	   the	   CD1	   pups	  were	  dead;	  8%	  of	  the	  CCR2-­‐/-­‐	  mice	  were	  barely	  alive	  and	  92%	  of	  them	  were	  dead	  (Chi-­‐square	  p=0.007).	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Figure 6.4 Time of labour.  
After operation, the time of delivery of CD1 and CCR2-/- mice was recorded. Preterm delivery occurred in 
both CD1 and CCR2-/- after intrauterine LPS injection. However, there was no difference between the two 
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6.2.5	  The	  effect	  of	  LPS	  on	  the	  myometrium	  of	  CCR2-­‐/-­‐	  mice	  To	  investigate	  whether	  knock	  out	  of	  CCR2	  would	  change	  the	  myometrial	  response	  to	  LPS,	  I	  challenged	  CCR2-­‐/-­‐	  mice	  with	  LPS.	  I	  took	  myometrial	  samples	  7	  hours	  after	  LPS	  and	  in	  labour	  and	  compared	  chemokine	  and	  cytokine	  expression	  to	  PBS	  treated	  controls.	   Left	   horn	   was	   used	   in	   this	   study	   to	   avoid	   the	   effect	   of	   injection	   on	  myometrium.	   At	   7	   hours,	   the	   expression	   of	   the	   chemokines	   CCL2,	   CCL5,	   CCL20,	  CXCL1,	   CXCL5	   and	   cytokines	   IL-­‐1β,	   TNFα,	   IL-­‐6	   was	   up	   regulated	   (Figure	   6.5.1a,	  p<0.01	  for	  CXCL5,	  p<0.05	  for	  other	  genes).	  In	  labouring	  samples,	  CCL2,	  CCL5,	  CXCL1	  were	  increased.	  (Figure	  6.5.1b,	  p<0.05).	  	  
	  
	  























































	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
Myometrial chemokine and cytokine expression in 
PBS/LPS treated CCR2-/- mice at 7h (left horn) 
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Figure 6.5 The effect of LPS on the myometrium of CCR2-/- mice 
a&b: CCR2-/- mice were given an intrauterine injection of LPS or PBS. Mice were sacrificed at 7 hours 
post injection or after the onset of labour, defined as the birth of the first pup. The myometrium from the 
left horn was used in this study to avoid any effect of the injection. Compared to PBS injected CCR2-/- 
mice, at 7 hours, the expression of the chemokines CCL2, CCL5, CCL20, CXCL1, CXCL5 and cytokines 
IL-1β, TNFα, IL-6 was increased and in labouring samples, CCL2, CCL5, CXCL1 were increased. Data	  were	  analyzed	  using	  unpaired	  t	  test	  or	  Mann	  Whitney	  test	  if	  data	  were	  not	  normally	  distributed.	  n=6	  for	   this	   experiment.	  Data were presented as median with interquartile range.  * indicates a significant 
difference of p<0.05, ** indicates p<0.01. 
 PBS	   treated	  CCR2-­‐/-­‐	  myometrial	  CCL2	   (p<0.01),	  CCL20	   (p<0.01),	  CXCL1	   (p<0.05),	  IL-­‐1β	  (p<0.01)	  and	  TNFα	  (p<0.01)	  were	  lower	  than	  CD1s	  at	  7	  hours	  post-­‐op	  (Figure	  6.6a)	   and,	   IL-­‐1β	   (p<0.01)	   and	   TNFα	   (p<0.05)	   were	   lower	   than	   CD1s	   in	   labour	  (Figure	   6.6c).	   After	   LPS	   injection,	   compared	   with	   the	   CD1s,	   CCR2-­‐/-­‐	   myometrial	  CCL2	  (p<0.01)	  and	  CCL5	  (p<0.05)	  were	  higher,	   IL-­‐1β	  (p<0.01)	  and	  TNFα	  (p<0.05)	  was	  lower	  at	  7	  hours	  post-­‐op	  (Figure	  6.6b);	  at	  the	  time	  of	  labour,	  CCL5	  (p<0.01)	  was	  higher	  and,	  CCL2	  (p<0.05)	  and	  IL-­‐1β	  (p<0.01)	  was	  lower	  in	  CCR2-­‐/-­‐	  (Figure	  6.6d).	  	  
Myometrial chemokine and cytokine expression in 
PBS/LPS treated CCR2-/- mice in labour (left horn) 
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Figure 6.6 Comparisons of the effect of LPS/PBS on CD1 and CCR2-/- mice myometrium 
a-d: CCR2-/- and wild type CD1 mice were given an intrauterine injection of LPS or PBS. Mice were 
sacrificed at 7 hours post injection or after the onset of labour, defined as the birth of the first pup. The 
myometrium from the left horn was used in this study to avoid any effect of the injection. At 7 hours in 
PBS treated mice, the myometrial expression of CCL2, CCL20, CXCL1,	   IL-­‐1β	  and	  TNFα	  was	   lower	   in	  CCR2-­‐/-­‐	  mice	  than	  in	  CD1	  mice.	  	  At 7 hours in LPS treated mice, the myometrial expression of CCL2	  and	  CCL5	  was	  higher	  and	  of	  IL-­‐1β	  and	  TNFα	  was	  lower	  in	  the	  CCR2-­‐/-­‐	  mice	  than	  in	  CD1	  mice.	  	  In	  labouring	  samples	  from	  PBS	  treated	  mice,	  the	  myometrial	  expression	  of	  IL-1β and TNFα was lower 
in CCR2-/- compared with CD1 mice. In	   labouring	   samples	   from	   LPS	   treated	  mice,	   the	  myometrial	  expression	  of	  CCL5	  was	  higher	  and	  of	  CCL2	  and	  IL-1β was lower in CCR2-/- compared with CD1 mice. Data	   were	   analyzed	   using	   unpaired	   t	   test	   or	   Mann	   Whitney	   test	   if	   data	   were	   not	   normally	  distributed.	  n=6	  for	  this	  experiment.	  Data were presented as median with interquartile range.  * indicates 
a significant difference of p<0.05, ** indicates p<0.01, *** indicates p<0.001. 	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Then	  the	  effect	  of	  LPS	  on	  MAPK,	  p65,	  c-­‐jun	  phosphorylation	  and	  COX-­‐2	  levels	  was	  assessed.	   Previously,	   in	   CD1	   mice,	   LPS	   administration	   increased	   the	  phosphorylation	  of	  MAPK	  and	  p65	  and	  COX-­‐2	  levels.	  To	  compare	  the	  effects	  of	  LPS	  and	  PBS	  in	  the	  CCR2-­‐/-­‐	  mice	  I	  took	  myometrial	  samples	  at	  7	  hours	  and	  in	  labour.	  As	  before,	   in	   order	   to	   avoid	   any	   direct	   effect	   caused	   by	   the	   injection,	   I	   only	   used	  myometrium	  from	  the	  left	  uterine	  horn.	  At	  7	  hours	  and	  in	  labour,	  both	  COX-­‐2	  levels	  and	   ERK	   activation	   tended	   to	   be	   increased,	   but	   neither	   were	   significantly	   higher	  than	  in	  PBS	  controls,	  phosphorylation	  of	  p65	  and	  c-­‐jun	  was	  the	  same	  at	  both	  time	  points	  (Figure	  6.7a-­‐b).	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PBS labouring LPS labouring 
Phospho-c-jun 
	  
Figure 6.7 The investigations of possible pathways involved in the effect of LPS to the myometrium 
of CCR2-/- mice 
a-b: CCR2-/- and wild type CD1 mice were given an intrauterine injection of LPS or PBS. Mice were 
sacrificed at 7 hours post injection or after the onset of labour, defined as the birth of the first pup. The 
myometrium from the left horn was used in this study to avoid any effect of the injection. Levels of COX-2 
and phosphorylation of ERK, p65 and c-jun were similar in the LPS and PBS injected CCR2-/- mice at 
both 7 hours and in labour. Data	  were	   analyzed	  using	   unpaired	   t	   test	   or	  Mann	  Whitney	   test	   if	   data	  were	   not	   normally	   distributed.	   n=6	   for	   this	   experiment.	   Data were presented as median with 
interquartile range.  	  
b	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I	  then	  compared	  myometrial	  samples	  from	  CCR2-­‐/-­‐	  and	  wild	  type	  mice	  treated	  with	  PBS	   and	   LPS	   at	   7	   hours	   and	   in	   labour.	   At	   7	   hours	   in	   the	   PBS	   treated	  mice,	   c-­‐jun	  phosphorylation	  and	  COX-­‐2	  levels	  were	  lower	  in	  the	  CCR2-­‐/-­‐	  mice,	  while	  in	  the	  LPS	  treated	   mice,	   phosphorylation	   of	   p65	   was	   reduced	   (p<0.05),	   ERK1/2	   increased	  (p<0.01)	  and	  c-­‐jun	  the	  same	  and	  the	   levels	  of	  COX-­‐2	  were	  reduced	   in	   the	  CCR2-­‐/-­‐	  mice	  (Fig.6.8a-­‐b,	  p<0.05).	  In	  the	  PBS-­‐treated	  labouring	  group,	  c-­‐jun	  phosphorylation	  was	  again	   lower	   in	   the	  CCR2-­‐/-­‐	  myometrial	   samples	   (Fig.6.8c,	  p<0.05);	  and	   in	   the	  LPS-­‐treated	  labouring	  group,	  ERK1/2	  phosphorylation	  was	  higher	  and	  c-­‐jun	  lower	  and	  in	  the	  CCR2-­‐/-­‐	  mice	  (Fig.6.8d,	  both	  p<0.01).	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Figure 6.8 The effect of LPS/PBS on myometrium of both CD1 and CCR2-/- 
a-b: In contrast in the PBS injected mice at 7 hours, COX-2 levels and c-jun phosphorylation were lower in 
the CCR2-/- myometrial samples. 7 hours after LPS administration, COX-2 levels and the phosphorylation 
of p65 were lower and ERK1/2 phosphorylation was higher in the CCR2-/- myometrial samples. c-d: In 
labouring samples, after PBS administration, only c-jun phosphorylation was lower in CCR2-/- myometrial 
samples. After LPS administration, the phosphorylation of ERK1/2 was increased and of c-jun was 
reduced. Data were analyzed using unpaired t test or Mann Whitney test if data were not normally 
distributed. n=6 for this experiment. Data were presented as median with interquartile range.  * indicates a 
significant difference of p<0.05, ** indicates p<0.01.  
d	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6.2.6	  Investigations	  of	  the	  mechanism	  responsible	  for	  improved	  pup	  
survival	  in	  CCR2-­‐/-­‐	  mice	  Earlier	   in	   the	  chapter,	  pup	  survival	  was	   found	  to	  be	   improved	  at	   the	   intermediate	  time	   point,	   but	   at	   the	   time	   of	   onset	   of	   parturition	   it	   was	   similar.	   To	   investigate	  whether	  this	  was	  because	  there	  was	  a	  less	  marked	  inflammatory	  response	  to	  LPS,	  I	  assessed	   1)	   pup	   brain	   inflammation,	   2)	   placental	   inflammation	   and	   3)	   maternal	  circulating	  cytokine	  levels.	  


































































Chemokine and cytokine expressions in CCR2-/- PBS/LPS 
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LPS labouring left horn
 
Figure 6.9 The effect of LPS on CCR2-/- pup brain 
a-c: Pup brain from the left horn was harvested at 3 hours, 7 hours and during labour after intrauterine 
b	  
c	  
Chemokine and cytokine expressions in CCR2-/- PBS/LPS 
treated pup brain (7h left horn ) 
Chemokine and cytokine expressions in CCR2-/- PBS/LPS 
treated pup brain (labouring left horn ) 
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PBS/LPS injection. LPS induced a decrease of IL-1β at 3 hours and a decrease of CXCL5 at 7 hours in 
CCR2-/- pup brain. n=6 for this experiment. Data were analyzed using unpaired t test or Mann Whitney 
test if data were not normally distributed. n=6 for this experiment. Data were presented as median with 
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Chemokine and cytokine expressions in CD1 and CCR2-/- 
PBS treated pup brain (3h left horn) 
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Figure 6.10 The effect of PBS on CD1 and CCR2-/- pup brain 
b	  
Chemokine and cytokine expressions in CD1 and CCR2-/- 
PBS treated pup brain (7h left horn) 
c	  
Chemokine and cytokine expressions in CD1 and CCR2-/- 
PBS treated pup brain (in labour left horn) 
	   Chapter	  6.	  CCR2	  knockout	  improved	  pup	  survival	  in	  	  a	  mouse	  model	  of	  preterm	  labour	   	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  	  	  
158	  
a-­‐c:	  Pup brain from the left horn was harvested at 3 hours, 7 hours and during labour after intrauterine 
PBS/LPS injection. At	   3	   hours,	   there	  was	   no	   difference	   of	   chemokine	   or	   cytokine	   expression.	   At	   7	  hours,	  in	  PBS	  control	  group,	  there	  were	  higher	  levels	  of	  CCL2,	  CCL20,	  CXCL1,	  CXCL5,	  IL-­‐1β,	  TNFα	  and	  IL-­‐6	  in	  CCR2-­‐/-­‐	  pup	  brain.	  In	  the	  labouring	  samples,	  the	  pup	  brains	  taken	  from	  PBS	  treated	  CCR2-­‐/-­‐	  mice	   expressed	  more	  CCL2,	   CCL20,	   CXCL1,	   IL-­‐1β,	   TNFα,	   and	   IL-­‐6	   in	   pup	  brain.	  Data were analyzed 
using unpaired t test or Mann Whitney test if data were not normally distributed. n=6 for this experiment. 
Data were presented as median with interquartile range.  * indicates a significant difference of p<0.05, ** 
indicates p<0.01, *** indicates p<0.001.	  	  	  Finally,	  for	  the	  pup	  brains,	  I	  compared	  the	  effects	  of	  LPS	  treatment	  in	  CCR2-­‐/-­‐	  and	  CD1	   mice.	   At	   3	   hours	   post	   injection,	   the	   pup	   brains	   taken	   from	   the	   LPS	   treated	  CCR2-­‐/-­‐	  mice	  showed	  higher	  CXCL1	  (p<0.01)	  and	  lower	  IL-­‐1β	  (p<0.05;	  Figure	  6.11	  a).	  At	  7	  hours,	  LPS	  exposed	  CCR2-­‐/-­‐	  pups	  expressed	  higher	  levels	  of	  CCL2	  (p<0.05),	  CXCL1	   (p<0.05)	   and	   IL-­‐1β	   (p<0.01)	   (Figure6.11b).	   In	   labouring	   samples,	   LPS	  exposed	  CCR2-­‐/-­‐	  pups	  expressed	  higher	   levels	  of	  CCL2	  (p<0.05),	  CCL20	   	   (p<0.01),	  CXCL1	  (p<0.05)	  and	  IL-­‐1β	  (p<0.01),	  but	  lower	  levels	  of	  IL-­‐6	  (p<0.01;	  Figure	  6.11c).	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LPS treated pup brain (3h left horn) 
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Figure 6.11 The effect of LPS on CD1 and CCR2-/- pup brain 
a-c: Pup brain from the left horn was harvested at 3 hours, 7 hours and during labour after intrauterine 
PBS/LPS injection. At	  3	  hours	  post	  injection,	  the	  pup	  brains	  taken	  from	  the	  LPS	  treated	  CCR2-­‐/-­‐	  mice	  showed	   higher	   CXCL1	   and	   lower	   IL-­‐1β.	   At	   7	   hours,	   LPS	   exposed	   CCR2-­‐/-­‐	   pups	   expressed	   higher	  levels	  of	  CCL2,	  CXCL1	  and	  IL-­‐1β.	  In	  labouring	  samples,	  LPS	  exposed	  CCR2-­‐/-­‐	  pups	  expressed	  higher	  levels	  of	  CCL2,	  CCL20,	  CXCL1	  and	  IL-­‐1β,	  but	  lower	  levels	  of	  IL-­‐6.	  Data were analyzed using unpaired t 
test or Mann Whitney test if data were not normally distributed. n=6 for this experiment. Data were 
presented as median with interquartile range.  * indicates a significant difference of p<0.05, ** indicates 
p<0.01.	  	  2) The	  chemokine/cytokine	  mRNA	  expression	  in	  the	  placenta	  was	  measured	  to	  assess	  the	   level	   of	   inflammation.	   At	   3	   hours,	   LPS	   induced	   increase	   of	   chemokines	   and	  cytokines	  expression	  in	  CD1	  mice	  (chapter	  5),	  but	  there	  is	  no	  change	  in	  placenta	  of	  CCR2-­‐/-­‐	  mice	  (Figure	  6.12a).	  At	  7	  hours	  after	  LPS,	  the	  placentae	  CCR2-­‐/-­‐	  mice	  had	  increased	   CCL5	   (p<0.05),	   CCL20	   (p<0.01),	   CXCL1	   (p<0.01),	   CXCL5	   (p<0.05)	   and	  TNFα	  (p<0.05)	  (Figure	  6.12b).	  In	  labour	  after	  LPS,	  the	  placentae	  CCR2-­‐/-­‐	  mice	  had	  increased	  CCL2	  (p<0.01),	  CCL5	  (p<0.05),	  CCL20	  (p<0.05)	  and	  IL-­‐6	  (p<0.05)	  (Figure	  6.12c).	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Chemokine and cytokine expressions in CD1 and CCR2-/- 
LPS treated pup brain (in labour left horn) 
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Figure 6.12 The effect of LPS on CCR2-/- placenta 
a-c: The chemokine/cytokine mRNA expression in the placenta was measured to assess the level of 
inflammation. At 3 hours, LPS induced increase of chemokines and cytokines expression in CD1 mice. 
There is no change in placenta of CCR2-/- mice. At 7 hours after LPS, the placentae CCR2-/- mice had 
increased chemokine CCL5, CCL20, CXCL1, CXCL5 and TNFα. In labour, CCL2, CCL5, CCL20 and 
IL-6 were increased in LPS injected CCR2-/- mice placentae. Data were analyzed using unpaired t test or 
Mann Whitney test if data were not normally distributed. n=6 for this experiment. Data were presented as 
median with interquartile range.  * indicates a significant difference of p<0.05, ** indicates p<0.01.	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Chemokine and cytokine expressions in PBS/LPS treated 
CCR2-/- placenta (in labour left horn) 
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Chemokine and cytokine expressions in PBS treated CD1 and 
CCR2-/- placentae (3h left horn) 
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Chemokine and cytokine expressions in PBS treated CD1 and 
CCR2-/- placentae (7h left horn) 
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Figure 6.13 Comparisons of chemokine/cytokine expression in placenta between PBS treated CD1 
and CCR2-/- mice 
a-c: At 3 hours after PBS treatment, the expression of CCL20 and IL-1β was lower in CCR2-/- placentae. 
At 7 hours, the expression of IL-1β, TNFα and IL-6 was lower in CCR2-/- placentae. In placentae 
obtained from labouring mice after PBS injection, the expression of CCL2 was lower in the CCR2-/- 
samples. Data were analyzed using unpaired t test or Mann Whitney test if data were not normally 
distributed. n=6 for this experiment. Data were presented as median with interquartile range.  * indicates a 
significant difference of p<0.05, ** indicates p<0.01. 	  Finally	   for	   the	   placental	   analysis,	   I	   assessed	   the	   response	   to	   LPS	   injection	   in	  placentae	  taken	  from	  CCR2-­‐/-­‐	  and	  CD1	  mice.	  At	  3	  hours	  after	  LPS	  treatment	  there	  was	  no	  difference	   in	   chemokine	   or	   cytokine	  mRNA	  expression	   in	   placentae	   taken	  from	  CCR2-­‐/-­‐	  and	  CD1	  mice.	  At	  7	  hours,	  the	  expression	  of	  CXCL1	  was	  less	  in	  CCR2-­‐/-­‐	   when	   treated	   with	   LPS	   (p<0.01,	   Figure	   6.14b).	   	   In	   placentae	   obtained	   from	  labouring	  mice	  after	  LPS	  injection,	  the	  expression	  of	  CCL2	  (p<0.01),	  CCL5	  (p<0.05),	  CCL20	   (p<0.05)	   and	   CXCL1	   (p<0.01)	   was	   lower	   in	   the	   CCR2-­‐/-­‐	   samples	   (Figure	  6.14c)	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CCR2-/- +LPS 7h 	  	  
a	  
Chemokine and cytokine expressions in LPS treated CD1 and 
CCR2-/- placentae (3h left horn) 
b	  
Chemokine and cytokine expressions in LPS treated CD1 and 
CCR2-/- placentae (7h left horn) 
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Figure 6.14 The effect of LPS on CD1 and CCR2-/- placentae 
a-c: At 3 hours after LPS treatment there was no difference in chemokine or cytokine mRNA expression in 
placentae taken from CCR2-/- and CD1 mice. At 7 hours, the expression of CXCL1 was less in CCR2-/- 
when treated with LPS. In placentae obtained from labouring mice after LPS injection, the expression of 
CCL2, CCL5, CCL20 and CXCL1 was lower in the CCR2-/- samples. Data were analyzed using unpaired t 
test or Mann Whitney test if data were not normally distributed. n=6 for this experiment. Data were 
presented as median with interquartile range.  * indicates a significant difference of p<0.05, ** indicates 
p<0.01 
 .In	   order	   to	   assess	   the	   pathways	   involved	   in	   LPS	   induced	   chemokine/cytokine	  expression,	  the	  activation	  of	  NF-­‐κB	  (p65)	  and	  MAPK	  pathways	  have	  been	  measured	  and	  compared	  between	   the	   two	  genotypes.	  At	  3	  hours	  after	   the	  PBS	   injection,	   the	  level	   of	   phosphorylated	   NF-­‐κB	   (p65;	   p<0.01)	   and	   c-­‐jun	   (p<0.05)	   were	   higher	   in	  CCR2-­‐/-­‐	  mice	  (Figure	  6.15a).	  At	  the	  time	  of	  labour	  after	  PBS	  treatment,	  the	  level	  of	  phosphorylated	  ERK2	   (p<0.001),	   phosphorylated	  NF-­‐κB	   (p65;	   p<0.001)	   and	   c-­‐jun	  
c	   Chemokine and cytokine expressions in LPS treated CD1 and 
CCR2-/- placentae (in labour left horn) 
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(p<0.05)	  were	  higher,	  but	  the	  level	  of	  COX-­‐2	  (p<0.01)	  was	  lower	  than	  CD1s	  (Figure	  6.15b).	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Figure 6.15 The effect of PBS to CD1 and CCR2-/- placentae 
a-­‐b:	  At	  3	  hours	  after	  the	  PBS	  injection,	  the	  level	  of	  phosphorylated	  NF-­‐κB	  p65	  and	  c-­‐jun	  were	  higher	  in	   CCR2-­‐/-­‐	   mice.	   At	   the	   time	   of	   labour	   after	   PBS	   treatment,	   the	   level	   of	   phosphorylated	   ERK2,	  phosphorylated	  NF-­‐κB	  and	  c-­‐jun	  were	  higher,	  but	  the	  level	  of	  COX-­‐2	  was	  lower	  than	  CD1s.	  Data were 
analyzed using unpaired t test or Mann Whitney test if data were not normally distributed. n=6 for this 
experiment. Data were presented as median with interquartile range.  * indicates a significant difference of 
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Figure 6.16 The effect of LPS on CD1 and CCR2-/- 
a-b: At	  3	  hours	  after	  LPS	  injection,	  COX-­‐2,	  phosphorylated	  NF-­‐κB	  (p65),	  c-­‐jun	  and	  ERK1	  were	  lower	  in	  CCR2-­‐/-­‐	  placenta.	  At	   the	   time	  of	   labour	  after	  LPS	   injection,	   the	  phosphorylation	  of	  NF-­‐κB	   (p65)	  and	  ERK1	  and	  ERK2	  and	  the	  levels	  of	  COX2	  were	  lower	  in	  CCR2-­‐/-­‐	  placenta.	  Data were analyzed using 
unpaired t test or Mann Whitney test if data were not normally distributed. n=6 for this experiment. Data 
were presented as median with interquartile range.  * indicates a significant difference of p<0.05, ** 
indicates p<0.01, *** indicates p<0.001. 
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3) Plasma	  IL-­‐6	  level	  in	  both	  CD1	  and	  CCR2-­‐/-­‐	  mother	  was	  measured	  in	  order	  to	  assess	  the	  effect	  of	  LPS	  at	  3	  hours,	  7	  hours	  and	  the	  time	  of	  labour.	  Firstly,	  the	  basal	  level	   of	   IL-­‐6	   was	  measured	   and	   showed	   no	   change	   through	   the	   gestation	   and	   in	  labour.	  At	  3	  hours,	   there	   is	  no	  change	  of	  plasma	  IL-­‐6	   in	  both	  PBS	  and	  LPS	  treated	  CD1	  or	  CCR2-­‐/-­‐	  mice.	  However,	  plasma	  IL-­‐6	   level	   in	  PBS	  treated	  CD1	  and	  CCR2-­‐/-­‐	  mice	   declined	   at	   7	   hours	   and	   in	   labour	   and	   there	   was	   no	   difference	   between	  genotypes.	  In	  the	  LPS	  treated	  mice,	  the	  levels	  of	  IL-­‐6	  remained	  elevated	  at	  7	  hours	  and	   at	   the	   time	   of	   labour.	   There	   was	   no	   difference	   between	   the	   two	   genotypes	  (p<0.001,Figure	  6.17).	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Figure 6.17 The effect of LPS/PBS on CD1 and CCR2-/- plasma IL-6 level 
Throughout the gestation, labour and 3 hours, there is no change of plasma IL-6 in both PBS and LPS 
treated CD1 or CCR2-/- mice. However, plasma IL-6 level in both PBS treated CD1 and CCR2-/- mice at 3 
hours is much higher than the level in PBS treated mice at 7 hours, the time point that I consider as basal. 
At 7 hours and the time of labour, IL-6 in LPS treated CD1 and CCR2-/- mice is significantly higher in 
PBS treated ones. There is no difference between the two genotypes. Unpaired t test were used when data 
are normally distributed, Mann Whitney test were used for non-parametric data. Data were presented as 
median with interquartile range.  * indicates a significant difference of p<0.05, ** indicates p<0.01.   
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6.3	  Discussion	  
In	  this	  chapter,	  I	  have	  investigated	  the	  impact	  of	  LPS	  intra-­‐uterine	  injection	  in	  CCR2-­‐/-­‐	   pregnant	   mice.	   In	   contrast	   to	   CD1	   mice,	   only	   small	   changes	   in	   chemokine	  expression	   were	   evident	   through	   pregnancy	   in	   the	   CCR2-­‐/-­‐	   mouse.	   However,	  ERK1/2,	   NF-­‐κB	   (p65)	   phosphorylation	   and	   COX-­‐2	   levels	   did	   increase	   with	  advancing	   gestation	   as	   did	   the	   numbers	   of	   total	   and	   myeloid	   macrophages,	  monocytes,	  and	  neutrophils	  in	  CCR2-­‐/-­‐	  mice	  myometrium.	  Compared	  to	  CD1	  mice,	  there	   was	   less	   leukocyte	   and	   macrophage	   infiltration	   in	   CCR2-­‐/-­‐	   myometrium.	  However,	   monocyte	   numbers	   were	   higher	   in	   CCR2-­‐/-­‐	   myometrium.	   After	   LPS	  injection,	  CCR2-­‐/-­‐	  mice	  went	  into	  labour	  at	  the	  same	  time	  as	  the	  CD1	  wild	  type	  mice.	  However,	   CCR2	   knockout	   did	   improved	   pup	   survival,	   although	   the	   mechanism	  responsible	  remains	  unclear.	  
Unlike	   results	   in	   the	  previous	   studies	  on	  CD1	  mice	   (chapter	  5)	  which	  showed	   the	  myometrial	  chemokine	  level	  going	  down	  on	  E6	  of	  pregnancy	  and	  rising	  from	  E6	  till	  the	   time	  of	   labour,	  CCR2-­‐/-­‐	  myometrial	   chemokines	  didn’t	   very	  much	   changes,	   or	  even	  decreased	  from	  E6.	   In	  human	  myometrium,	  ERK1/2	  and	  p65	  pathways	  were	  showed	   to	   involve	   in	   the	   regulation	   of	   chemokine	   expressions	   (chapter	   3).	   The	  differences	  in	  chemokine	  expressions	  in	  mouse	  myometrium	  may	  be	  a	  result	  of	  the	  different	  pathways	  being	  activated.	  	  	  
In	   CCR2-­‐/-­‐	   mouse	   myometrium,	   phosphorylation	   of	   ERK1/2	   increased	   and	   c-­‐jun	  decreased	   in	   E16,	   which	   is	   the	   same	   in	   CD1s,	   however	   p65	   phosphorylation	  increased	   in	   CCR2-­‐/-­‐	   mice,	   in	   contrast	   to	   the	   CD1s.	   ERK1/2	   phosphorylation	   is	  increased	  in	  CCR2-­‐/-­‐	  mice	  in	  non-­‐pregnant	  and	  E16	  samples	  compared	  to	  the	  wild	  type,	  which	  may	  be	  a	  result	  of	   the	   infiltration	  of	  different	   leukocyte	  subtypes.	  The	  activation	  of	  ERK	  pathways	   is	  required	  for	  neutrophil	  extracellular	  trap	  formation	  311	   and	   the	   ERK	   pathway	   is	   also	   involved	   in	   the	   adhesion	   of	   neutrophils	   312.	   The	  change	   of	   COX-­‐2	   expressions	   in	   my	   study	   may	   be	   secondary	   to	   the	   increased	  ERK1/2	   activation202	   or	   may	   be	   a	   consequence	   of	   the	   greater	   inflammatory	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infiltration.	  However,	  whether	  the	  increase	  in	  COX-­‐2	  in	  both	  of	  the	  strains	  has	  pro-­‐contractile	  or	  pro-­‐relaxant	  effects	  will	  be	  determined	  by	  the	  expression	  and	  activity	  of	  the	  downstream	  prostaglandin	  synthetic	  enzymes.	  NF-­‐κB	  (p65)	  phosphorylation	  is	  relatively	  increased	  in	  E16	  CCR2-­‐/-­‐	  mouse	  myometrium	  and	  may	  be	  important	  in	  the	  increased	  chemokine	  expression	  as	  p65	  has	  a	  key	  role	  in	  chemokine	  expression	  278,	  allowing	  the	  process	  of	  pregnancy	  and	  parturition	  to	  occur	  normally	  
Several	   studies	   have	   showed	   that	   CCR2-­‐/-­‐	   mice	   have	   similar	   or	   lower	   levels	   of	  monocytes/macrophages	   than	   observed	   in	  wild	   type	  mice,	   both	   basally	   and	   after	  stimulation	   266,313-­‐315.	   It	   has	   been	   postulated	   that	   a	   negative	   feedback	   loop	   exists	  between	   chemokines	   and	   their	   receptors.	   In	   CCR2-­‐/-­‐	  mice	   challenged	  by	   LPS,	   the	  level	  of	  CCL2	  dramatically	  increased	  in	  the	  lung	  in	  association	  with	  lower	  numbers	  of	   trafficking	  monocytes266.	   In	  my	   study,	   I	   observed	   a	   higher	   level	   of	  myometrial	  CCL2	  mRNA	  expression	  in	  CCR2-­‐/-­‐	  mice	  than	  in	  wild	  type	  CD1s	  during	  pregnancy.	  Furthermore,	   other	   chemokines,	   such	   as	   CCL5,	   CCL20,	   CXCL1	   and	  CXCL5	   are	   also	  higher	   in	   CCR2-­‐/-­‐	   mice.	   This	   is	   consistent	   with	   the	   observation	   that	   PMN	   and	  lymphocyte	   infiltration	   into	   inflammatory	   sites	   is	   normal	   in	   CCR2-­‐/-­‐,	   probably	  because	  neutrophils	  lack	  CCR2	  and	  so	  are	  unaffected	  by	  CCR2-­‐/-­‐	  knockdwon	  316,317.	  Indeed,	   occasionally,	   PMN	   have	   been	   reported	   to	   infiltrate	   in	   greater	   numbers	   in	  CCR2-­‐/-­‐	  mice	  266,315.	  In	  an	  influenza	  mouse	  models	  on	  CCR2-­‐/-­‐	  mice,	  higher	  numbers	  of	  local	  granulocytes	  as	  well	  as	  neutrophils	  was	  observed	  after	  viral	  infection,	  which	  normally	   requires	   a	   local	   expression	   of	   soluble	   CC	   and	   CXC	   chemokines.	   In	   same	  model,	   the	   greater	   neutrophil	   count	   may	   have	   been	   due	   to	   their	   increased	  expression	   of	   CXCR2,	   perhaps	   increased	   via	   the	   elevated	   levels	   of	   eotaxin	   318,319.	  	  	  Furthermore,	  expression	  of	   the	  chemokines	  CCL2,	  CCL10,	  MIP-­‐3	  and	  MIP-­‐2α	  were	  also	   reported	   to	   be	   greater	   in	   CCR2-­‐/-­‐	   mice315,316,320.	   In	   chapter	   5,	   I	   found	   that	  myometrial	   leukocyte	   numbers	   increased	   on	   E18	   as	   compared	   to	   non-­‐pregnant	  levels	   in	   agreement	  with	   other	   studies	   9,17.	   I	   found	   the	   same	   increase	   in	   CCR2-­‐/-­‐	  mice.	  However,	  as	  would	  be	  expected,	  on	  day	  18,	  CCR2-­‐/-­‐	  mice	  had	  lower	  numbers	  of	  macrophages,	  but	   there	  was	  a	   trend	   for	  PMNs	   to	  be	   increased	  and	   there	  was	  a	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significant	  increase	  of	  Gr1high	  monocytes.	  It	  has	  been	  reported	  previously	  that	  only	  Gr1+	  monocytes	   infiltrated	   inflammatory	   sites	   in	   CCR2-­‐/-­‐	  mice	   313.	   The	   increased	  Gr1+	   monocytes	   in	   my	   study	   might	   be	   due	   to	   activation	   of	   the	   parallel	   CSF-­‐1-­‐regulated	  system,	  which	  also	  regulates	  tissue	  monocytes	  trafficking.	  Consistent	  with	  this,	   several	   studies	   did	   not	   find	   any	   evidence	   that	   these	   cells	   required	   CCR2	   to	  enter	   inflammatory	   sites.	   Instead,	   it	   seemed	   that	   the	   local	   infiltration	   of	   Gr1+	  monocytes	  was	   primarily	   regulated	   by	   the	   level	   of	   egress	   from	   the	   bone	  marrow	  compartment.	   Consequently,	   it	  may	  be	  worthwhile	   assessing	   the	   level	   of	   CFS-­‐1	   in	  both	  CD1	  and	  CCR2-­‐/-­‐	  mice.	  	  	  	  	  
In	  the	  LPS	  induced	  preterm	  labour	  model	  in	  the	  CD1	  mouse,	  LPS	  is	  injected	  into	  the	  uterus	  on	  E16	  and	  parturition	  starts	  about	  14	  hours	   later.	  This	   is	  similar	   to	  other	  reports	   165,263,321.	   The	   time	   of	   onset	   was	   not	   delayed	   in	   CCR2-­‐/-­‐	   mice,	   perhaps	  because	   despite	   the	   CCR2	   deficiency,	   LPS	   is	   still	   able	   to	   induce	   neutrophil	  myometrial	   infiltration	   and	   the	   increase	   in	   the	   expression	   of	   other	   chemokines.	  Although	   the	   total	   leukocyte	   and	   macrophage	   count	   was	   lower	   in	   CCR2-­‐/-­‐	   mice	  other	  mechanisms	  were	  able	   to	  more	   than	   compensate	   to	   induce	  parturition	   11,17.	  Compared	   to	   wild	   type	   mice,	   LPS	   induced	   a	   higher	   level	   of	   granulocytes	   and	  neutrophils	  in	  CCR2-­‐/-­‐	  mice	  315.	  Compared	  to	  CD1,	  LPS	  induced	  similar	  increase	  of	  chemokines	  and	  cytokines	   in	  CCR2-­‐/-­‐	  myometrium.	  At	   the	   time	  of	   labour	  post-­‐op,	  chemokine	  levels	  remain	  high	  and	  cytokine	  levels	  were	  back	  to	  normal	  in	  CCR2-­‐/-­‐,	  but	  IL-­‐6	  remained	  increased	  in	  CD1s.	  After	  PBS	  injection,	   inflammation	  in	  CCR2-­‐/-­‐	  myometrium	   was	   relatively	   lower	   than	   CD1s	   at	   7	   hours	   as	   well	   as	   in	   labour.	  Cytokine	   levels	   were	   lower	   in	   CCR2-­‐/-­‐	   myometrium	   with	   LPS	   injection,	   which	  indicates	   an	   anti-­‐inflammatory	   effect	   of	   CCR2	   deletion.	   However,	   in	   CCR2-­‐/-­‐,	   LPS	  induced	  more	  CCL2	  mRNA	  expression	  at	  7	  hours,	  but	  less	  at	  in	  labour.	  The	  relatively	  greater	  expression	  of	  CCL5	  at	  both	  LPS	   time	  points	  may	  drive	  a	   relatively	  greater	  infiltration	   of	   granulocytes	   322,	   allowing	   LPS-­‐parturition	   to	   proceed	   in	   a	   similar	  manner	  to	  that	  observed	  in	  the	  CD1	  mice.	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At	  7	  hours,	  after	  LPS	  treatment,	  CCR2-­‐/-­‐	  mice	  had	   low	  COX-­‐2	  and	  phosphorylated	  p65,	  but	  a	  higher	   level	  of	  ERK	  phosphorylation	   compared	   to	  PBS	  controls;	  during	  labour,	  both	  PBS	  and	  LPS	  treated	  CCR2-­‐/-­‐	  mice	  showed	  low	  c-­‐jun	  phosphorylation.	  However,	  CCR2-­‐/-­‐	  mice	  had	  higher	  ERK	  activation.	  This	  may	  mean	  that	  infiltrating	  leucocytes	   could	   activate	   distinct	   intracellular	   signalling	   pathways,	   however,	   this	  possibility	  requires	  further	  study.	  	  
In	  this	  study	  I	  found	  that	  CCR2-­‐/-­‐	  had	  a	  better	  pup	  survival	  rate	  than	  CD1s	  with	  LPS,	  however	  LPS	  treatment	  did	  not	   increase	  pup	  brain	   inflammation	   in	  CD1	  mice	  at	  3	  and	  7	  hours.	  After	  all	  the	  pups	  were	  dead,	  at	  the	  time	  of	  labour,	  there	  was	  a	  marked	  inflammatory	  change.	  Nevertheless,	  I	  investigated	  the	  possibility	  that	  inflammation	  was	   lower	   in	   the	  pups	  of	  CCR2-­‐/-­‐	  mice.	   Interestingly,	   the	  chemokine	  and	  cytokine	  levels	  were	  relatively	  higher	  in	  CCR2-­‐/-­‐	  pups	  than	  the	  CD1	  pups	  at	  7	  hours	  and	  in	  labour.	  These	  observations	  probably	  reflect	  the	  differences	  in	  the	  timing	  of	  CCR2-­‐/-­‐	  and	  CD1	  pup	  death.	  At	  3	  hours	  with	  LPS	  when	  all	  pups	  were	  still	  alive,	  the	  level	  of	  IL-­‐1β	   is	   lower	   than	   the	   CD1s,	   which	   indicates	   a	   protection	   to	   the	   pup	   brain	  inflammation	  from	  CCR2	  deletion	  as	  both	  IL-­‐1β	  and	  IL-­‐6	  are	  mediators	  of	  maternal	  immune	   activation	   induced	   pup	   death	   and	   behavioural	   abnormality	   323,324.	   Since	  both	   of	   the	   two	   strains	   were	   mated	   with	   wild	   type	   studs,	   their	   pups	   were	  heterozygous	   and	   homozygous,	   respectively.	   The	   differences	   in	   genotypes	   of	   the	  pups	  may	  have	  influenced	  their	  response	  to	  LPS,	  resulting	  in	  different	  pup	  survival.	  In	  order	  to	  investigate	  this	  further,	  we	  plan	  to	  mate	  heterozygous	  males	  and	  females	  to	  give	  wild	  type,	  heterozygous	  and	  homozygous	  pups	  in	  the	  same	  litter	  to	  see	  if	  pup	  genotype	  influences	  survival.	  	  I	   studied	   inflammation	   in	  placenta	   to	   understand	  whether	   it	   played	   a	   role	   in	   pup	  brain	  damage.	  LPS	  administration	  also	  induced	  chemokine	  and	  cytokine	  expression	  in	   the	  placenta	  of	  CD1	  mice	   in	  agreement	  with	   the	   findings	  of	  several	   researchers	  who	   reported	   that	   LPS	   injection	   activated	   NF-­‐κB	   and	   increased	   IL-­‐1β,	   IL-­‐6	   and	  TNFα	   expression	   325,326.	   CCR2-­‐/-­‐	   placenta	   exposed	   to	   LPS	   showed	   no	   increase	   in	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chemokines	  or	  cytokines	  at	  3	  hours,	  by	  7	  hours,	  the	  expression	  of	  some	  chemokines	  and	   of	   TNFα	  were	   increased,	   and	   remained	   elevated	   in	   labouring	   samples	   (albeit	  with	  slightly	  less	  marked	  increases).	  These	  changes	  were	  reflected	  in	  the	  activation	  of	   the	   MAPK	   and	   NF-­‐κB	   pathways.	   In	   comparison	   to	   the	   CD1	   mice,	   LPS-­‐induced	  placental	   inflammation	   was	   less	   marked	   in	   terms	   of	   chemokine	   expression	   and	  activation	   of	   the	   MAPK	   and	   NF-­‐κB	   pathways.	   The	   lower	   level	   of	   cytokine	   and	  chemokine	  level	  in	  the	  placentae	  may	  be	  the	  reason	  of	  higher	  pup	  survival	  of	  CCR2-­‐/-­‐	  mice.	   Injection	  of	   LPS	   (IP)	   elevated	   the	  placental	   and	  amniotic	   fluid	   IL-­‐1β,	   IL-­‐6	  and	   TNFα	   325.	   Other	   studies	   have	   shown	   that	   maternal	   immune	   activation	   is	  associated	  with	  pup	  brain	  inflammation	  and	  injury	  with	  increased	  IL-­‐1β	  and	  TNFα	  mRNA	  expression.	  Furthermore,	  several	  stress	  related	  factors	  were	  up	  regulated	  as	  well327,328.	   In	  my	  study,	  CD1	  pup	  brain	  CCL2,	   IL-­‐1β,	   IL-­‐6	  expression	  was	   increased	  after	   LPS	   injection	   during	   labour.	   However,	   there	   is	   no	   change	   of	   chemokine	   or	  cytokine	   in	   CCR2-­‐/-­‐	   pup	   brain.	   However,	   these	   differences	   do	   not	   relate	   to	   the	  improved	  pup	  survival	  observed	   in	   the	  CCR2-­‐/-­‐	  mice,	  which	   is	  probably	  mediated	  through	  reduced	  placental	  damage,	  which	  could	  be	  the	  consequence	  of	  differences	  in	  genotypes	  of	  pups.	  In	  agreement	  with	  other	  studies328-­‐330,	  the	  IL-­‐6	  in	  maternal	  plasma	  are	  up	  regulated	  in	   CD1	   mouse.	   Along	   with	   the	   up-­‐regulated	   chemokines	   induced	   by	   LPS,	   CCR2	  knockdown	   did	   not	   prevent	   the	   effect	   of	   LPS	   on	   plasma	   IL-­‐6	   expression.	  Interestingly,	  at	  the	  3	  hours,	  IL-­‐6	  is	  much	  higher	  than	  the	  rest	  two	  time-­‐points	  both	  in	   PBS	   and	   LPS	   group,	  which	   indicates	   that	   there	   is	   an	   acute	   inflammatory	   effect	  caused	  by	  the	  surgery.	  	  	  
This	  study	  shows	  that	  CCR2-­‐/-­‐	  does	  not	  prevent	  LPS-­‐induced	  preterm	  delivery	  but	  is	   associated	   with	   improved	   pup	   survival.	   In	   general,	   there	   was	   less	   marked	  cytokine	  and	  chemokine	  expression	   in	  CCR2-­‐/-­‐.	  However,	  basal	   level	  of	  phosphor-­‐ERK	  was	  higher	  in	  CCR2-­‐/-­‐	  mice,	  which	  may	  relate	  to	  high	  level	  of	  neutrophils,	  CCL5	  and	  CCL2,	  which	  require	  a	  further	  study.	  	  These	  data	  indicate	  that	  although	  CCR2	  is	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a	  major	  mediator	  inflammation,	  that	  it	  is	  not	  indispensible	  to	  LPS-­‐induced	  preterm	  delivery,	   rather	   the	   system	  possesses	   sufficient	   redundancy	   to	  be	  able	   to	   respond	  normally	  to	  LPS	  in	  terms	  of	  labour	  induction.	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7.1	  Introduction	  
In	  my	  human	  studies,	  I	  found	  that	  CCL20	  expression	  was	  increased	  in	  the	  lower	  uterine	  segment	  with	   the	  onset	  of	  PTL.	   It	  has	  been	   implicated	   in	   the	   innate	   immune	   response	  and	  is	  thought	  to	  regulate	  dendritic	  cell	  and	  lymphocyte	  function	  331.	  CCL20	  is	  also	  called	  liver	  and	  activation-­‐regulated	  chemokine	  (LARC),	  macrophage	  inflammatory	  protein-­‐3α	  (MIP-­‐3α)	  or	  Exodus-­‐1	  and	  is	  the	  only	  chemokine	  that	  interacts	  with	  its	  receptor,	  CCR6.	  Dendritic	   cells	   are	   bone	   marrow-­‐derived	   “sentinels”	   of	   the	   immune	   system,	   which	  express	   functional	   CCR6.	   When	   inflammation	   occurs,	   chemokines	   stimulate	   dendritic	  cells	   to	   leave	   the	   bone	   marrow	   and	   migrate	   via	   the	   blood	   stream	   to	   the	   target	   site.	  Similarly,	  some	  breast	  cancers	  express	   increased	   levels	  of	  CCL20	  and	  this	   is	  associated	  with	   the	   infiltration	  of	   a	   high	  number	  of	   immature	  dendritic	   cells	   into	   the	   tumour	   332.	  Recently,	   an	   in	  vitro	   study	  demonstrated	   that	  when	  hematopoietic	  progenitor	   cells	  are	  incubated	  with	   an	   appropriate	  mixture	   of	   cytokines	   and	  monocytes	   that	   they	   develop	  into	  dendritic	   cells	  with	   functional	  CCR6	   333.	  CCR6	   is	  also	  expressed	  on	  both	  CD4+	  and	  CD8+T	   cells	   271,272,334,	   while	   in	   B-­‐lymphocytes,	   CCR6	   expression	   is	   restricted	   to	  functionally	  mature	  cells	  capable	  of	  responding	  to	  antigen	  challenge	  272.	  	  
CCL20	  expression	  is	  regulated	  by	  cytokines	  and	  other	  inflammatory	  factors	  via	  a	  variety	  of	  transcription	  factors	  including	  NF-­‐κB,	  AP-­‐1	  and	  C-­‐EBP	  335-­‐337.	  In	  vitro	  studies	  showed	  that	   NF-­‐κB	   activation	   increases	   the	   expression	   of	   CCL20	  mRNA	   in	   human	  myometrial	  cells	  278	  and	  the	  intradermal	  injection	  of	  IL-­‐1	  and	  TNFα	  induce	  a	  rapid	  increase	  in	  both	  CCL20	  and	  CCR6	  mRNA	  in	  mouse	  epidermal	  keratinocytes	  338.	  While	  the	  administration	  of	  IL-­‐10	  suppresses	  the	  expression	  of	  CCL20	  and	  reduces	  the	  number	  of	  dendritic	  cells	  in	  human	  papilloma	  virus	  infected	  cervix	  tissues	  339.	  CCL20	  levels	  increase	  in	  the	  amniotic	  fluid	  (AF)	  with	  the	  gestational	  age	  and	  are	  higher	  in	  spontaneous	  labour	  and	  in	  patients	  with	   intra-­‐amniotic	   infection/inflammation	   182.	   Myometrial	   gene	   array	   studies	   found	  that	   CCL20	   expression	   is	   greater	   in	   samples	   from	   woman	   in	   labour	   at	   term	   167	   and	  similar	   results	  were	   found	   in	   labouring	   chorioamniotic	  membranes	  at	   term	   340.	   In	   this	  chapter	   I	   have	   investigated	   the	   expression	   and	   regulation	   of	   CCR6	   in	   human	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7.2	  Results	  
7.2.1	  Human	  myometrial	  expression	  of	  CCR6	  in	  pregnancy	  and	  labour	  Myometrial	  chemokine	  receptors	  CCR6	  decreased	   in	   term	   labour	  (TL)	  when	  compared	  to	  term	  non-­‐labour	  in	  both	  upper	  and	  lower	  segment	  myometrium	  (p<0.05,	  Figure	  7.1).	  	  
	  




















































Figure 7.1 Expression of human myometrial CCR6   
Paired upper and lower segment human myometrial samples were obtained from four groups of women (mean 
gestational age ± SD in each case), at preterm no labour (PTNL; 31.5 ± 3.5 wks; mean ± SD; n=8), PTL (32.3 ± 
4.1 wks; n=8), term no labour (TNL; 38.0 ± 1.2 wks; n=8) or TL (39.4 ± 0.5 wks; n=8). See table 2.3 for details 
regarding phenotypes of these samples. Messenger RNA expression was measured by quantitative rtPCR. There 
is a decrease of CCR6 in lower segment myometrium at term labour when compare to preterm labour. n=8 for 
this experiment. Comparisons were made between groups using a Mann Whitney test for non-parametric data 
and a t test for parametric data. Data were presented as median with interquartile range. * indicates a significant 
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Figure 7.2 The regulations of human myometrial CCR6   
a-c: Human myometrial cells were 1) exposed to 16% stretch for 0, 1, 3 and 6 hours; 2) incubated with or 
without 1ng/mL IL-1β, TNFα or CXCL8, 10nM PGE2, PGF2α  and 100nM oxytocin for 1, 6 and 24 
hours. At the end of incubation RNA was extracted and converted to cDNA. Copy numbers of CCR6 
mRNA were measured by quantitative rtPCR. CCR6 mRNA was increased by IL-1β, decreased by PGF2α 
and oxytocin. n=6 for this experiment, data analysed using ANOVA Test if data distribution was 
parametric, and Friedman’s Test if data distribution was non-parametric, with a Dunn's Multiple 
Comparisons post test. Data were presented as Min and Max. * indicates a significant difference of 
p<0.05, ** indicates a significant difference of p<0.01. 
d: Human myometrial cells were incubated with or without 1ng/mL IL-1β, TNFα or CXCL-8, 10nM 
PGE2, PGF2α  and 100nM oxytocin for 1, 6 and 24 hours. At the end of incubation protein was extracted. 
Protein expression of CCR6 was measured by Western blot. n=4 for this experiment, densitometry was 
measured and analysed using Friedman test was used with Dunn's Multiple Comparisons post hoc test.  
p<0.05 at 1 and 6 hours and p<0.01 at 24 hours with oxytocin treatment. Data are shown as madian with 
interquartile range, and * indicates p<0.05. ** indicates p<0.01. 
e: Human myometrial cells were pre-incubated with oxytocin for 0 and 24 hours. Cells were collected, 
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7.2.3	  PGF2α	  and	  oxytocin	  down-­‐regulation	  of	  human	  myometrial	  CCR6	  
























































































	  	  	  


















































































Figure 7.3 PGF2α and oxytocin down-regulation of human myometrial CCR6 mRNA expression via PLC 
Human myometrial cells were incubated with or without 10nM PGF2α, 100nM oxytocin, PGF2α+PLC inhibitor 
or oxytocin+ PLC inhibitor for 6 and 24 hours. At the end of incubation mRNA was extracted and converted to 
cDNA. Copy numbers of CCR6 mRNA were measured by quantitative rtPCR. n=6 for this experiment, data 
analysed using ANOVA Test if data distribution was parametric, and Friedman’s Test if data distribution was 
non-parametric, with a Dunn's Multiple Comparisons post hoc test. Data are shown as the median, the 25th and 
75th percentiles and the range, and * indicates CCR6 down regulated by PGF2a or oxytocin, p<0.05. # indicates 
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Figure 7.4 The effect of CCL20 on other myometrial chemokines 
Human myometrial cells were incubated with 1ng/ml, 10ng/ml and 100ng/ml CCL20 for 6 and 24 
hours. Cells were harvested and RNA were extracted and converted into cDNA. The levels of 
chemokines were measured afterwards by rtPCR. The treatment of IL-1β was used as a positive control 
to this experiment. At 6 hours, 100ng/ml of CCL20 increased the expression of CXCL5. At 24 hours, 
both CCL2 and CCL5 were increased with the three different concentrations of CCL20. n=6 for this 
experiment, data analyzed using ANOVA Test with a Dunn's Multiple Comparisons post hoc test. Data 
are shown as the median with interquartile range, and * indicates p<0.05, ** indicates p<0.01, *** 
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7.2.5	  Time	  of	  delivery	  after	  LPS	  treatment	  and	  pup	  outcomes	  of	  CCR6-­‐/-­‐	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Figure 7.5 Time of delivery and pup outcome of CCR6-/- mice.  
a: After intrauterine LPS injection, CCR6-/- mothers had preterm delivery when compared to PBS injected 
control ones. b: Compared to CD1 wild type mice with intrauterine LPS injection, CCR6-/- mothers had a 20±9 
hours longer delivery time. Data were analyzed using unpaired T test. n=6 for this experiment. Data were 
presented as mean with SEM. * indicates a significant difference of  p<0.05, ** indicates p<0.01.     
c-d: LPS treated CCR6-/- mice had 26% alive pups and 74% dead pups, when all the CD1 pups were dead 
during labour (Chi-square p<0.001). 
7.2.6	  Myometrial	  chemokine	  and	  cytokine	  expression	  of	  LPS	  treated	  CCR6-­‐
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Figure 7.6 Myometrial chemokine and cytokine expressions in CCR6-/- mice.  
Both CD1 and CCR6-/- mice were given intrauterine injection of LPS or PBS. At the time of labour post-op, 
animals were sacrificed and left horn myometrium was harvested and snap frozen at -70°C. RNA was extracted 
and converted into cDNA. In left horn uterus of CCR6-/- mice, CCL5 is increased after LPS treatment during 
labour. Compared to CD1, myometrial expression of CCL2 and IL-6 were lower in CCR6-/- mice. Data were 
analyzed using unpaired t test. n=6 for this experiment. Data were presented as Mean with SEM. * indicates a 
significant difference of p<0.05. 	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Figure 7.7 Plasma IL-6 in CCR6-/- mice.  
There was no difference of IL-6 in CCR6-/- and CD1 mice at NP, E6 and E16. After LPS injection, the level of 
plasma IL-6 was increased in CCR6-/- mice compared with PBS control. The level was also lower in LPS treated 
CCR6-/- mice when compared with LPS treated CD1 ones. Data were analyzed using unpaired T test. n=6 for 
this experiment. Data were presented as Mean with SEM. ** indicates a significant difference of p<0.01, *** 
indicates p<0.001 when LPS treated CCR6-/- mice are compared with PBS control. $$$ indicates p<0.001 when 
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7.3	  Discussion	  
In	   an	   earlier	   chapter,	   I	   found	   that	   human	   myometrial	   CCL20	   mRNA	   expression	   was	  increased	   in	   the	   lower	   segment	   in	   women	   in	   preterm	   labour.	   In	   this	   chapter,	   I	  demonstrated	  that	   in	  human	  myometrium,	  CCR6	  mRNA	  expression	  was	  reduced	  in	  the	  upper	  and	  lower	  uterine	  segments	  in	  term	  labour.	  CCR6	  expression	  was	  not	  changed	  by	  myometrial	  cell	  stretch	  and	  inflammatory	  cytokines	  generally	  had	  no	  effect,	  although	  IL-­‐1β	  treatment	  did	  result	  in	  a	  transient	  increase	  in	  CCR6	  mRNA	  expression	  at	  1	  hour.	   	  In	  contrast,	  treatment	  with	  oxytocin	  resulted	  in	  a	  marked	  down	  regulation	  of	  CCR6	  mRNA	  expression	  and	  this	  effect	  was	  mediated	  via	  the	  PLC	  pathway.	  Since	  CCR6	  is	  expressed	  on	  myometrial	  cells	  I	  investigated	  the	  effect	  of	  CCL20	  on	  myometrial	  chemokine	  expression	  and	   found	   that	   CCL20	   treatment	   increased	   the	   expression	   of	   both	   CCL5	   and	   CCL2,	  suggesting	   that	   CCL20	   may	   influence	   myometrial	   cell	   function	   as	   well	   as	   acting	   as	   a	  chemokine	  to	  inflammatory	  cells.	  Given	  the	  specific	  changes	  in	  CCL20	  and	  CCR6,	  I	  then	  used	  the	  CCR6	  KO	  mouse	  to	  study	  the	  response	  to	  LPS.	  PTL	  was	  delayed	  in	  the	  CCR6-­‐/-­‐	  mouse,	  with	  improved	  pup	  survival.	  These	  changes	  were	  associated	  with	  a	  less	  marked	  inflammatory	  change	  in	  the	  myometrium	  and	  maternal	  circulation.	  
Normal	  labour	  is	  an	  inflammatory	  process	  with	  large	  numbers	  of	  leukocytes	  infiltrating	  the	  myometrium.	   It	   is	   clear	   from	  previous	  studies	   that	  CCL20/CCR6	  axis	  has	  a	  critical,	  non-­‐redundant	   role	   in	   the	   control	   of	   immune	   response	   by	   regulating	   the	  migration	   of	  immature	   DCs	   and	   lymphocytes271	   and	   in	   a	   previous	   chapter	   I	   found	   the	   CCL20	  increased	  at	  preterm	  labour	  in	  lower	  segment	  myometrium	  suggesting	  that	  it	  may	  have	  a	   role	   in	   the	   inflammatory	   infiltration	   of	   the	   myometrium	   that	   occurs	   in	   labour.	  Interestingly,	  its	  receptor	  CCR6	  showed	  no	  change	  in	  preterm	  labour	  and	  a	  decrease	  at	  term	  labour	  in	  both	  upper	  and	  lower	  segment	  myometrium.	  Chemokine	  receptors,	  which	  are	  structurally	  identical	  to	  signaling	  receptors	  but	  which	  do	  not	  transduce	  an	  activation	  signal,	   were	   termed	   “decoy”	   receptors	   and	   act	   to	   bind	   and	   sequester	   chemokines	   344.	  CCR6	  on	  B	  cells	  has	  been	  shown	  to	  behave	  as	  a	  decoy	  receptor	  271.	  If	  myometrial	  CCR6	  behaved	   in	   this	   manner,	   a	   reduction	   in	   expression	   at	   term	   would	   result	   in	   greater	  amounts	   of	   free	   CCL20,	   which	   could	   promote	   the	   inflammatory	   infiltration	   of	   the	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myometrium.	  The	  labour-­‐associated	  decline	  seems	  to	  be	  induced	  by	  the	  combination	  of	  prostaglandins	  and	  oxytocin	  acting	  via	  PLC.	  	  
Primary	   cultured	   myometrial	   cells	   can	   produce	   CCL20.	   Myometrial	   CCL20	   mRNA	  expression	   increased	  with	   advancing	   gestation	   and	   again	  with	   the	   onset	   of	   labour.	   In	  other	  cell	  types,	  CCL20	  increased	  CXCL8	  synthesis,	  and	  in	  this	  chapter	  I	  found	  that	  CCL20	  increased	   CCL5,	   CCL2	   and	   CXCL8	   expression,	   suggesting	   that	   CCL20	   may	   have	   other	  functions	  other	  than	  acting	  as	  a	  chemokine	  and	  raising	  the	  possibility	  that	  chemokines	  in	  general	  may	  modulate	  myometrial	  function.	  	  
In	   the	  CCR6-­‐/-­‐	  studies,	   I	  observed	  that	  LPS-­‐induced	  preterm	  delivery	  was	  delayed	  and	  pup	   survival	   improved.	   Similarly,	   in	   a	   mouse	   model	   of	   LPS	   induced	   peritonitis,	   the	  deletion	  of	  CCR6	  caused	   lower	  chemokine	  and	  cytokine	  expression	  and	  was	  associated	  with	   an	   improved	   outcome.	   The	   number	   of	   monocytes	   and	   dendritic	   cells	   were	   also	  lower	  in	  CCR6-­‐/-­‐	  mice	  compared	  to	  wild	  type274.	  My	  results	  agree	  with	  this	  study	  and	  the	  decreased	  chemokine	  and	  cytokine	  levels	  in	  both	  myometrium	  and	  plasma	  suggest	  that	  CCL20/CCR6	   has	   an	   important	   role	   in	   LPS-­‐induced	   parturition	   and	   may	   suggest	   a	  potential	   role	   for	   CCR6	   antagonists	   in	   the	   management	   of	   human	   PTL	   and	  chorioamnionitis.	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8.1	  Final	  summary	  and	  discussion	  
Preterm	  delivery	  is	  a	  critical	  problem,	  which	  is	  the	  most	  important	  cause	  of	  prenatal	  mortality	   and	   morbidity.	   To	   date,	   the	   clinical	   management	   of	   preterm	   labour	   is	  limited	   and	   relatively	   unsuccessful	   in	   terms	   of	   improving	   neonatal	   outcomes.	  Recently,	   human	   labour	   has	   been	   discovered	   to	   be	   associated	   with	   a	   marked	  leukocyte	  infiltration	  into	  myometrium.	  As	  a	  key	  mediators	  of	  leukocyte	  trafficking,	  chemokines	   are	   very	   likely	   to	   play	   a	   role	   in	   this	   inflammatory	   process,	   indeed,	  myometrial	   expression	   increases	   in	   term	   labour167.	   Therefore,	   the	   studies	   in	   this	  thesis	  focus	  on	  the	  expression	  and	  regulation	  of	  chemokine/chemokine	  receptors	  in	  human	  myometrial	  cells	  as	  well	  as	  their	  role	  in	  the	  inflammatory	  infiltration	  of	  the	  myometrium	  associated	  with	  labour.	  	  
In	   the	   studies	   of	   chemokine	   expression	   and	   regulation	   in	   human	  myometrium,	   I	  found	  that	  chemokines	  CCL2,	  CCL5,	  CCL20,	  CXCL1,	  CXCL5	  and	  CXCL8	  are	  increased	  in	  human	  labour	  and	  also	  with	  the	  advancing	  gestational	  age.	  However,	  I	  observed	  different	  patterns	  of	  increase	  in	  chemokine	  expression	  in	  upper	  and	  lower	  segment	  myometrium,	   preterm	   and	   term	   labour,	   which	   suggest	   potentially	   different	   roles	  (inducing	  contraction,	  remodeling)	   in	  human	   labour	  as	  well	  as	  attracting	  different	  subtypes	   of	   leukocytes.	   These	   changes	   may	   be	   driven	   by	   inflammation	   and	  mechanical	   stretch	   since	   in	   myometrial	   cultures,	   stretch,	   IL-­‐1β	   and	   TNFα	   all	  increased	  chemokine	  expression	  via	  both	  NF-­‐κB	  and	  MAPK	  pathways.	   In	  contrast,	  the	   pro-­‐labour	   factors,	   PGF2α	  and	   oxytocin,	   reduced	   the	   expression	   of	  myometrial	  chemokines.	   These	   data	   suggest	   that	  myometrial	   chemokine	   expression	   increases	  before	   the	   onset	   of	   human	   labour,	   potentially	   in	   response	   to	   stretch	   and/or	  inflammatory	  cytokines	  and	  may	  therefore	  play	  an	   important	  role	   in	   its	  onset	  and	  progression.	   Increased	   chemokine	   expression	   first	   followed	   by	   an	   influx	   of	  inflammatory	   cells,	  which	   then	   increase	   local	   cytokine	   levels.	   These	   inflammatory	  cytokines	  may	  then	  act	  to	  increase	  myometrial	  contractility	  directly	  and/or	  through	  increased	  PG	  synthesis.	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In	   contrast	   to	   the	   behaviour	   of	   the	   chemokines,	   the	   chemokine	   receptors	   CCR2,	  CXCR1	   and	   CXCR2	   behave	   differently	   in	   human	  myometrium.	   Their	   expression	   is	  not	   affected	   by	   preterm	   labour,	   but	   reduced	   in	   term	   labour	   samples.	   Some	  chemokine	  receptors	  act	  as	  decoys,	  for	  example	  the	  CCR6	  receptor	  on	  lymphocytes,	  it	  is	  possible	  that	  myometrial	  chemokine	  receptors	  have	  this	  role,	  however	  there	  is	  no	   evidence	   to	   support	   this.	   The	   alternative	   is	   that	   the	   receptors	   are	   functional,	  mediating	   the	  effects	  of	   chemokines	  on	  myometrial	   cell	   function.	  Certainly,	   I	  have	  shown	   that	   both	   CCL20	   and	   CXCL8	   affect	   myometrial	   cell	   function.	   	   Chemokine	  receptor	  expression	  is	  minimally	  modulated	  by	  stretch	  and	  cytokines,	  but	  markedly	  down-­‐regulated	  by	  oxytocin,	  suggesting	  that	  the	  labour-­‐induced	  decline	  is	  primarily	  mediated	   through	   oxytocin.	   However,	   in	   the	   case	   of	   CXCR2,	   I	   found	   a	   negative	  association	  with	  CXCL8	  expression	  in	  myometrial	  tissues	  and	  in	  vitro,	  CXCL8	  down-­‐regulated	   myometrial	   CXCR2	   expression	   suggesting	   that	   in	   the	   case	   of	   CXCR2,	  CXCL8	  may	   also	   have	   a	   role	   in	   its	   reduction	   in	   labouring	   samples.	   This	   reduction	  with	   labour	  would	   favour	   the	   idea	   of	   the	  myometrial	   receptors	   acting	   as	   decoys,	  limiting	  the	  effect	  of	  locally	  released	  chemokines.	  	  
In	  order	   to	  better	  understand	   the	   role	  played	  by	   chemokines	  during	   spontaneous	  and	   LPS-­‐induced	   labour,	   I	   studied	   three	  mice	   genotypes	   (wild	   type,	   CCR2-­‐/-­‐	   and	  CCR6-­‐/-­‐).	  In	  wild	  type	  mice,	  I	  found	  that	  myometrial	  chemokine	  expression	  initially	  declined	  at	  E6,	  but	   then	   increased	  during	  pregnancy,	  resulting	   increased	  densities	  of	   monocytes,	   macrophages	   and	   neutrophils	   in	   the	   myometrium.	   LPS	   induced	   a	  marked	   increased	   inflammation	   in	   the	   myometrium	   as	   well	   as	   in	   the	   placenta,	  which	   caused	   a	   preterm	   delivery	   and	   was	   associated	   with	   pup	   death.	   	   The	  intrauterine	   injection	   and	   laparotomy	   procedure	   caused	   a	   systemic	   and	   local	  inflammatory	   reaction,	   as	   shown	   by	   the	   increased	   circulating	   levels	   of	   IL-­‐6	   and	  higher	  IL-­‐6	  in	  plasma	  of	  PBS	  group.	  This	  will	  cause	  the	  limitation	  of	  the	  use	  of	  this	  model.	  Therefore,	  the	  IVT	  methods	  will	  be	  worth	  to	  be	  developed	  in	  this	  study.	  	  	  	  	  
However,	   CCR2-­‐/-­‐	   showed	   limited	   changes	   in	   chemokine	   expression	   during	  pregnancy	  and	  the	  myometrial	   leucocyte	   infiltration	  was	  generally	   less	   in	  CCR2-­‐/-­‐	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mice,	   with	   the	   exception	   of	   a	   higher	   neutrophil	   count.	   An	   LPS	   induced	   preterm	  delivery	  mouse	  model	  was	  used	  in	  all	  of	  three	  genotypes.	  In	  wild	  type	  mice,	  10mg	  intrauterine	   LPS	   injection	   on	   E16	   caused	   preterm	   delivery	   and	   100%	   fetal	   death	  within	   14	   hours	   of	   the	   treatment.	   LPS	   induced	  markedly	   increase	   of	   chemokines	  and	  cytokines	  in	  the	  myometrium	  and	  placenta	  with	  activation	  of	  NF-­‐κB	  and	  MAPK	  pathways.	   	   The	  CCR2	  knockout	   did	   not	   delayed	   LPS	   induced	  preterm	   labour.	   The	  basal	   chemokine	   CCL2,	   CCL5	   levels	   in	   CCR2-­‐/-­‐	  myometrium	  were	   higher	   than	   in	  CD1	   mice;	   this	   may	   be	   a	   result	   of	   the	   loss	   of	   CCR2	   and	   so	   the	   usual	   negative	  feedback.	  The	  greater	  neutrophil	  infiltration,	  which	  have	  compensated	  for	  the	  lower	  levels	  of	  other	  leucocytes.	  However,	  generally,	  Despite	  the	  greater	  neutrophils,	  the	  cytokine	  levels	  were	  relatively	  lower	  in	  the	  CCR2-­‐/-­‐	  mice.	  The	  deletion	  of	  CCR2	  was	  associated	   with	   lower	   phosphorylation	   of	   p65	   and	   c-­‐jun	   after	   LPS	   treatment.	  However,	   the	  phosphorylated	  ERK	  is	  higher	   in	  CCR2-­‐/-­‐	  myometrium	  and	  this	  may	  be	   associated	  with	   the	   increased	   chemokine	   levels	   and	   neutrophils.	   Furthermore,	  the	   inflammation	   in	   CCR2-­‐/-­‐	   placentae	   was	   much	   lower	   than	   in	   wild	   type	   mice,	  which	   may	   explain	   the	   improved	   pup	   survival.	   These	   results	   suggested	   an	  important	  role	  of	  the	  deletion	  of	  CCR2	  in	  blocking	  the	  maternal-­‐fetal	  inflammatory	  response	  to	  LPS.	  
Because	  of	  the	  importance	  of	  dendritic	  cells	  in	  the	  immune	  system,	  a	  further	  study	  of	   CCL20/CCR6	   axis,	   which	   is	   a	   key	   regulator	   of	   dendritic	   cell	   trafficking,	   was	  performed.	  Human	  myometrial	  CCR6	  expression	  behaved	  in	  a	  similar	  manner	  to	  the	  other	  chemokine	  receptors	  and	  was	  down	  regulated	  by	  PGs	  and	  oxytocin	  via	  PLC.	  CCL20	   has	   an	   effect	   of	   inducing	   the	   expression	   of	   other	   chemokines	   in	   human	  myometrium.	  According	  to	  my	  preliminary	  studies,	  compared	  to	  wild	  type	  mice,	  the	  LPS	   induced	  preterm	   labour	  was	  delayed	  and	  pup	  survival	  was	   improved	  as	  well.	  The	   inflammation	   in	   myometrium	   and	   plasma	   are	   all	   much	   lower	   than	   the	   wild	  types.	  These	  data	  suggest	  an	  important	  role	  of	  CCL20/CCR6	  system	  in	  regulating	  the	  LPS	  induced	  inflammation.	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In	   conclusion,	  my	   results	   suggested	   that	   chemokines/chemokine	   receptors	  have	  a	  role	   in	   the	  process	  of	   labour.	  CCL20/CCR6	  plays	  a	  major	  role	   in	   the	   inflammatory	  response	  and	   its	   inhibition	  may	  be	  an	  effective	   treatment	  of	  preterm	   labour,	  both	  inhibiting	  labour	  and	  improving	  neonatal	  outcomes.	  Although	  CCR2	  knockdown	  did	  improve	   fetal	   survival,	   but	   the	   effects	   were	   less	   marked	   than	   found	   with	   CCR6	  knockdown.	  	  
8.2	  Future	  work	  
The	  future	  work	  will	  be:	  
1) Investigation	   the	   changes	   of	   different	   leukocytes	   subtype	   in	   human	  myometrium	  through	  gestation	  and	  labour.	  	  2) The	   effect	   of	   LPS/PBS	   on	   the	   inflammatory	   cells	   (ie,	  monocytes/macrophages,	  dendritic	  cells	  and	  neutrophils)	  infiltration	  of	  CD1,	  CCR2-­‐/-­‐	   and	   CCR6-­‐/-­‐	   mice,	   as	   in	   myometrium,	   placenta	   and	   pup	   brain	   at	  different	  time	  points	  (ie.	  3h,	  7h	  and	  in	  labour).	  3) Investigation	   of	   other	   potential	   pathways	   regulating	   the	   migration	   of	  CCL2/CCR2	  drived	  cells	  (ie.	  CSF-­‐1	  pathways)	  	  4) Behavioural	   test	   on	   CD1,	   CCR2-­‐/-­‐	   and	   CCR6-­‐/-­‐	   survived	   pups	   in	   order	   to	  investigate	  and	  compare	  the	  damage	  caused	  by	  maternal	  inflammatory,	  and	  how	  the	  deletion	  of	  CCR2	  and	  CCR6	  protect	  pup	  brain	  damage.	  5) Longitudinal	  chemokine	  expression	  in	  CCR6-­‐/-­‐	  myometrium.	  	  6) The	   effect	   of	   LPS/PBS	   on	   CCR6-­‐/-­‐	   (myometrium,	   placenta,	   pup	   brain)	   in	  different	  time	  points.	  7) Investigate	   the	   possibility	   of	   using	   CCR2	   and/or	   CCR6	   antagonist	   to	   stop	  prematurity.	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Appendices	  
Appendix 1 Chemokine expression in prolonged cell culture at 6,24 and 54 hours 
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Appendix 3 Chemokine receptor expression in prolonged cell culture 
1h 6h 24
h 1h 6h 24
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